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Abstract 
This work described in this thesis investigated the role of the sarcoplasmic reticulum (SR) 
in the regulation of normal mechanical function of the isolated heart, with the focus of the 
work resting on the Ca2+ release channel, the ryanodine receptor (RyR) and the SR Ca2+ 
pump, the sarco-endoplasmic reticulum Ca2+ ATPase (SERCA).  This was performed by 
characterising left ventricular mechanical function in an isolated working heart model in 
the face of pharmacological manipulation of the above intracellular SR proteins.  The 
following were the aims of this project. 
1.  Characterisation of ex vivo working heart left ventricular mechanical function using 
miniaturised single and multi-segment pressure-conductance technology 
2.  Characterisation of working heart mechanical function under conditions where SR Ca2+ 
cycling is altered; i) perfusion with elevated [Ca2+]o and β-adrenergic stimulation to induce 
SR Ca2+ loading and ii) in a rabbit coronary artery ligation model of left ventricular 
dysfunction.  Following this, the influence of acute perfusion of the compound K201 in 
healthy hearts and in the above experimental conditions was investigated. 
3.  Investigation of the specific contribution of SR Ca2+ uptake to normal left ventricular 
contractility and relaxation by specific pharmacological blockade of SERCA in the isolated 
working heart. 
     
Hearts from male New Zealand White rabbits were cannulated via the aorta and a 
pulmonary vein ostium and perfused in working heart mode.  Contractile function and 
changes in left ventricular volume during the cardiac cycle were assessed using a 3F 
pressure-conductance catheter inserted into the left ventricle via the aorta.  The isolated 
working heart was found to produce a maximal stroke volume under identical loading 
conditions and and pacing frequency using a volume of air within the compliance chamber 
of 15 ml of air.  Using an atrial filling pressure of 7.4 mmHg and an afterload of 60 mmHg 
the preparation was also found to have stable function in working mode for 60 – 90 min 
with <10% decline in cardiac output. 
 
To assess the effect of the compound K201 on cardiac mechanical function isolated 
working hearts were perfused with increasing concentrations of K201 (0.3, 1.0 and 3.0) for 
4 min at each concentration.  When normalised to control hearts paced at equivalent rates 
0.3 µM K201 led to a significant increase in end diastolic pressure (EDP) but did not alter 
other indices of mechanical function.  1.0 μΜ and 3.0 μΜ K201 led to a significant decline 
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in left ventricular peak pressure and dP/dtmax, impairment of relaxation (reduced dP/dtmin, 
increased EDP and τ) and a depression of heart rate and stroke volume.  At 3.0 μΜ 
depression of mechanical function was of a sufficient extent as to cause cessation of 
forward flow (aortic flow) in 3 of the 8 hearts studied.  In a subset of experiments where 
heart rate was kept constant via electrical stimulation of the right atrium, exposure to 1.0 
μΜ K201 led to a decline in mechanical function that was of a similar degree to that of 
unpaced hearts.    
 
High Ca2+ loading conditions were simulated by raising [Ca2+]o from 2.5 mM to 4.5 mM, 
followed after 5 min by addition of 150 nM isoproterenol (ISO).  Increasing [Ca2+]o led to 
a sustained increase in stroke volume and systolic function (dP/dtmax and peak systolic 
pressure) with no steady state change in dP/dtmin or end diastolic pressure.  Addition of ISO 
led to a transient improvement in all indices of mechanical function lasting approximately 
20s.  In hearts perfused with 4.5 mM [Ca2+]o and ISO only (n=11) mechanical function 
declined thereafter such that by 600s post-ISO addition aortic flow had ceased in all but 5 
of the 11 hearts in this group.  In contrast, hearts perfused with 1.0 µM K201 30s after 
addition of ISO (n=9) all maintained aortic flow and demonstrated significantly improved 
peak systolic pressure, dP/dtmax and dP/dtmin at 600s post-ISO in comparison to hearts not 
perfused with K201.  In addition, mean inter-peak interval variability determined from left 
ventricular pressure recordings (used as an index of arrhythmicity) was significantly lower 
in K201 treated hearts 600s post-ISO addition in comparison to non-treated hearts.  K201 
also led to a preservation of left ventricular peak pressure and stroke volume when applied 
300s post-ISO.  Despite being detrimental to mechanical function in healthy hearts K201 
preserved function in a pharmacological model of high calcium loading. 
 
Left ventricular dysfunction was surgically induced in rabbits by coronary artery ligation.  
Ex vivo mechanical function was assessed 8 weeks post-op using a 3 segment multi-
segmental pressure-conductance catheter inserted into the left ventricle with each segment 
delineating 3 discrete functional regions within the ventricular chamber; apex, mid and 
base.  Hearts were paced at 200 beats.min-1 throughout.  8 week ligation hearts exhibited a 
significantly reduced ejection fraction and higher end systolic volumes in comparison to 
sham operated controls.  Assessment of regional mechanical function in 8 week ligation 
hearts revealed that a significantly greater proportion of total stroke volume and stroke 
work was performed by the mid segment vs. the apex, while regional function was similar 
between all segments in the sham operated controls. Treatment with 1.0 µM K201 led to a 
decline in systolic function and impairment of relaxation (decreased dP/dtmin and increased 
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τ) in sham operated control hearts similar to that shown in chapter 3.  In contrast, aside 
from dP/dtmax which was significantly reduced from baseline, K201 had no significant 
effect on mechanical function in 8 week ligation hearts.  No region specific effects of K201 
were detected, as the percentage contribution of each region to total stroke volume and 
stroke work remained unchanged in both groups after treatment with K201.  The effects of 
K201 on mechanical function in hearts with left ventricular dysfunction appear to be 
altered in comparison to both healthy and sham operated hearts.      
 
SR Ca2+ uptake was inhibited in an isolated working rabbit heart model using the specific 
pharmacological SERCA2a inhibitor thapsigargin (TG).  Hearts were paced at 220 
beats.min throughout the investigation.  The experimental endpoint for TG treated hearts 
was reached when hearts no longer produced an aortic flow.  Hearts perfused in working 
heart mode with the thapsigargin vehicle for 60 min acted as controls.  At the end of each 
experiment left ventricular tissue samples were homogenised in a protease-phosphatase 
inhibitor cocktail and stored for subsequent analysis.  A significant decline in systolic and 
diastolic functional parameters was evident 5 min after addition of TG, with no significant 
changes demonstrable in the vehicle control group at this timepoint.  In TG treated hearts 
function had declined even further by the endpoint.  In a subset of TG treated hearts end 
systolic and end diastolic volumes were shown to decline over time, indicative of impaired 
left ventricular filling and diastolic abnormalities.  Analysis of SERCA uptake by Elliott et 
al. (2009) using tissue homogenates from the current investigation revealed that at the time 
of aortic flow cessation SERCA activity was < 10 %, suggesting that SR Ca2+ uptake may 
decrease to very low levels before working heart function fails.             
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Definitions/Abbreviations 
AP     Action potential 
APD     Action potential duration 
ATP     Adenosine triphosphate 
ATPase     Adenosine triphosphatase 
Ba2+     Barium ion 
C-terminal    Carboxy-terminal 
Ca2+     Calcium ion 
Ca2+ ATPase    Calcium pump 
CaMKII    Ca2+/Calmodulin-dependent protein kinase II 
cAMP     cyclic adenosine monophosphate 
CCh     carbachol chloride 
CICR     Calcium-induced calcium release 
COS-1     CV-1 (simian) cell line containing SV-40 genetic material 
CPA     Cyclopiazonic acid 
CPK     Creatine phosphokinase 
CPVT     Catecholaminergic polymorphic ventricular tachycardia 
DAD     Delayed afterdepolarisation 
DIDS     4,4’-diisothiocyanatostilbene-2,2’-disulfonic acid 
DKO     double knockout 
DM-Nitrophen    1-(2-Nitro-4,5-dimethoxyphenyl)-1,2-diaminoethane- 
     N,N,N,’,N’-tetraacetic acid 
DMSO     Dimethyl sulfoxide 
dP/dtmax    Maximum rate of left ventricular pressure rise 
dP/dtmin     Maximum rate of left ventricular pressure fall 
EC coupling    Excitation-contraction coupling 
EDP     End diastolic pressure 
EDPVR    End diastolic pressure-volume relationship 
EDV     End diastolic volume 
EF     Ejection fraction 
EGTA     Ethyleneglycol-bis(β-aminoethyl)-N,N,N’,N’-tetraacetic  
     acid 
Em     Membrane potential 
ESPVR     End systolic pressure-volume relationship 
ESV     End systolic volume 
FKBP12    FK506 binding protein (12 kDa) 
FKBP12.6    FK506 binding protein (12.6 kDa) 
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HR     Heart rate 
IAA     Iodoacetate 
IR     Ischaemia-reperfusion 
ISO     Isoproterenol 
K+     Potassium ion 
KCa     Calcium dissociation constant 
LDH     Lactate dehydrogenase 
Li+     Lithium ion 
LTCC     L-type Ca2+ channel 
LV     Left ventricular 
LVDP     Left ventricular developed pressure 
LVEDP    Left ventricular end diastolic pressure 
MI     Myocardial infarction 
mM     Millimolar (concentration) 
MPTP     Mitochondrial permeability transition pore 
mRNA     Messenger ribonucleic acid 
Na+     Sodium ion 
NCX     Na+/Ca2+ exchanger 
NHE     Na+/H+ exchanger 
Ni+     Nickel ion      
nM     Nanomolar (concentration) 
NO     Nitric oxide 
NOS     Nitric oxide synthase 
pCa     -log [Ca2+] 
PCr     Phosphocreatine 
Pi     Inorganic phosphate 
PKA     Protein kinase A 
PKC     Protein kinase C 
PKC-δ     Delta-isoform of protein kinase C 
PLB     Phospholamban 
PMCA     Plasma membrane Ca2+ ATPase 
Po     Open probability 
PSP     Peak systolic pressure 
RyR     Ryanodine receptor 
RyR2     Cardiac ryanodine receptor 
SEM     Standard error of the mean 
SERCA    Sarco-endoplasmic reticulum Ca2+ ATPase 
SR     Sarcoplasmic reticulum 
SV     Stroke volume 
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TBQ     2,5-Di(tert-butyl)-1,4-Benzohydroquinone 
TG     Thapsigargin 
TnC     Troponin C 
TnI     Troponin I 
TnG     Transgenic 
T-tubule    Transverse tubule 
VLA     Ventricular long axis 
Vmax     Maximum velocity 
VSL     Variable segment length 
WT     Wild type 
µM     Micromolar (concentration) 
ºC     Degree Celcius 
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1.1 Excitation-Contraction Coupling 
In life the heart is responsible for the continuous flow of blood throughout the body, 
allowing transport of vital nutrients, hormones, signalling factors etc. to and from the 
tissues of the body.  During the normal cardiac cycle the chambers of the heart contract 
and relax in a tightly regulated fashion in order to pump blood as efficiently as possible.  
The millions of cardiac myocytes which comprise the chambers of the heart are tightly 
coupled to one another forming a functional syncytium which allows electrical activation 
of the heart, beginning at the sino-atrial node, to spread quickly through the conduction 
system of the heart, resulting in near synchronous depolarisation and subsequent 
contraction of the atria and then the ventricles.  The heart is a complex organ however, 
with decades of research devoted to elucidating the underlying mechanisms which link 
electrical excitation of the cardiac tissue to activation of the myofilament machinery, a 
process known as excitation-contraction (EC) coupling.  It is now widely accepted that 
cardiac muscle is most likely activated by a process known as calcium-induced calcium 
release (CICR), described in detail by Fabiato using mechanically skinned canine 
cardiomyocytes (Fabiato, 1983; Fabiato, 1985).  Calcium ions are key second messengers 
in the mechanisms linking electrical excitation of the cardiac myocyte to contraction of the 
heart.  Regulation of Ca2+ cycling between the myoplasm, intracellular organelles and the 
extracellular space is critical for the control of heart rhythm and cardiac contractile force 
both in health and in cardiac disease states such as heart failure.    
 
The following chapter is intended to give the reader an introduction to a number of 
intracellular Ca2+-handling processes relevant to this thesis and from this attempt to 
address some of the key outstanding issues which will be discussed in the proceeding 
chapters.  While the complex nature of cardiac EC coupling does not allow discussion of 
each component to be given equal weighting this is not intended to suggest that certain 
elements are more important than others.  Rather this reflects the focus of the thesis and the 
subject matter which has been investigated and discussed in the forthcoming chapters.     
1.1.1  Calcium-Induced Calcium release 
Research over the past 30 years has provided more detailed insight into the specific 
processes involved in cardiac E-C coupling at the myocyte level.  Information is now 
available on the locations and relative contributions of specific ion transport mechanisms 
within the cardiac myocyte, as well as the regulation of specific transporters and release 
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channels by subsidiary proteins, small molecules and second messengers.  A schematic of 
the basic processes intrinsic to myocyte contraction and relaxation is shown in Figure 1.1.  
The cardiac action potential spreads as a wave of depolarization across the surface 
sarcolemma and down into surface membrane invaginations known as T-tubules.  
Depolarisation of voltage-sensitive Ca2+ channels located there triggers an influx of Ca2+ 
into the cell as an inward Ca2+ current (ICa).  This influx of Ca2+ in turn activates the 
release of a proportionately greater amount of Ca2+ from the sarcoplasmic reticulum in a 
process known as Ca2+-induced Ca2+ release.  This process is critical in determining the 
amount Ca2+ released and therefore the strength of contraction. 
 
 
Figure 1.1 Ca2+ dynamics within the ventricular myocyte.  Schematic representation of major Ca2+ 
transport fluxes within the myocyte, with inset showing time course of rabbit ventricular myocyte action 
potential (black line), intracellular Ca2+ transient (blue line) and contraction (red dashed line).  (ATP, 
ATPase; NCX, Na+/Ca2+ exchange; PLB, phospholamban; SR, sarcoplasmic reticulum; RyR, Ryanodine 
receptor).  (Figure taken from Bers (2002) Nature 415, 198-205). 
1.1.1.1 Ca2+ Influx via the L-Type Ca2+ channel 
The main source of trigger ICa for CICR originates from Ca2+ influx via L-type Ca2+ 
channels (LTCCs) which are located primarily in the T-tubule membrane in close 
proximity to the SR terminal cisternae (Carl et al., 1995).  Contribution of the T-type Ca2+ 
channels to EC coupling mechanisms in adult ventricular myocytes is believed to be 
negligible, with small to undetectable levels of T-type channel protein present in guinea-
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pig, rabbit and rat (Bers & Perez-Reyes, 1999).  ICa is dependent on membrane potential 
(Em), becoming activated at -40 mV and reaching a peak at approximately +10 mV, 
declining thereafter as the channel approaches its reversal potential at approximately +60 
mV (Beuckelmann & Wier, 1988).  This results in the appearance of a bell-shaped 
relationship between Em and peak ICa as is shown in Figure 1.3.  
  
 
Figure 1.2 Voltage dependence of ICa in cardiac muscle.  Both ICa (A(i)) and [Ca2+]i  (A(ii)) exhibit a bell-
shaped dependence on voltage (or Em).  B.  Despite the sigmoidal relationship between Em and charge 
movement, normalised ICa, intracellular Ca2+ transient and myocyte contraction all demonstrate a bell-shaped 
appearance in relation to Em illustrating that charge movement is not responsible for Ca2+-induced release of 
Ca2+ from the SR.  (Adapted from (A) Bueckelmann et al. (1988) J.Physiol. 405 233-255, and (B) Bers 
(2001) Excitation-Contraction coupling and Cardiac Contractile Force, 2nd edition, Kluwer Academic, 
Dortrecht, The Netherlands). 
 
The amount of Ca2+ entering the cell in most cases would not be sufficient to activate the 
myofilament contractile machinery as has been demonstrated in skinned cardiac myocyte 
preparations (Fabiato, 1983).  Data from intact myocytes predicts an estimated total Ca2+ 
influx into the cytosol of ~60 µmol/l cytosol for activation of a normal twitch in ventricular 
myocytes, corresponding to approximately 40 % of maximal developed force at 25-30ºC 
(Harrison & Bers, 1989).  Quantification of Ca2+ entry via LTCCs during the action 
potential has yielded estimates for rabbit ventricular myocytes between 21 and 25 µmol 
Ca/l cytosol (Yuan et al., 1996), however these values are thought to be an overestimation 
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as EGTA, a Ca2+ chelator, was present in the intracellular environment which may reduce 
Ca2+-dependent inactivation of  LTCCs (Bers & Perez-Reyes, 1999).  More physiological 
estimates for the total amount of Ca2+ entering during the action potential have been placed 
at ~12 µmol/l cytosol in rabbit ventricular myocytes (Puglisi et al., 1999).  Therefore, the 
Ca2+ required for activation of the myofilaments must come from a separate source.               
1.1.2 The Sarcoplasmic Reticulum 
The sarcoplasmic reticulum (SR) is an extensively networked, tubular organelle enclosed 
entirely within the intracellular space of the cardiac myocyte.  Its main function is the 
storage and release of calcium which is a requirement for normal contractile function of the 
heart.  In cardiac myocytes the sarcolemmal membrane and SR couple closely in junctions 
known as dyads.  Estimates suggest that in ventricular myocytes from rabbits, rats and 
mice the junctional couplings between the SR and T-tubules is 4 to 6 times greater than 
between the surface sarcolemma (Page & Surdyk-Droske, 1979).  Between species, 
distribution is not equal; in rabbit the fraction of sarcolemmal membrane involved in 
dyadic junctions (4.6 % surface sarcolemma, 20.6 % T-tubular) is lower in comparison to 
mice and rats (6.5-7.7 % surface sarcolemma, 40-48 % T-tubular), reflecting the species-
dependent differences in SR Ca2+ dependence for contraction (Bers, 1985; Page & Surdyk-
Droske, 1979).  In mammalian ventricular myocardium LTCCs located in the T-tubules are 
closely associated with large molecular weight proteins at the junctions between the SR 
and the sarcolemmal membrane, now known to be the SR Ca2+ release channel, the 
Ryanodine receptor. 
1.2 Structure of the Ryanodine receptor 
The cardiac ryanodine receptor exists as a large homotetrameric protein, consisting of 4 
identical subunits of molecular weight 565 kDa.  While three subtypes are known to exist 
in a variety of tissues, RyR2 is the predominant isoform in cardiac muscle.  Figure 1.3 
depicts a schematic representation of the RyR2 monomer.  Around 90% of the channel is 
located in the N-terminal region, described as the foot-process noted in early electron 
micrographic images, in which a large number of regulatory proteins, including 
calmodulin, FKBP12.6 (calstabin-2), protein phosphatases 1 and 2A and protein kinase A 
(PKA) bind and coordinate channel function (Yano et al., 2006).  The C-terminal, 
composed of 4-10 transmembrane domains, comprises the remaining 10% of the channel.  
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Figure 1.3 Schematic diagram of the cardiac RyR subunit.  The large N-terminal domain of RyR2 
contains binding sites for many regulatory proteins, including FKBP12.6, PKA, Calmodulin and protein 
phosphatases 1 and 2A.  (Diagram taken from Yano et al. (2006) Nat. Clin. Pract. 3(1) 43-52).  
1.2.1 Evidence for Ca2+- Induced Ca2+ release 
Fabiato demonstrated using skinned cardiac myocyte preparations that Ca2+ release from 
the SR and subsequently contraction could be induced by simulation of ICa using rapid Ca2+ 
application.  The trigger for Ca2+ release from the SR was shown to be a function of the 
rate of change of [free Ca2+]; rapid application induces SR Ca2+ release whereas slow 
gradual application only serves to load the SR (Fabiato, 1983).  This is in contrast to the 
charge-coupled release mechanism proposed for skeletal muscle, where Ca2+ release from 
the SR is dependent on charge movement (Melzer et al., 1986).  Support for CICR as the 
mechanism of SR Ca2+ release in cardiac muscle (versus a charge-coupled release 
mechanism) comes from several experimental observations; 1.  Buffering extracellular 
Ca2+ with 4 mM EGTA causes the LTCC to carry a large Na+ current, but while a 
measurable ionic current flows under these circumstances and there is charge movement 
due to LTCC activation, neither a [Ca2+]i transient nor contraction are evoked (Nabauer et 
al., 1989).  The same scenario is encountered using Ba2+ as the charge carrier, highlighting 
the requirement for Ca2+ entry as the triggering stimulus for Ca2+ release from the SR.  2.  
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Flash photolysis of photolabile Ca2+ chelators (Nitr-5 and DM-nitrophen) has been 
demonstrated to induce [Ca2+]i transients in intact ventricular myocytes.  Valdeolmillos et 
al. (1989) demonstrated flash photolysis of Nitr-5 induced contractions in isolated rat 
ventricular myocytes that were sensitive to Ryanodine and could also be invoked in the 
presence of 10 mM Ni to block ICa (Valdeolmillos et al., 1989).  Similar experiments 
performed by Niggli & Lederer (1990) under a constant holding potential of -40 mV (to 
eliminate the possibility of depolarization-induced SR Ca2+ release) confirmed that 
photolysis of caged Ca2+ could induce CICR independent of depolarisation, highlighting 
the requirement for a sudden increase in [Ca2+]i to induce SR Ca2+ release and contraction 
(Niggli & Lederer, 1990).  Altering the holding Em between -100, 0 or +100 mV also had 
no effect on the amplitude of the contractions invoked by photolysis of caged Ca2+, 
providing further evidence that CICR is not influenced by a voltage-dependent mechanism. 
1.2.2 CICR and the theory of ‘Local Control’ 
Problems are encountered when attempting to explain the mechanisms governing calcium-
induced calcium release.  The theory itself implies a high gain positive feedback system, 
whereby the triggering of an initial release of Ca2+ from the SR will cause the system to 
feedback upon itself and allow release to continue to completion.  On the contrary, 
experimental evidence shows that CICR is not an ‘all-or-none’ process, and SR Ca2+ 
release is graded by ICa (Lederer et al., 1990).  Furthermore, early termination of ICa leads 
to abbreviation of SR Ca2+ release.  Simulated model systems have been proposed to try 
and explain this apparent dichotomy.  Common pool models operate on the assumption 
that there is a single cytosolic pool of Ca2+ accessible to both the Ca2+ entering from the 
extracellular space and released from the SR, the concentration of which governs the 
release of Ca2+ from the SR (Stern, 1992).  Such models however predict a system where 
very small adjustments in amplification would result in the appearance of spontaneous 
behaviour.  The close juxtaposition of LTCCs and RyRs in the dyadic junctions allows 
prediction of an alternative model of CICR, where Ca2+ enters the dyadic cleft and is 
immediately in very close proximity to Ca2+ sensitive sites on the RyRs.  This would 
permit these sites to be much less sensitive to global intracellular Ca2+ concentrations, 
reducing the likelihood of regenerative Ca2+ release occurring.  This ‘Local Control’ 
theory was advanced by Stern (1992), who proposed two models of CICR; a) a ‘Ca2+-
synapse’ model, where 1 LTCC triggered the release of Ca2+ from a single RyR, and b) a 
‘Cluster bomb’ model, in which single LTCCs activated a cluster of RyRs (Stern, 1992).  
Gradation of release by the inward calcium current could be accounted for using both 
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models, however, in keeping with the high gain of CICR, single SR release channel Ca2+ 
flux using the Ca2+-synapse model would have to be unfeasibly large.  The Cluster bomb 
model therefore initially appeared more appropriate and was supported by reports which 
demonstrate the ratio of ryanodine receptors to LTCCs in junctional regions is 
approximately 1:4-10, depending on species (Bers & Stiffel, 1993; Wibo et al., 1991). 
1.2.3 Ca2+ sparks represent local release events from the 
sarcoplasmic reticulum 
The idea of local control was supported by the description of visualised SR Ca2+ release 
events in ventricular myocytes known as Ca2+ sparks (Cheng et al., 1993; Lukyanenko et 
al., 2000; Parker et al., 1996).  The physical separation of individual clusters of RyR2s 
limits the possibility of Ca2+ release from one cluster activating neighbouring clusters due 
to Ca2+ diffusion limitations.  The cumulative effect of thousands of Ca2+ sparks, 
temporally and spatially synchronised by the action potential and ICa are believed to 
produce the upstroke of the [Ca2+]i transient.  While the existence of these local release 
events aids the acceptance of CICR as the dominant mechanism for activation of 
contractile elements in cardiac EC coupling, the system described thus far is still 
regenerative.  Further mechanisms must exist to explain termination of SR Ca2+ release.  
Currently several mechanisms have been proposed which may account for termination of 
Ca2+ sparks. 
 
1.  All of the RyR2s and L-type Ca2+ channels within a cluster may inactivate at the same 
time, a process termed ‘stochastic attrition’ (Stern, 1992).  This process could potentially 
operate as a dominant mechanism for spark termination in the ‘Ca2+-synapse’ model 
described above, as local [Ca2+]i would decline quickly following closure of the SR Ca2+ 
release channel.  While it is likely this process contributes to termination of SR Ca2+ 
release to some degree, as cluster size increases above 3-4 the probability that stochastic 
attrition alone could explain release termination is exponentially reduced (Stern, 1992). 
 
2.  SR Ca2+ levels become depleted preventing further release.  This view has not gained 
acceptance as experimental evidence suggests that a significant releasable fraction of Ca2+ 
is still present following Ca2+ release.  In addition, interventions which increase RyR 
sensitivity to activation induce long-lasting local Ca2+ release events (sparks) which 
maintain a similar amplitude throughout the period of release (Cheng et al., 1993).  While 
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the entire SR may not become depleted, it is possible that local depletion within the SR 
near a release cluster may occur (see below).   
 
3.  Ca2+-dependent inactivation of release, first proposed by Fabiato (1985) (Fabiato, 1985) 
states that Ca2+ binds to a high affinity binding site on the RyR2 at a slow rate, inducing 
inactivation and refractoriness of the channel.  While inactivation itself is not directly 
supported by experimental evidence, an extension of this idea was proposed known as 
Ca2+-dependent adaptation of RyR.  It has been noted in studies where RyRs are 
incorporated into planar lipid bilayers that prolonged elevation of [Ca2+] using flash 
photolysis of caged Ca2+ initially increases RyR open probability (Po), but this gradually 
diminishes over time (Zahradnikova et al., 1999).  Further stimulating increases in [Ca2+] 
can however, elicit activation of the channels.  These findings were explained by 
observations that RyRs exhibit three separate modes of gating, characterised by prolonged 
and frequent channel openings (high open probability, H-mode), short and infrequent 
opening (low open probability, L-mode) and no openings (inactivated, I-mode) (Fill et al., 
2000; Zahradnikova et al., 1999).  The major problem with adaptation is the time course 
over which it is believed to operate is ~10 times slower than the time course for 
termination of SR Ca2+ release within individual clusters of RyRs. 
 
While the above mechanisms may operate to some extent in SR Ca2+ release termination 
none can adequately explain experimental findings from permeabilised and intact 
myocytes.  Current investigations have begun to focus on the role of luminal [Ca2+]SR in 
the control of Ca2+ release termination.  Buffering SR Ca2+ with low-affinity Ca2+ buffers 
drastically altered the relationship between ICa and SR Ca2+ release, and significantly 
increased Ca2+ spark amplitude and duration, suggesting that SR luminal [Ca2+] determines 
SR release termination and refractoriness of RyR (Terentyev et al., 2002).  SR Ca2+ release 
termination is also markedly altered in intact myocytes expressing mutations of the SR 
Ca2+ buffering protein calsequestrin which reduce SR Ca2+ buffering, allowing quicker 
restoration of local SR [Ca2+] following release and reduction of luminal Ca2+-dependent 
RyR refratoriness (Terentyev et al., 2008).  Moreover, Ca2+ release appears to terminate at 
the same threshold luminal [Ca] regardless of initial SR Ca2+ content (Terentyev et al., 
2008; Zima et al., 2008).  This recent work provides compelling evidence that local 
luminal SR [Ca2+] is a critical determinant of SR Ca2+ release termination although it does 
not completely explain termination of long-lasting release events.  An alternative model of 
SR Ca2+ release termination was proposed earlier by Sobie et al. (2002) based on the 
observation of a coupled-gating mechanism between individual RyRs within a cluster in 
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both skeletal and cardiac muscle (Sobie et al., 2002).  In skeletal and cardiac muscle, RyRs 
within a cluster are functionally linked by unique FK506 binding proteins (FKBP), which 
exist in the RyR macromolecular complex in a 4:1 stoichiometry with the channel (1 FKBP 
molecule per channel subunit).  Coupled gating, conferred in cardiac RyR2s by the specific 
binding protein FKBP12.6, provides a mechanism for termination of SR Ca2+ release 
within an entire cluster, whereby functionally linked RyRs open and close simultaneously, 
effectively inhibiting neighbouring individual channels from reactivating one another.  
Sobie et al. (2002) incorporated this observation into a mathematical model of SR Ca2+ 
release termination, termed the ‘sticky cluster’ hypothesis, additionally consolidating the 
potentially large variability in RyR cluster size.  The model was successful in marrying 
many of the experimentally observed features of Ca2+ sparks with simulated data, 
including a robust termination of SR Ca2+ release and largely similar Ca2+ spark 
characteristics irrespective of cluster size.  The model failed however, to approximate Ca2+ 
spark width closely, with simulated Ca2+ sparks appearing roughly half the width of those 
observed experimentally (Sobie et al., 2002).   
 
A coherent theory of SR Ca2+ release termination therefore has yet to be completely 
defined and further work is required to describe all features of SR Ca2+ release observed 
experimentally.  It is likely however that termination of SR Ca2+ release involves several of 
the mechanisms described above.      
1.3 Ca2+ removal from the cytosol  
Activation of the contractile machinery occurs when [Ca2+]i is elevated sufficiently to 
allow Ca2+ to bind to Troponin C (TnC), releasing the inhibitory binding of Troponin I 
with actin and enabling actin-myosin interaction and cross-bridge formation.  Following 
activation of the myofilament contractile machinery and systolic contraction [Ca2+]i must 
decline back to resting levels in order that the individual myocytes and ultimately the 
chambers of the heart may relax to fill with blood again before the initiation of the 
subsequent contraction.  To this end there are four Ca2+ removal systems present within the 
intracellular environment, the relative contributions of which are varied and species-
dependent (see below). 
 
1.  The sarcolemmal Ca2+-ATPase is a 138 kDa P-type ion motive transport enzyme, 
deriving energy from ATP molecules which is transferred to a phosphorylated intermediate 
(an aspartyl residue), enabling transport of 1 Ca2+ ion across the sarcolemmal membrane 
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for every ATP molecule hydrolysed.  The sarcolemmal Ca2+-ATPase consists of 10 
transmembrane domains accounting for ~20% of the total protein, with the cytosolic 
portion making up the remaining 80%.  The carboxy terminal tail of the Ca2+-ATPase 
includes a 30 amino-acid sequence believed to be the binding site for calmodulin, as well 
as the phosphorylation site for both PKA and PKC.  The reported maximal transport rate 
(Vmax) in intact rabbit ventricular myocytes is ~2 µmol/l cytosol/s (Bassani et al., 1995).   
 
2.  The mitochondrial Ca2+-uniporter.  Uptake of Ca2+ into the mitochondria is driven by 
the large negative membrane potential across the mitochondrial membrane (Gunter & 
Gunter, 2001).  Thus, Ca2+ entry into the mitochondria does not occur through ionic 
exchange mechanisms but simply by diffusion of Ca2+ down its electrochemical gradient 
(Gunter & Pfeiffer, 1990).  Mitochondrial Ca2+ uptake can be inhibited by application of 
ruthenium red as well as Ru360, a distinct ruthenium compound.  Ca2+ uptake velocity is 
close to zero below 200 nM cytosolic [Ca2+], and as such mitochondrial Ca2+ uptake does 
not occur at rest in cardiac myocytes, where diastolic [Ca2+]i are in the order of 100-150 
nM (Gunter & Gunter, 2001).   
 
3.  The Na+/Ca2+ exchanger (NCX).  The major mechanism of Ca2+ removal from the cell 
is via NCX, a transporter located on the sarcolemmal membrane at sites distinct from RyR 
clusters in the junctional cleft.  NCX transports 3 Na+ ions in exchange for 1 Ca2+ ion, thus 
creating a net positive charge and generation of current.  Transport across the membrane 
occurs in a consecutive fashion.  As an example, with the channel face on the outer 
membrane open 3 Na+ ions bind and a conformational alteration in the channel transports 
these ions into the myocyte.  1 Ca2+ ion then binds to the now open face of the channel on 
the cytosolic side and the reverse conformational change transports this ion out of the 
myocyte, and one full channel cycle is completed (Bers, 2001).  NCX exhibits Ca2+i-
dependent activation characteristics such that regulatory [Ca2+]i is required for the channel 
to operate regardless of the intracellular substrate being removed.  High [Na+]i causes 
inactivation of the channel although this may not be physiologically relevant as the [Na+]i 
required to elicit such a response is >30 mM (Matsuoka & Hilgemann, 1992).  The 
transport action of the channel is reversible and highly dependent on Em.  Thus, during the 
initial phases of the action potential when Em is high Ca2+ influx via NCX is 
thermodynamically favoured.  Under certain experimental conditions (rapid reduction of 
[Na+]o, elevation of [Na+]i) activation of contraction induced by large (or long 
depolarisations in voltage-clamped cells) can occur when LTCC blockade is imposed 
(Barcenas-Ruiz et al., 1987; Chapman & Tunstall, 1980).  The contribution of NCX to 
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contraction is thought to be limited under physiological conditions however, and may only 
become significant in circumstances where [Na+]i is substantially increased (Bers et al., 
1988).     
 
4.  The sarco-endoplasmic reticulum Ca2+-ATPase (SERCA).  SERCA is responsible 
for re-sequestration of Ca2+ into the SR following the Ca2+i transient.  Like the sarcolemmal 
Ca2+-ATPase SERCA belongs to the P-type family of ion-motive transport proteins, 
however the two pumps are structurally and functionally quite distinct.  Transport of Ca2+ 
into the SR lumen is described using a two-state model proposed by Mackinose (1973) 
(Makinose, 1973).  In the ‘ground state’ (E1) 2 Ca2+ ions and 1 molecule of ATP bind to 
high affinity binding sites on the cytosolic surface of the enzyme.  The terminal phosphate 
of ATP (γ-phosphate) is donated to an aspartyl residue (Asp351) in the phosphorylation 
domain of SERCA, resulting in a conformational change which prevents Ca2+ escaping 
from the enzyme complex (E1P.2Ca2+).  The enzyme undergoes a further transition from a 
high to low energy state (E2P), resulting in transfer of the occluded Ca2+ ions from a high 
affinity binding site to low affinity binding sites facing the inner lumen of the SR, from 
which the 2 Ca2+ ions dissociate from the enzyme complex and enter the SR.  As the 
phosphate is dissociated from the enzyme complex, SERCA returns to the E1 state, 
restoring the high affinity Ca2+ binding sites to the cytosolic surface of the membrane.  
Species-dependent differences exist in the density of SR Ca2+ pump sites and probably 
reflect the relative dependence on SERCA for cytosolic Ca2+ removal (discussed below).  
Estimates of the pump density in rabbit and rat permeabilised ventricular myocytes using 
thapsigargin titration were 7.7 µM.kg wet weight-1 and 54.6 µM.kg wet weight-1, 
respectively (Hove-Madsen & Bers, 1993).  Structural features and differences between 
SERCA isoforms are discussed in detail in section 1.4.    
 
In cardiac myocytes of most mammalian species SR Ca2+ uptake via SERCA is the 
dominant mechanism of Ca2+ removal from the cytosol, however species variation does 
exist.  Ca2+ efflux via NCX is ~2-3 fold faster in rabbit ventricular myocytes in comparison 
to rat, with SR Ca2+ uptake via SERCA exhibiting a similar increased rate of cytosolic Ca2+ 
removal in rat vs. rabbit myocytes.  Estimates suggest that the relative contributions of 
SERCA and NCX to Ca2+ removal following the Ca2+i transient to be approximately 70 % 
and 28 % respectively in rabbit ventricular myocytes, and 92 % and 7 % respectively in rat 
(Bassani et al., 1994).  In intact ventricular myocytes, blockade of NCX and SERCA 
function using 0 Na+/0 Ca2+ solutions and perfusion with caffeine, respectively, revealed 
that decay time of the Ca2+i transient was >20s (Bassani et al., 1992).  Further blockade of 
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either mitochondrial Ca2+ uptake (using FCCP and oligomycin) or sarcolemmal Ca2+ 
uptake (using 10-100 mM [Ca2+]o) lengthens the decay time of caffeine-induced transients 
to >60s.  The combined contribution of the sarcolemmal Ca2+-ATPase and the 
mitochondrial Ca2+ uniporter (dubbed the ‘slow transport mechanisms’) to normal decay of 
the [Ca2+]i is therefore negligible, with estimates in both rat and rabbit ventricular 
myocytes suggesting a similar value of 1-2 % of the total Ca2+ removed (Bassani et al., 
1994).                 
1.4 The SR Ca2+ ATPase is responsible for Ca2+ uptake 
into the sarcoplasmic reticulum 
A key feature of the sarco-endoplasmic reticulum Ca2+ ATPase along with other P-type 
ion-motive ATPases is the transfer of the terminal phosphate of ATP to an aspartyl residue 
located at the catalytic site, enabling a reversible conformational change of the enzyme 
(Inesi et al., 2005).  The SERCA pump is a 110-kDa protein, encoded by three distinct 
genes in vertebrate species, alternative splicing of which currently accounts for over 10 
distinct splice variants.  The SERCA1 gene encodes an adult (SERCA1a) and fetal 
(SERCA1b) isoform, expressed in fast-twitch skeletal muscle (Brandl et al., 1986), whilst 
SERCA2 encodes a further two isoforms, SERCA2a, expressed mainly in cardiac and slow 
twitch skeletal muscle, and a ubiquitously expressed isoform SERCA2b.  SERCA3 
isoforms have also been identified in a number of non-muscle tissues (Periasamy & 
Kalyanasundaram, 2007; Treiman et al., 1998).  The different SERCA isoforms exhibit a 
high degree of structural homogeneity, with SERCA1a and 2a sharing approximately 84 % 
amino acid sequence conservation (Periasamy & Kalyanasundaram, 2007).  A structural 
diagram of the SR Ca2+-ATPase is shown in Figure 1.4.  The protein consists of 10 
transmembrane regions (M1-M10) with additional α-helical ‘stalk’ regions on segments M1-
M5 facing the cytosolic side of the SR membrane.  The high affinity Ca2+ binding sites are 
most likely located in the transmembrane regions M4-M6 which are believed to form a 
pore-like structure that traps Ca2+ during occlusion.   
1.4.1 Phospholamban is an endogenous mediator of SR Ca2+ 
uptake in cardiac muscle 
In cardiac muscle SR Ca2+ uptake via SERCA is regulated by the inhibitory protein 
phospholamban.  Phospholamban (PLB) exists as a pentamer within the SR membrane 
consisting of 5 identical subunits stabilized by leucine-isoleucine zipper motifs between 
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the transmembrane α-helices of the protein.  It is now widely recognized that PLB 
monomers confer inhibition of SERCA while the pentamer configuration acts as the PLB 
reservoir in cardiac muscle.  Evidence to support this comes from the observation that PLB 
mutants in which the transmembrane leucine-isoleucine zipper interactions are disrupted 
inhibits pentamerisation, resulting in a greater inhibition of SERCA (Cornea et al., 1997).  
Interaction of PLB with SERCA2a inhibits SR Ca2+ uptake by decreasing the affinity of 
SERCA for Ca2+ (increasing the KCa value).  This inhibitory effect can be relieved through 
phosphorylation of PLB by PKA or Ca2+/Calmodulin-dependent protein kinase II 
(CaMKII) as well as with the use of monoclonal antibodies for PLB.  Removal of PLB’s 
inhibitory effect on SR Ca2+ uptake by cAMP-dependent PKA phosphorylation is a major 
contributor to the positive inotropic effect mediated by β-adrenergic stimulation.  PKA 
phosphorylation of PLB at Ser16 increases SERCA’s affinity for Ca2+ (reduces KCa) 
resulting in an increase in the rate of Ca2+ uptake (Hicks et al., 1979).  PLB is also 
phosphorylated by CaMKII at Thr17, resulting in a reduction in KCa similar to that 
produced by PKA phosphorylation at Ser16.  Genetic deletion of the PLB gene in 
transgenic mouse studies significantly enhances cardiac contractility and relaxation 
measured using isolated working heart preparations, however the ability to elicit a positive 
inotropic response using β-agonists is lost (Luo et al., 1994), despite intact β-adrenergic 
receptor signalling pathways and comparable upregulation of cAMP and phosphorylation 
of Troponin I and C (Kiss et al., 1997).  PLB knockout mice also exhibit altered 
intracellular Ca2+ handling properties, including increased Ca2+ spark amplitude and 
frequency, and increased RyR sensitivity to trigger ICa (Santana et al., 1997).  These effects 
are almost exclusively mediated by an elevated SR Ca2+ load in PLB knockout, as 
reduction of SR Ca2+ content to wild type levels abolishes these differences.  
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Figure 1.4 Structural diagram of SERCA.  The protein consists of 10 transmembrane domains (M1-M10) 
the first 5 of which also include an α-helical ‘stalk’ region extending into the cytosolic face of the protein.  
The large cytosolic portion, consisting of the β-strand domain, the phosphorylation site, nucleotide binding 
domain and hinge domains, comprises the bulk of the molecule.  Numbers indicate amino acid positions at 
the end of each transmembrane sequence.  (Diagram taken from Tada (2003) Circ. J. 67(9) 729-737).       
1.4.2 SERCA isoforms exhibit functional heterogeneity with 
regard to Ca2+-transport properties 
Despite a high level of sequence homology between SERCA isoforms, functional 
differences with regard to Ca2+ affinity and ATP turnover rates have been reported in a 
number of investigations.  SERCA2b has been shown to have a lower ATP and Ca2+ 
turnover rate in comparison to SERCA2a (Lytton et al., 1992) however it exhibits roughly 
2-fold higher affinity for Ca2+ than SERCA2a (Verboomen et al., 1992; Verboomen et al., 
1994).  SERCA1a and SERCA2a demonstrate very similar Ca2+ dependence, however the 
Ca2+ uptake rate of SERCA1a is approximately twice as fast (Cavagna et al., 2000).  Due 
to the observed differences in Ca2+ uptake properties between isoforms a number of studies 
have elected to investigate the consequences of SERCA2a replacement with, or 
upregulation of, variant SERCA isoforms to normal myocyte Ca2+ handling and overall 
cardiac function (see below).  
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1.4.2.1 Overexpression of SERCA2a enhances cardiac contractility and Ca2+- 
handling dynamics 
The relationship between levels of SERCA and cardiac contractile function have been 
investigated using adenoviral gene transfection (Hajjar et al., 1997) and transgenic over-
expression in rat and mouse models (Baker et al., 1998; He et al., 1997; Maier et al., 2005; 
Muller et al., 2003).  He et al. (1997) reported that transgenic mice expressing a rat 
SERCA2a gene demonstrated a 20% increase in SERCA2a protein levels relative to PLB 
expression (He et al., 1997).  This phenotype exhibited an increased rate of [Ca2+]i 
transient decay and relaxation in isolated myocytes, with baseline left ventricular dP/dtmax 
and dP/dtmin increased, and a significantly reduced relaxation constant, τ.  These functional 
differences between transgenic mice and controls were abolished following a low dose (1 
ng) injection of isoproterenol, and the relaxation constant τ in transgenic mice under 
resting conditions was not significantly altered following isoproterenol, suggesting that the 
rate of relaxation in transgenic mice under resting conditions was almost maximal (He et 
al., 1997).  A similar study by Baker et al. (1998) found that transgenic over-expression of 
SERCA2a in mice resulted in enhanced LV contractility and relaxation, and an increase in 
the maximal rate of SR Ca2+ uptake (Vmax), although the affinity of SERCA for Ca2+ was 
unchanged vs. controls (Baker et al., 1998).  Crucially, unlike the previous study the 
investigators found an increase in Ca2+i transient amplitude and cell shortening, though this 
could be explained by the increased level of protein expression which was 1.5 fold greater 
than control, in comparison to the 20% increase reported in the previous investigation (He 
et al., 1997).  Enhanced LV function was also described by Muller et al. (2003) in a rat 
model of SERCA2a over-expression (Muller et al., 2003).  The investigators were also 
able to demonstrate a correlation between the levels of SERCA2a protein expression in 
aortic banded and sham operated transgenic rats, and the measured relaxation constant τ 
from isolated working heart experiments, suggestive of SERCA’s critical role in active 
relaxation (Muller et al., 2003).  The enhancement of cardiac contractility seen following 
increased expression of SERCA2a has been shown to be beneficial in pressure-overload 
hypertrophy leading to heart failure (del Monte et al., 2001; Miyamoto et al., 2000; Muller 
et al., 2003).          
1.4.2.2 Expression of the SERCA1a isoform in small animal models 
Ji et al. (1999) investigated the functional consequences of ectopic over-expression of 
SERCA1a in the heart using a transgenic mouse model (Ji et al., 1999a).  The generated 
model resulted in significant remodelling of the cardiac SR, expressing ~80% SERCA1a 
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and ~20% SERCA2a, with overall SERCA protein expression increased 2.5 fold.  In 
agreement with previous studies using expression of SERCA isoforms in COS-1 cells, 
maximal rate of Ca2+ uptake (Vmax) was 1.9-fold higher in cardiac homogenates from 
transgenic mice vs. non-transgenic controls, but the apparent Ca2+ affinity of SERCA was 
unchanged.  The increase in Vmax was explained by an increase in the total amount of 
active SERCA pumps in transgenic mouse cardiomyocytes (Ji et al., 1999a).  Lalli et al. 
(2001) investigated the consequences of SERCA1a expression in transgenic mouse hearts 
on intracellular Ca2+ handling and myocyte contractile function (Lalli et al., 2001).  
Histological analysis revealed no significant differences between left ventricular myocytes 
from wild-type (WT) or transgenic (TnG) mice, and mortality curves were similar for both.   
While no changes were found in function or protein expression of NCX, RyR2 and L-type 
Ca2+ channel protein expression were reduced by ~20 % and ~30-35% in TnG mice 
respectively.  This resulted in a decline in the maximal binding capacity of RyR2, as well 
as reduced peak ICa.L compared to WT.  Despite these alterations, the increased SR Ca2+ 
uptake kinetics present in TnG mice resulted in an increase in Ca2+ transient amplitude, 
faster Ca2+ removal and increased force production, consistent with an increased SR Ca2+ 
content in isolated myocytes, suggesting that ectopic expression of SERCA1a enhances 
contractility despite eliciting downregulation of other Ca2+ cycling proteins (Lalli et al., 
2001).  Talukder et al. (2007) demonstrated a significant cardioprotective effect against 
ischaemia-reperfusion injury in isolated perfused mouse hearts overexpressing SERCA1a 
(Talukder et al., 2007).  Recovery of left ventricular developed pressure (LVDP) and end 
diastolic pressure (LVEDP) was significantly greater in SERCA1a+/+ hearts vs. non-
transgenics, with SERCA1a+/+ hearts also exhibiting significantly reduced infarct size and 
duration of post-reperfusion arrhythmic episodes.  In contrast to the apparent success of 
transgenic overexpression of SERCA1a with regards to improved cardiac function and 
cardioprotection, adenoviral-mediated gene transfer of the SERCA1a isoform has resulted 
in mixed findings (Logeart et al., 2006; O'Donnell et al., 2008).  O’Donnell et al. (2008) 
reported a 34 ± 15 % increase in total SERCA levels in rat hearts 3 days after adenoviral 
gene transfer of SERCA1 (O'Donnell et al., 2008).  Aortic banding was used to induce LV 
hypertrophy in both gene transfected and untreated controls.  While LVDP and dP/dtmin in 
isolated working heart preparations were shown to be improved in gene transfected rat 
hearts vs. controls, in vivo echocardiographic measurements revealed a 10-15 % increase in 
LV diastolic and systolic dimensions, and 17 % decrease in fractional shortening in gene 
transfected rats exposed to aortic banding compared to animals that underwent aortic 
banding alone.  In this case compensatory mechanisms present in vivo may have resulted in 
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a masking of the beneficial effects of SERCA1a over-expression on cardiac function 
(O'Donnell et al., 2008).       
1.4.2.3 Expression of the SERCA2b isoform in transgenic animal models 
The role of SERCA2b, a ubiquitously expressed SERCA isoform, in cardiac muscle was 
investigated by Greene et al. (2000) using a mouse model over-expressing the rat 
SERCA2b transgene (Greene et al., 2000).  They reported an 8-10 fold increase in protein 
levels of SERCA2b but no change in SERCA2a levels in comparison to wild-type controls.  
There was no detectable difference in the maximal uptake rate of Ca2+ (Vmax) in 
SERCA2b-overexpressing mice, however the pump affinity for Ca2+ was significantly 
increased in transgenics.  This alteration in uptake function translated into increased LV 
systolic and diastolic function (Greene et al., 2000).  The physiological importance of the 
SERCA2a isoform to normal cardiac function was further explored by replacement of 
SERCA2a with the SERCA2b isoform (Ver et al., 2001).  Mice lacking the SERCA2a 
isoform and instead expressing SERCA2b demonstrated a 49% reduction in overall 
SERCA2 protein expression and greater than 2-fold increase in PLB protein levels 
compared to wild type controls.  Postnatal mortality was increased in transgenics, while 
mice surviving to adulthood exhibited signs of mild concentric hypertrophy, impairment of 
contractile and relaxation function and a reduction in maximal Ca2+ uptake rates by ~50%.  
A question remained over the role of increased PLB protein expression in this model.  This 
may be responsible for the observed contractile dysfunction by working synergistically 
with the reduced cardiac SERCA2 expression, as removal of PLB’s inhibitory effect on 
SERCA has been shown to improve cardiac function (Hoshijima et al., 2002; Minamisawa 
et al., 1999).  Vangheluwe et al. (2006) investigated this hypothesis by studying a double 
knockout (DKO) mouse from cross-bred PLB-/- and SERCA2b/b transgenic mice 
(Vangheluwe et al., 2006b).  DKO mice exhibited significantly reduced life expectancy, 
increased concentric hypertrophy and development of diastolic dysfunction.  Β-Adrenergic 
stimulation using Dobutamine also failed to elicit a positive inotropic response in DKO 
mice, suggesting a lack of inotropic reserve in this model.  It is now thought that the SR 
Ca2+ ATPase affinity for Ca2+ operates within a physiological range, with significant 
perturbation of this affinity in either direction resulting in a detrimental cardiac phenotype 
(Vangheluwe et al., 2006a; Vangheluwe et al., 2006b).    
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1.5 SR Ca2+ handling abnormalities significantly alter 
cardiac mechanical function 
The observation that the SR contributes such a large proportion of the Ca2+ required for 
contraction in most mammalian species obviates the notion that alterations in the function 
of the SR Ca2+ release channel or in the Ca2+ uptake by SERCA could potentially impact 
on normal contractile function in the whole heart.  Indeed, as described in the section 
above enhancement of SERCA2a expression and function in transgenic mouse models may 
result in a positive inotropic response and enhancement of cardiac contractility.  Two such 
conditions are described below in which disruption of SR Ca2+ handling mechanisms are 
thought to be a major contributing factor to the development of contractile dysfunction; 
Ca2+ overload, and chronic myocardial infarction.    
1.5.1 Ca2+ Overload 
Ca2+ overload can be defined as an excessive increase in intracellular Ca2+ levels which 
overwhelms the Ca2+ regulatory mechanisms of the cell resulting in a depression of 
contractility and the appearance of abnormal electrical activity.  Examples of both are well 
documented in the case of cardiac glycoside toxicity, which has allowed experimental 
characterization of Ca2+ overload, and which will be discussed in greater detail later in this 
chapter.  The decline in peak force development and appearance of ventricular 
extrasystoles is linked to spontaneous Ca2+ release from the sarcoplasmic reticulum.  
Fabiato & Fabiato (1972) noted that in skinned cardiomyocytes from rat ventricle that 
bathing Ca2+ levels greater than 100 nM led to cyclic oscillations in cell contraction 
(Fabiato & Fabiato, 1972).  Modification of free [Ca2+]i by increasing EGTA 
concentrations led to a decline in this spontaneous contractile activity.  These spontaneous 
contractions are now known to result from spontaneous Ca2+ release from the SR but by 
themselves do not necessarily indicate Ca2+ overload.  Rat ventricular myocytes exhibit 
such spontaneous behaviour when bathed in physiological solution, but interventions 
resulting in elevated [Ca2+]o levels (catecholamines, Na+-K+ pump inhibition) are required 
to elicit the same response in rabbit ventricular myocytes which exhibit far less 
spontaneous activity under resting conditions (Capogrossi & Lakatta, 1985; Kort & 
Lakatta, 1984).   
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1.5.1.1 Mechanical abnormalities and negative inotropy in Ca2+ overload 
The consequences of increasing [Ca2+]o levels in a ferret papillary muscle preparation were 
investigated by Allen et al. (1985) who concluded that the decrease in contractile force 
resulted from the spontaneous oscillatory Ca2+ release events from the SR contributing 
directly to a decrease in Ca2+ availability for subsequent stimulated contractions due to a 
decreased SR load (Allen et al., 1985), a finding supported by several other investigations 
(Capogrossi et al., 1987; Capogrossi & Lakatta, 1985).  Capogrossi et al. (1986) 
investigated the impact of spontaneous Ca2+ release on electrically stimulated contractions 
in isolated rat and rabbit ventricular myocytes, demonstrating that when such spontaneous 
release events occur during the diastolic period between stimulation they have a negative 
impact on cell shortening amplitude (Capogrossi et al., 1986).  Diaz et al. (1997) 
demonstrated that the reduction in SR Ca2+ content during spontaneous release could be 
measured by assessing the integral of the Na+-Ca2+ exchange (NCX) current following 
rapid application of caffeine to deplete SR stores (Diaz et al., 1997).  It was found that in 
rat ventricular myocytes a measureable decline in SR Ca2+ content was apparent following 
spontaneous release events, and that the amount of Ca2+ lost in this way can be accounted 
for by the amount removed from the cell via NCX (Diaz et al., 1997).    In Ca2+ overload 
conditions (bathing [Ca2+]o at 10 mM) intact ventricular myocytes exhibit increased Ca2+ 
spark frequency and an increased propensity for initiation of Ca2+ waves (Cheng et al., 
1996).  In multi-cellular preparations the decline in force may be complicated by 
heterogeneous activity between cardiomyocytes, as Ca2+ waves occurring in a large enough 
population of cells within multi-cellular preparations would result in asynchronous 
activation of contractile elements and an increase in diastolic tension, potentially 
contributing to a Ca2+-dependent increase in diastolic tone (Stern et al., 1988).  Therefore a 
decline in peak force production and negative inotropy are, at least in part, explained by 
reduction in SR Ca2+ content following spontaneous Ca2+ release events from the SR along 
with an increase in diastolic tone.  The SR is not the only structure believed to be 
susceptible to Ca2+ overload; Ca2+ accumulation within the mitochondria is thought to 
contribute to the negative inotropic effects of Ca2+ overload.  Excessive mitochondrial Ca2+ 
uptake has been demonstrated to cause a reduction in oxidative phosphorylation, reducing 
the available levels of ATP for critical cellular processes (Holmuhamedov et al., 2001).  In 
agreement with this theory, metabolic inhibitors (NaCN, oligomycin) in small 
concentrations have little effect on developed force in Purkinje fibres bathed in 
physiological Tyrode’s solution, but in the presence of Strophanthidin (a cardiac glycoside) 
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the initial inotropic response is lost, and force declines at a faster rate than in 
strophanthidin alone (Vassalle & Lin, 2004). 
1.5.1.2 Electrical abnormalities in Ca2+ overload 
Electrical disturbances associated with Ca2+ overload, like the negative inotropic effects 
already discussed, are mediated by spontaneous Ca2+ release from the SR.  Activation of a 
transient inward current (ITI) arises from ionic movements across the sarcolemmal 
membrane by electrogenic transporters (Berlin et al., 1989) and is the mechanism 
responsible for the appearance of delayed after depolarisations (DADs) (Kass et al., 1978; 
Schlotthauer & Bers, 2000).  Zygmunt et al., (1998), using canine mid-myocardial cells 
concluded that ITI was the result of both inward NCX current (INa/Ca) and Ca2+-dependent 
inward Chloride current (ICl(Ca)) with the relative contributions of INaCa and ICl(Ca) reported 
as approximately 60 and 40 % respectively (Zygmunt et al., 1998).  Verkerk et al. (2000) 
examined the contribution of INa/Ca and ICl(Ca) to ITI in sheep ventricular and purkinje fibres 
(Verkerk et al., 2000). They found a component of ITI, blocked by the anion channel 
inhibitor DIDS (4,4’-diisothiocyanatostilbene-2,2’-disulfonic acid) that could be attributed 
to a Chloride (Cl-) current.  The remainder of ITI not blocked by DIDS (termed DIDS-
insensitive current) could be abolished by replacement of [Na+]o with Li+.  The fact that 
inhibition of ITI was complete following the combination of these two manoeuvres led the 
authors to conclude that contribution by non-specific inward current to ITI was most likely 
negligible (Verkerk et al., 2000)  Schlotthauer and Bers (2000) noted that in ITI, membrane 
potential (Em) is constant, whereas during DADs Em changes throughout such that 
alteration of the electrochemical gradients which drive the aforementioned currents may 
have a profound effect on their relative contribution to DADs (Schlotthauer & Bers, 2000).  
The authors therefore investigated the contribution of INa/Ca and ICl(Ca) to delayed after 
depolarisations using caffeine-induced DADs (cDADs).  They found that in rabbit 
ventricular myocytes, blockade of INa/Ca with 0Ca2+/0Na+ solution  led to a >90 % reduction 
in cDAD amplitude, while specific blockade of ICl(Ca) with niflumate (50 µM) could only 
account for < 10 % (Schlotthauer & Bers, 2000).  This heavy reliance on INa/Ca for 
generation of DADs appears to hold true for guinea pig ventricular myocytes also (Fedida 
et al., 1987).  Katra & Laurita (2005) attempted to better define the origin of triggered 
activity induced due to spontaneous SR Ca2+ release using optical mapping techniques in a 
canine left ventricular wedge preparation (Katra & Laurita, 2005).  Under conditions of 
enhanced calcium entry (selective blockade of IKs and stimulation of the β-adrenergic 
system) spontaneous SR Ca2+ release and DADs resulted from a relatively large cluster of 
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cells and could also originate from multiple sites through the transmural wall (although 
mostly occurring closer to the endocardium).  Sites of spontaneous Ca2+ release origin 
were also associated with slower Ca2+ uptake and higher diastolic Ca2+ levels (Katra & 
Laurita, 2005).  The consequences of ITI and DADs due to Ca2+ overload is ultimately the 
increased propensity for generation of an action potential leading to triggered arrhythmias 
(Kimura et al., 1984; Schlotthauer & Bers, 2000). 
1.5.2  When does Ca2+ Overload occur? 
In addition to the influence of excessive β-adrenergic stimulation (discussed in detail in 
Chapter 4) a number of conditions have been shown to result in Ca2+ overload yet the 
mechanisms underlying each can be quite different.   
 
1)  Cardiac glycosides.  It has long been established that the positive inotropic actions of 
cardiac glycosides are evoked through inhibition of the Na+-K+ ATPase, leading to a rise in 
[Na+]i levels (Khatter et al., 1989).  This leads to a reduction in Ca2+ extrusion via NCX 
activity and a net increase in [Ca2+]i, which is effective in loading the SR and increasing 
SR Ca2+ content (Blaustein et al., 1998).  An increase in Ca2+ influx may also occur via 
NCX when [Na+]i levels rise sufficiently (Satoh et al., 2000). Cardiac glycoside toxicity 
results in the appearance of triggered arrhythmias and a reduction in Ca2+ transient 
amplitude (Terada et al., 1994).  Satoh et al (2000) demonstrated the influence of NCX-
mediated Ca2+ influx on the toxicity of cardiac glycosides in rat ventricular myocytes by 
selective blockade of Ca2+ influx via NCX using KB-R7943 (Satoh et al., 2000).  KB-
R7943 was selective for Ca2+ influx via NCX and did not alter Ca2+ efflux through the 
exchanger or normal EC coupling mechanisms.  While KB-R7943 was able to prevent 
Ca2+ oscillations and arrhythmic activity induced by 50 µM strophanthidin, the inotropic 
effects of strophanthidin administration were not prevented, suggesting that a decrease in 
Ca2+ efflux following cardiac glycoside treatment (caused by an increase in [Na+]i was 
sufficient to promote a positive inotropic response in rat ventricular myocytes, however net 
Ca2+ influx via NCX is required for cardiac glycoside-induced Ca2+ overload (Satoh et al., 
2000).  Recent evidence has challenged the traditional view of cardiac glycoside action, 
suggesting that alternative intracellular interaction sites may exist (Nishio et al., 2002; 
Nishio et al., 2004; Sagawa et al., 2002).  Sagawa et al. (2002) demonstrated that digoxin 
and actodigin led to an increase in opening of cardiac Ryanodine receptors incorporated 
into planar lipid bilayers, without altering open duration (Sagawa et al., 2002).  Nishio et 
al., (2002) found that Ouabain was capable of inducing its positive inotropic, and toxic 
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effects even in the absence of functional NCX or Na+-K+ ATPase (Nishio et al., 2002).  A 
follow-up investigation by the same group looked at the effects of Ouabain on SR Ca2+ 
release in intact and permeabilised cat ventricular myocytes (Nishio et al., 2004).  They 
discovered that Ouabain led to a reduction in Ca2+ spark frequency but enhanced SR Ca2+ 
leak in the complete absence of Na+ in intact cells.  Removal of potential sarcolemmal 
mechanisms with the use of permeabilised myocytes yielded similar results, suggesting 
that mechanisms other than Na+-K+ ATPase blockade may contribute to the effects of 
cardiac glycosides.  This view was challenged by Altamirano et al., (2006) however, who 
found no change in Ca2+ spark characteristics, and no significant inotropic effect in the 
absence of Na+ or during blockade of NCX, suggesting that any secondary mechanisms of 
cardiac glycoside action do not significantly contribute to their inotropic effects 
(Altamirano et al., 2006). 
     
2)  Ischaemia-Reperfusion Injury.  Since the work of Zimmerman & Hulsmann (1966) 
on Langendorff-perfused rat hearts, it has been known that when solution containing 
normal [Ca2+] is re-introduced to the mammalian heart following 5-10 min of perfusion 
with a Ca2+-free medium this quickly leads to loss of contractile and electrical function and 
extensive myocardial tissue damage (Chapman & Tunstall, 1987; Zimmerman & 
Hulsmann, 1966).  This phenomenon, known as the ‘calcium paradox’, is thought to arise 
from excessive cellular Ca2+ influx leading to Ca2+ overload.  While it is highly unlikely 
such a situation would ever occur in vivo, with regards to the final outcome it shares 
striking similarities with the physiological phenomenon of ischaemia-reperfusion injury, 
both of which result in excessive accumulation of intracellular Ca2+, severe sarcolemmal 
disruption, alteration of mitochondrial morphology and loss of high energy phosphates 
(Alto & Dhalla, 1979; Chapman & Tunstall, 1987).  Prolonged periods of ischaemia 
(decreased blood supply to the tissues) followed by reperfusion have long been known to 
result in myocardial damage and necrosis.  It has been demonstrated by a large number of 
studies that in myocardial tissue that has undergone severe disruption there is a significant 
increase in Ca2+ levels (Ferrari et al., 1986; Meissner & Morgan, 1995; Tani, 1990).  Ca2+ 
accumulation occurs following reperfusion (Higgins & Blackburn, 1984; Tani, 1990) and 
use of specific Ca2+ channel antagonists as well as calmodulin inhibition has been shown to 
be effective in limiting Ca2+ overload following ischaemia and reperfusion (Das et al., 
1989; Higgins & Blackburn, 1984).  While Ca2+ overload from ischaemia-reperfusion 
results in contracture and increased propensity for arrhythmias as described above (Ferrier 
et al., 1985), evidence also points toward specific accumulation of Ca2+ within the 
mitochondria (via the mitochondrial Ca2+-uniporter) and not the cytosol per se as being in 
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part responsible for mediation of post-ischaemic reperfusion injury (Miyamae et al., 1996; 
Miyata et al., 1992).  It is now understood that during ischaemia mitochondria switch from 
oxidative phosphorylation to anaerobic mechanisms in order to continue ATP synthesis, 
leading to accumulation of lactate within the cell which cannot be washed away.  This 
leads to a decline in intracellular pH (pHi) and acidosis (Baines, 2009).  Stimulation of the 
Na+/H+ exchanger (NHE) occurs in an attempt to offset the decline in pHi resulting in 
accumulation of Na+ within the cell.  Upon reperfusion there is a large influx of Na+ in 
exchange for H+ to re-establish pHi to normal levels.  This is thought to result in 
stimulation of NCX to remove Na+ and bring in Ca2+, leading to a large influx of Ca2+ and 
concomitant cell injury (Karmazyn et al., 1999).  Evidence for this view is supported by 
studies using NHE inhibitors such as cariporide (HOE642), and amiloride derivatives 
which limit intracellular Na+ loading and reduce IR-induced injury (Hartmann & Decking, 
1999; Meng & Pierce, 1990; Stromer et al., 2000; ten Hove et al., 2003) although studies 
also suggest that this effect may also be mediated by direct action on NHE within the inner 
mitochondrial membrane (Ruiz-Meana et al., 2003).  Accumulation of Ca2+ within the 
mitochondria has also been implicated in opening of the mitochondrial membrane 
permeability transition pore (MPTP) and cell necrosis. Moreover, Toda et al. (2007) 
demonstrated that cariporide was able to attenuate mitochondrial Ca2+ overload and 
significantly delay MPTP opening in a rat ventricular myocyte model of oxidative stress 
(Toda et al., 2007).  Ca2+ overload associated with ischaemia-reperfusion injury therefore 
represents an indirect mechanism of Ca2+ loading as a result of disruption of normal 
intracellular ion-handling processes.  Although Ca2+ overload is not the only complication 
arising from ischaemia-reperfusion injury it is clearly a significant contributor to 
detrimental effects associated with this phenomenon, including a contributory role in cell 
apoptosis and necrosis.    
1.5.3 Myocardial infarction alters intracellular Ca2+ handling 
properties 
One of the leading causes of heart failure in humans is coronary artery disease leading to 
the formation of a myocardial infarct (MI).  Significant modifications in the contractile and 
electrophysiological properties of cardiac myocytes are thought to underlie the 
advancement of contractile dysfunction and progressive decline in cardiac output.  Animal 
models of myocardial infarction, the most prevalent of which is the coronary artery ligation 
model, have afforded greater insight into the cellular alterations underlying the 
development of contractile dysfunction in chronically infarcted hearts and a large body of 
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evidence now exists demonstrating that in infarcted hearts the viable myocytes undergo 
significant alterations with respect to intracellular Ca2+ handling properties.  Depression or 
prolongation of the [Ca2+]i transient is believed to play a significant role in the contractile 
dysfunction seen clinically in heart failure patients (Beuckelmann et al., 1992; Gwathmey 
et al., 1987) and in animal models of myocardial infarction (Ng et al., 1998).  The 
amplitude of the systolic [Ca2+]i transient has been shown to be significantly reduced in 
patients with end stage heart failure, resulting from a significantly reduced SR Ca2+ content 
in comparison to non-failing myocytes (Lindner et al., 1998; Pieske et al., 1999).  Similar 
findings are also reported in pacing, and coronary artery ligation-induced models of heart 
failure (Hobai & O'Rourke, 2001; Neary et al., 2002b).  These findings suggest that 
alteration in SR Ca2+ uptake and/or release mechanisms may play a significant role in the 
development of left ventricular dysfunction seen in heart failure.  
1.5.3.1 SR Ca2+ uptake 
A consistent finding in clinical and animal models of heart failure is an alteration in the 
expression and function of proteins involved in cytosolic Ca2+ removal, including SERCA 
(Currie & Smith, 1999; Hasenfuss et al., 1994b; Schmidt et al., 1998), its regulatory 
protein phospholamban (Currie & Smith, 1999), and NCX (Studer et al., 1994a).  
Yamaguchi et al. (1997) demonstrated a reduced SR Ca2+ uptake rate in permeabilised 
ventricular myocytes from 8 week ligation rat hearts (Yamaguchi et al., 1997).  Afzal & 
Dhalla found that Ca2+ uptake in SR vesicles prepared from 16 week ligation rat hearts was 
reduced by ~65%, although protein expression was only reduced by 30% (Afzal & Dhalla, 
1996).  The study reported that the Ca2+ and ATP affinity of SERCA was unaltered, and 
that stimulation of Ca2+ uptake activity by exposing SR vesicles to PKA or calmodulin 
resulted in a significant greater % increase in SR Ca2+ uptake of failing SR vesicles in 
comparison to controls at all concentrations used.  However, maximal Ca2+ uptake rate 
(Vmax) remained significantly depressed in failing SR vesicles following PKA/calmodulin 
stimulation in comparison to controls.  The authors concluded this was likely to have 
occurred due to an alteration in phospholamban expression or function although neither 
parameter was directly measured (Afzal & Dhalla, 1996).  In a rabbit coronary artery 
ligation model of myocardial infarction, left ventricular dysfunction was evident 8 weeks 
after coronary artery ligation, with a significantly reduced ejection fraction in comparison 
to sham operated controls (41.1% vs. 73.8%) (Ng et al., 1998).  Peak systolic pressure and 
the maximal rates of pressure rise and fall (measured in isovolumically beating 
Langendorff perfused hearts) were also significantly depressed.  This model was associated 
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with an ~50% reduction in SERCA and PLB protein expression, however the SERCA:PLB 
ratio was not evaluated.  Isolated SR vesicle preparations from 8 week ligation animals 
also revealed that SR Ca2+ uptake was reduced to ~50% of that seen in sham hearts (Currie 
& Smith, 1999).  A reduced level of protein expression and function of SERCA and its 
regulatory protein PLB therefore appears frequently in characterization of heart failure 
models and could explain the decline in SR Ca2+ content seen in a number of heart failure 
studies 
1.5.3.2 The ryanodine receptor in heart failure   
As described above, Ca2+ release from the sarcoplasmic reticulum provides a large 
proportion of the Ca2+ required for contraction and as such the function of the SR Ca2+ 
release channel, the Ryanodine receptor, is critical in maintaining the highly graded 
mechanism of CICR.  Β-adrenergic stimulation of the cardiac myocyte activates a 
signalling cascade resulting in activation of PKA which binds to the RyR and increases 
channel Po.  Marx et al. (2000) reported that PKA ‘hyper-phosphorylation’ of RyR at 
Ser2808 occurred in failing human hearts, resulting in dissociation of the regulatory protein 
FKBP12.6 from the channel complex, increased sensitivity to activation by luminal Ca2+ 
and the induction of channel sub-conductance states (Marx et al., 2000).  A similar finding 
was reported in a canine pacing-induced heart failure model, as well as a number of MI 
models (Obayashi et al., 2006; Wehrens et al., 2005; Yano et al., 2000)  The resultant 
conformational change in RyR induced significant Ca2+ leak through the channel.  These 
findings lent weight to the theory that diastolic Ca2+ leak from the sarcoplasmic reticulum 
may contribute to altered contractile function in heart failure by participating in the decline 
of SR Ca2+ content, as well as increasing the propensity for diastolic Ca2+ release events to 
occur which may serve as a triggering mechanism for DADs and ventricular arrhythmias.   
 
Several controversies have arisen however which suggest this may not be the complete 
story.  Some studies have shown no effect of PKA hyper-phosphorylation at Ser2808 
(Ser2809 in rabbits) on FKBP12.6 binding to RyR2 (Stange et al., 2003; Xiao et al., 2004).  
Furthermore, the enhanced diastolic Ca2+ leak following β-adrenergic stimulation has been 
demonstrated in a rabbit MI model of heart failure to be mediated through phosphorylation 
of RyR by CaMKII, not PKA (Ai et al., 2005; Curran et al., 2007).  Recently, the idea of 
defective inter-domain interactions between the N and C-terminals of the RyR has been 
proposed in a number of studies (Tateishi et al., 2009; Yamamoto et al., 2008).  In SR 
vesicles from normal canine hearts introduction of domain peptides which correspond to 
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the amino acid sequence of interacting zipper domains leads to a conformational change in 
the channel and the appearance of a significant Ca2+ leak without dissociating FKBP12.6 
from the channel complex (Tateishi et al., 2009).  SR vesicles from failing canine hearts 
however already exhibited a similar Ca2+ leak profile which was not altered with addition 
of the same domain peptide.  The relative roles of PKA phosphorylation of RyR2 and 
dissociation of FKBP12.6 from the channel complex to induction of diastolic Ca2+ leak in 
heart failure therefore remains controversial.       
1.6 Isolated perfused heart preparations 
Investigations using isolated single cell preparations have revealed an enormous amount of 
information regarding specific function of Ca2+ cycling proteins within the ventricular 
myocyte, their interaction in EC coupling, and alteration in disease states.  How such 
observations impact cardiac function at the whole organ level however cannot be directly 
extrapolated from such work.  A fuller understanding of how intracellular components of 
cardiac EC coupling impinge on the normal function of the heart may be obtained using 
more physiologically relevant in vivo models.  Specific manipulation of cardiac function in 
the intact animal however is frequently complicated by alterations in vascular tone, 
circulating factors, and in the case of pharmacological interventions, non-specific extra-
cardiac effects.  In this respect the isolated perfused heart preparation offers a number of 
unique advantages to studying cardiac function.  The basic preparation offers a high level 
of reproducibility and can be modified to allow measurement of a vast array of 
physiological indices.  The major advantage lies in the ability to rigorously control the 
experimental conditions imposed on the heart without confounding systemic effects such 
as sympathetic and vagal stimulation, circulating factors and the potential influence of 
anaesthetic on the preparation.  Since the perfusion medium of the heart (most commonly a 
crystalloid buffer solution) is strictly controlled by the investigator, isolated heart 
preparations are superbly suited to the investigation of cardiac responses to metabolic 
substrate supply, hypoxia and pharmacological interventions.  Regional and global changes 
in coronary flow can readily be manipulated to induce ischaemia.  Indeed, isolated heart 
preparations have proven to be an invaluable analytic tool in the study of ischaemia-
reperfusion injury and associated phenomena, including myocardial stunning and 
preconditioning. 
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1.6.1.1 The isolated mammalian heart preparation according to Langendorff 
In 1898 Oscar Langendorff described the isolated mammalian heart preparation, in which 
an excised intact heart (principally from cats, although he did employ rabbit and canine 
cardiac preparations) could be kept alive for a prolonged period by delivery of blood to the 
aortic root through a cannula attached to the ascending aorta (Skrzypiec-Spring et al., 
2007; Zimmer & Millar, 1998).  Using a constant perfusion pressure head, blood was 
delivered to the aortic root in a retrograde fashion, causing the aortic valves to close and 
blood to flow through the coronary circulation, eventually exiting from the coronary sinus 
into the right atrium.  Measurement of cardiac contractile function can be achieved using 
this preparation.  Ventricular pressure parameters may be recorded by inflation of a latex 
balloon in the left ventricle as depicted in Figure 1.5, introduced via the left atrium, and 
recording of isovolumic ventricular pressure parameters through an attached microtip 
pressure transducer.  One disadvantage of this is that isovolumic contractions are less 
energetically demanding in comparison to in vivo contractions which produce pressure-
volume work during the cardiac cycle (Merx & Schrader, 2009). 
   
 
Figure 1.5 Isolated perfused heart according to Langendorff.  The isolated heart is cannulated via the 
aorta and perfused from a constant pressure head using blood or crystalloid buffer perfusate (pictured).  
Insertion of a latex balloon into the LV attached to a pressure transducer allows the investigator to set end 
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diastolic pressure and measure isovolumetric contractions.  (Diagram taken from Sutherland & Hearse (2000) 
Pharmacol. Res. 41(6) 613-627). 
1.6.1.2 The isolated working heart preparation can be used to investigate 
cardiac mechanical function  
The aforementioned problems associated with measurement of contractile function using 
Langendorff perfused hearts was addressed by Neely et al. (1967) who investigated the use 
an isolated heart preparation capable of performing ex vivo pressure-volume work (Neely 
et al., 1967). This preparation, termed the isolated working heart, modified the existing 
setup described by Langendorff by additional cannulation of the pulmonary ostium 
separately and introduction of perfusion solution to the left atrium, where it would enter 
the left ventricle and be ejected out through the aorta against a hydrostatic pressure head.  
This setup is advantageous for investigation of cardiac mechanical function as the 
pressure-volume work performed by the heart is more physiologically relevant than the 
isovolumic pressure measurements attainable from the use of the balloon insertion method. 
1.6.1.3 The pressure-volume loop allows description of the intrinsic 
contractile and relaxation properties of the left ventricle 
The importance of ventricular volume with respect to contractility of the myocardium has 
been apparent since the classic description of the Frank-Starling mechanism, whereby an 
increase in filling pressure, induced by increasing the volume filling the heart, augments 
ventricular contractility and stroke volume.  Due to the technical difficulty in obtaining 
accurate volume measurement within the heart however, the utility of the pressure-volume 
(PV) diagram for the description of intrinsic myocardial contractility did not receive much 
attention until the latter half of the 20th century, when a fundamental series of experiments 
using the isolated blood-perfused canine heart preparation revealed that intrinsic contractile 
and relaxation properties for any given ventricle could be described independent of load by 
fitting an appropriate relationship to the end systolic and end diastolic pressure-volume 
points obtained by altering the loading conditions imposed on the ventricle (Suga et al., 
1973; Suga & Sagawa, 1974; Sunagawa et al., 1983).  Simultaneous measurement of 
pressure and volume within the ventricular chambers of the heart (most commonly the left 
ventricle) allows the 4 phases of the cardiac cycle, isovolumic contraction, ejection, 
isovolumic relaxation and ventricular filling, to be conveniently visualised in a diagram 
known as the pressure-volume loop.  From such a plot direct comparisons of a number of 
useful functional indices can be made between hearts exposed to varying experimental 
conditions, including ejection fraction and stroke volume.  Crucially however, intrinsic 
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contractile properties of the ventricle independent of load can be obtained by transiently 
altering loading conditions imposed on the ventricle without altering myocardial 
contractility.  The relationship between end-systolic and end-diastolic pressure volume 
points from the resultant family of PV loops may then be used to describe the intrinsic 
systolic (ESPVR) and diastolic (EDPVR) properties of the ventricle, as shown in Figure 
1.7.  The ESPVR is commonly described using a linear relationship with a unique slope 
(Ees) and volume intercept (Vo), while the EDPVR is inherently non-linear and is often 
described using a mono-exponential curve fit. 
   
Figure 1.6 The pressure-volume loop.  A.  Idealised pressure-volume diagram highlighting the 4 phases of 
the cardiac cycle.  End systole and end diastole are demarcated by the upper left and lower right hand corners 
of the loop, respectively.  Transiently altering loading conditions by (B) preload reduction or (C) increasing 
afterload creates a family of PV loops.  End systolic pressure volume points form a linear end-systolic 
pressure-volume relationship (ESPVR) characterised by a slope (Ees) and volume intercept (Vo), while the 
end diastolic pressure-volume points describe a non-linear end diastolic pressure volume relationship 
(EDPVR).  (Panels adapted from Burkhoff et al. (2005) Am. J. Physiol. 289(2) 501-512). 
A number of techniques now exist which allow determination of ventricular volume in the 
intact animal including echocardiography and magnetic resonance imaging.  The 
disadvantage of such techniques with regard to volume analysis is that they rely on 
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averaging of steady state images and therefore lack the continuous volume signal required 
for transient loading/unloading manoeuvres.  Conductance catheter technology overcomes 
this limitation by enabling instantaneous and continuous volume recording within the left 
ventricle, allowing assessment of ventricular pressure-volume relationships.  The technique 
involves insertion of a multi-electrode catheter into the left ventricular chamber via the 
aorta to encompass the entire ventricular long axis.  The catheter measures relative changes 
in the conductance of blood during the cardiac cycle, reflective of ventricular filling and 
ejection during the cardiac cycle, which is then calibrated to achieve a measure of true 
volume.  The technical aspects of conductance catheter technology are described in detail 
in the General Methods chapter.  While predominantly employed for in vivo studies, the 
use of combined pressure and volume measurement greatly enhances the potential of the 
isolated working heart for assessment of cardiac mechanical function, and several reports 
have validated its use in ex vivo working heart preparations from a number of species, 
including mice, dogs and swine.   
1.7 Aims 
Manipulation of intracellular Ca2+ handling dynamics, with particular emphasis on the 
sarcoplasmic reticulum Ca2+ release channel and the Ca2+ pump, has been extensively 
investigated using single cell preparations.  The consequences of interventions which alter 
SR Ca2+ handling proteins to whole heart mechanical function are however, less well 
characterised.  Therefore the initial aim of the work described in this thesis was to set up 
and characterise an isolated working heart preparation using rabbit hearts that would act as 
a platform for manipulation of SR function using various pharmacological approaches.  In 
order to assess the impact of such interventions on mechanical function, this preparation 
was paired with a miniaturised pressure-conductance catheter which affords assessment of 
left ventricular function through analysis of both pressure and volume data instantaneously 
and continuously recorded within the left ventricle. 
The next set of aims was to characterise the influence of the 1, 4-benzothiazepine 
derivative K201 on cardiac function in healthy hearts and under various experimental 
conditions where SR Ca2+ release via the RyR is believed to be altered.  K201 has been 
demonstrated in single cell studies to interact with the cardiac RyR, stabilising the channel 
in its closed state and inhibiting SR Ca2+ release.  Alteration of RyR function has been 
proposed to be a major contributor to arrhythmogenicity and contractile abnormalities in 
various cardiac disorders including ischaemic heart failure.  The effects of this compound 
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on cardiac contractile function in healthy intact hearts however have yet to be described.  
Therefore the second aim was to characterise working heart mechanical function following 
exposure to varying concentrations of K201.  The study then aimed to investigate the 
influence of acute perfusion of K201 under conditions where SR Ca2+ release is thought to 
be altered; 1) using elevated [Ca2+]o and β-adrenergic stimulation, known to cause Ca2+ 
overload in intact ventricular myocyte preparations and 2) in a rabbit ligation model of left 
ventricular dysfunction.   
The final set of aims was to assess the contribution of intact SR Ca2+ uptake to normal left 
ventricular contractility and relaxation by perfusion of isolated working hearts with the 
selective SERCA inhibitor thapsigargin to inhibit Ca2+ uptake into the SR.
   
 
 
 
 
 
 
 
 
  
2 General Methods 
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2.1 The isolated working heart technique  
The technique is based on the principle that a heart isolated from the body can be studied 
ex vivo for a prolonged period of time provided the coronary circulation is perfused with 
oxygenated blood or equivalent physiological solution (Skrzypiec-Spring et al., 2007).  
When perfusion solution is delivered to the coronary circulation in a retrograde fashion, 
also known as Langendorff  perfusion, the heart will not perform external work (ejection of 
blood from the left ventricular chamber into the aorta) as no fluid will be present in the left 
ventricle (Merx & Schrader, 2009).  Cannulating the left side of the heart and introducing 
perfusion solution into the left atrium, and subsequently the left ventricle allows the heart 
to perform pressure-volume work (Merx & Schrader, 2009). 
2.1.1 Experimental Setup 
Figure 2.1 shows the equipment setup used for the isolated working heart experiments.  
The setup was based upon an approach described by Neely et al. (Neely et al., 1967).  A 
dual-head peristaltic pump controlled the flow of perfusate directed towards a number of 
bubble traps, depicted in Figures 2.1 & 2.2.  With a bubble trap open to air, any solution 
required by the heart would enter under a hydrostatic pressure head dictated by the height 
of the chamber, with the remainder returning to one of two reservoirs through an overflow.  
The system was capable of initially perfusing hearts in Langendorff mode (Figure 2.1 (ii)) 
under constant pressure, adjustable via the height of bubble trap B2.  Flow could be 
redirected via several three-way taps located around the system to then establish working 
heart in non-recirculating mode (Figure 2.2 (i)).  In this configuration hearts were provided 
with solution via the main 5 L reservoir, with smaller 2.5 L containers heated in a separate 
water bath providing a backup volume.  For experiments requiring perfusion of a fixed 
volume the recirculating reservoir was filled and flow could be redirected back through the 
system via the second pump head to establish the working heart in recirculating mode 
(Figure 2.2 (ii)).  Two 5 µm pore in-line filters (Millipore; Billerica, MA) arranged in 
parallel facilitated the removal of unwanted debris from the recirculating perfusate.  This 
bypass configuration permitted the replacement of filter membranes during experiments 
where necessary.  The recirculating volume in experiments where recirculation of solution 
was required was 540 ml.  A defined length of tubing was present between the reservoirs 
and the heart used in either working heart mode which meant that there was a time delay 
between the addition of a drug or agent to the reservoir and that drug/agent reaching the 
heart and perfusing through the coronary circulation.  This time was initially determined by  
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the speed of the peristaltic pump delivering solution to the preload chamber, with the rate 
of inflow into the heart contributing to the remaining delay.  To eliminate differences in 
time delay between experiments the pump speed was adjusted to deliver 450 ml of solution 
per min during drug additions.  This was calculated as a delay of 14.4 ± 0.5 s from addition 
to a reservoir to reaching the heart.  
  
In both recirculating and non-recirculating working heart modes, left atrial filling pressure 
was dictated by the height of bubble trap B1.  The afterload imposed on each heart was 
dictated by the height of the afterload chamber, which was also partially filled with 
perfusate.  An in-line ultrasonic flowmeter (Malema; Florida, US) was located between the 
aortic cannula and the compliance chamber for continuous monitoring of aortic flow.     
2.1.2 Perfusion of the isolated working heart 
2.1.2.1 Inflow tract design  
Cardiac output of the isolated working heart can be augmented under a diverse set of 
experimental conditions, for example by increasing left atrial filling pressure or by 
applying an inotropic agent to the perfusion medium.  It was therefore essential that both 
the peristaltic pump and the left atrial cannula were able to provide a volume that would 
exceed the maximum cardiac output expected in the isolated working rabbit heart for any 
given inotropic state.  This ensures that the cardiac output of the isolated heart is not 
limited by the constraints of the perfusion system itself.  Values for mean cardiac output 
vary significantly between studies depending on the setup used, the perfusion medium and 
the loading conditions imposed for the individual investigation, however mean baseline 
cardiac outputs as high as 272 ± 32 ml.min-1 have been reported for crystalloid buffer 
perfused working rabbit hearts (Vanagt et al., 2007).  In vivo cardiac outputs in the rabbit 
as assessed by thermodilution tend to be higher but are susceptible to variability depending 
on anaesthesia used (Chalmers et al., 1967; Desager et al., 1979; Edwards et al., 1959; 
Neutze et al., 1968).  Reported values range from 110 ml.kg-1.min-1 (anaesthetized with 
sodium pentobarbital) to 215 ml.kg-1.min-1 (unanaesthetised) (Neutze et al., 1968).  The 
range of cardiac outputs expected in a 3 kg rabbit in vivo therefore would potentially be 
between 330 to 645 ml.min-1.  Using 5.5 mm internal diameter silicon tubing the peristaltic 
pump was capable of a maximum flow rate of 1500 ml.min-1.  4.5 mm was found to be the 
largest internal diameter possible for the atrial cannula.  Correct cannulation of the 
pulmonary orifice became very challenging with larger cannulae. Using a 4.5 mm internal 
diameter it was possible to achieve a maximum flow of 470 ml.min-1 at a left atrial filling 
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pressure of 10 cmH2O (7.4 mmHg), with stepwise increments of this maximum attained 
through increasing filling pressure.   
2.1.2.2 Outflow tract design 
The design of the aortic outflow tract is crucial in determining the aortic impedance 
experienced by the isolated working heart.  The aorta and large arteries in vivo are partially 
distensible which allows the arterial lumen to increase in diameter during systole.  This 
Windkessel or elastic reservoir effect serves to prevent excessive increases in blood 
pressure during systole.  In the isolated working heart system, a compliance chamber 
partially filled with air was located in the aortic outflow line which provided an aortic 
Windkessel to compensate for the lack of elasticity of the outflow tubing (Belz, 1995; 
Podesser et al., 1993).  Previous investigators have shown that the pressure drop across the 
proximal portion of the aortic cannula is critical to the long-term stability of the isolated 
working heart (de Windt et al., 1999; Van Bilsen et al., 1991) and a major determinant of 
this is the internal diameter of the cannula.  The largest possible internal diameter of the 
aortic cannula was 4.5 mm.  Using this diameter ensured pressure drop was kept as low as 
possible whilst maintaining ease of cannulation of the aortic stub. 
  
Both the aortic and left atrial cannulae were designed with offshoot arms, each fitted with a 
sealable plastic haemostasis valve, through which the pressure and conductance catheters 
were inserted.  The side ports were also used for perfusion of various drugs and solutions 
where timing was critical and addition via the main reservoir was not possible.  Cannulae 
were made of clear plastic which facilitated the detection and removal of air bubbles that 
formed in the openings prior to cannulation. 
2.1.3 Experimental preparation 
2.1.3.1 Solution preparation and system priming 
Prior to beginning of experimentation thorough cleaning of the equipment and glassware 
was performed.  10 – 15 L of double-distilled water was perfused through the system 
followed by 2 L of boiling de-ionised water.  A bicarbonate buffer based Tyrode’s solution 
was prepared containing (in mM) NaCl (116), NaHCO3 (20), Na2HPO4 (0.4), MgSO4 (1), 
KCl (4), CaCl2 (2.5) and Glucose (11), gassed with a 95% O2 – 5% CO2 mixture to 
maintain pH at 7.4.  All solutions were suction filtered through a 5 µm pore filter using a 
5L Buchner flask and a stainless steel filter apparatus before entering the system to remove 
any possible debris.  A water bath was linked via a network of Tygon tubing connections to 
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all water-jacketed glassware components on the system, allowing solution temperature to 
be maintained at 37 ºC throughout.  The isolated working heart system was primed prior to 
experiments to fill the system with Tyrode’s solution for perfusion of the isolated heart.  
Care was taken to ensure no air bubbles were present in any of the tubing in order to 
prevent air emboli occurring in coronary circulation.  Bubble traps were primed with 
solution up to the level of the overflow, leaving a volume of air to capture stray bubbles 
before they could enter the heart.  After priming the afterload line and filling the 
compliance chamber with an appropriate volume of air, perfusion was switched to 
Langendorff mode before the outflow lines were clamped and the peristaltic pump stopped. 
2.1.3.2 Heart Isolation and cannulation 
Surgical removal of the heart was a licensed procedure, performed by one of two 
technicians (Aileen Rankin or Michael Dunne) licensed to carry out the procedure, with 
assistance provided by myself.  New Zealand White rabbits weighing 3.0 – 4.0 kg, were 
injected with 0.5 ml Heparin (5000 IU.ml-1) and an overdose of sodium pentobarbital (100 
mg.kg-1).  Following thoracotomy hearts were quickly excised from the animal and 
submerged in a beaker containing cold (4 ºC) Tyrode’s solution.  Hearts were weighed 
before being moved to the working heart system.  The peristaltic pump was started again 
and perfusate was allowed to flow freely through the aortic cannula, with a portion of the 
flow returning to the main reservoir via an overflow on bubble trap B2.  Hearts were 
quickly cannulated via the aorta and perfused in a retrograde fashion at a pressure of 60 
mmHg.  The entire process from injection of the animal to initiation of perfusion took no 
longer than 3 min to achieve.  A small cut was made in the base of the pulmonary artery to 
ensure unimpeded flow of the coronary perfusate exiting from the right side of the heart.  
Excess fat and lung tissue was removed to reveal a common pulmonary vein ostium.  The 
left atrial inflow cannula was left to drip constantly to ensure no air bubbles were present 
during cannulation. The cannula was positioned over the ostium which was carefully 
cannulated, taking time to ensure there were no leaks present.  A pair of platinum 
subdermal needle electrodes were positioned on the right atrium.  These connected to a 
constant voltage isolated stimulator and train generator (Digitimer; Hertfordshire, UK) for 
experiments requiring electrical pacing of the heart. 
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2.1.4 Working heart perfusion and pressure-volume 
catheterization 
2.1.4.1 Insertion of PV catheter   
Following completion of the necessary preparatory steps, working heart was initiated.  The 
aortic outflow tract was switched from Langendorff bubble trap B2 to the working heart 
afterload chamber.  The air and overflow openings on bubble trap B1 were opened, 
perfusate was redirected to the left atrial cannula and working heart was established.  
Where appropriate, perfusate recirculation was instituted first.  Hearts were then given a 5 
min stabilization period to equilibrate.  A 3F pressure-volume catheter (Scisense; Ontario, 
Canada) was situated in a haemostasis valve connected to the aortic cannula.  The 
haemostasis valve was opened slightly to allow unrestricted movement of the catheter and 
the tip was slowly advanced past the aortic valves and into the left ventricular cavity. The 
haemostasis valve was then closed to secure the catheter within the left ventricle.  
2.1.4.2 Establishment of baseline working heart function  
Haemostasis valve positioning was manipulated in order to obtain a desirable pressure-
volume loop, which was defined as the widest and straightest PV loop achievable.  Using 
this rule allowed achievement of the largest stroke volume possible in order to minimize 
the calibration factor alpha (see Section 2.3.4).  Afterwards the valve was clamped into 
position.  Hearts were paced by switching on the isolated stimulator and train generator 
and setting the frequency of stimulation as required (usually 3.3 Hz).  Afterload was then 
adjusted depending on the requirements of the experiment and hearts were left to 
equilibrate for 5 minutes.  
2.1.4.3 Introduction of saline bolus 
A 0.15 ml bolus of 20 % saline at 37 ºC was injected into the left atrial inflow line via a 
side-port to estimate parallel conductance.  Hearts were then left for a further 5 minutes 
before baseline functional measurements were obtained.  The entire process from initiation 
of working heart to measurement of baseline function took on average 30 min to complete.  
Parallel conductance estimation is explained in detail in Section 2.3.3 later in this chapter. 
2.1.4.4 Estimation of left ventricular pressure-volume relations 
Estimation of left ventricular pressure-volume relations was performed by transient 
occlusion of the left atrial inflow line to obtain a family of pressure-volume loops, and 
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commencement of the experimental procedure took place thereafter.  Ventricular pressure 
volume relations are described in greater detail in Section 2.3.7 of this chapter.  Coronary 
flow was measured at regular intervals throughout the experiment by manual timed 
collection of perfusate dripping from the heart into a graduated cylinder.  Cardiac output 
was calculated as the sum of aortic flow and coronary flow and was used to estimate alpha 
in volume signal calibration (described in detail in Section 2.3.4).  It should be noted that 
the sum of aortic flow and coronary flow was also equal to the inflow volume. 
2.1.5 Data recording 
All electrical and electronic recording equipment was connected to an 8-channel Powerlab 
A-D convertor (ADInstruments; Oxfordshire, UK), linked to a Dell Personal Computer.  
Data were captured at a sampling rate of 1000 Hz using ADInstruments LabChart Data 
Acquisition software version 5.5.6 and displayed throughout on a 22“ monitor connected to 
the PC.  Following the end of experiments data were immediately saved to the PC and 
backed up on an external hard disk for off-line analysis. 
2.2 Assessment of left ventricular function using 
miniaturised pressure-volume catheterisation. 
Simultaneous measurement of pressure and volume is regarded as the most effective means 
of permitting extensive characterization of intact heart function experimentally 
(Georgakopoulos et al., 1998; Kass, 1992).  Currently the gold standard for assessment of 
intact heart function involves the use of pressure-volume catheters.  Virtually all of the 
data gathered during this study stem from the use of miniaturized pressure-volume 
technology.  The following sections will briefly explain the theory of pressure and volume 
catheterisation separately before describing calibration of each.  While this technique has 
been used extensively in vivo in a large number of species including rabbit, there are very 
few descriptions of pressure-volume technology in isolated working heart preparations 
(Araki et al., 2005; Burkhoff et al., 1985; Grieve et al., 2004; How et al., 2005), with no 
description of its use in an isolated working rabbit heart preparation available at the time of 
writing.  This therefore necessitated detailed characterization of miniaturized pressure-
volume technology in relation to its application to the isolated working rabbit heart. 
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2.2.1 Why study the pressure-volume loop? 
The advantage of instantaneous pressure-volume measurement lies in the ability to assess 
load-independent indices of contractility and relaxation.  Measurement of volume and 
ventricular chamber dimensions obtained by echocardiography or MRI alone offer 
information about the pump function of the heart under a particular set of loading 
conditions, but these techniques rely on averaging of steady state images over several 
seconds and therefore do not provide load-independent assessment of contractility, which 
requires interventions that acutely alter loading conditions.  The pressure-conductance 
catheter technique in contrast provides an instantaneous and continuous signal for pressure 
and volume.  Occlusion manoeuvres performed during conductance catheterization permit 
assessment of end systolic and end diastolic pressure volume relationships (ESPVR and 
EDPVR respectively) allowing characterization of the intrinsic contractile properties of the 
ventricle and providing information useful for both clinical and basic research (Burkhoff et 
al., 2005). 
2.2.2 Pressure measurement by micromanometer pressure 
transducer 
The current favoured method of pressure measurement in the intact heart is through the use 
of ultra-miniature pressure tipped transducers.  These solid-state pressure transducers 
consist of a thin silicon diaphragm sensing apparatus with 2 implantable semiconductor 
strain gauges whose electrical resistance changes upon deformation, with the change 
corresponding linearly to a change in pressure (Zimmer & Millar, 1998).  Measurement of 
left ventricular pressure was performed using a 3F Scisense variable segment length (VSL) 
combined pressure-volume catheter inserted into the left ventricular chamber via the aorta 
(segment lengths; 12, 15, 17 and 19 mm – Figure 2.3B(ii)).  An SPR-320 2F 
micromanometer-tipped catheter (Millar; Texas, US) was inserted via a side-port 
haemostasis valve connected to the aortic cannula for measurement of aortic pressure.  
Measurement of atrial pressure was also performed by insertion of a Millar SPR-851 
pressure-volume catheter into the left atrial cannula via a second side-port haemostasis 
valve.  Pictures of the Scisense and Millar PV catheters and amplifier control boxes are 
shown in Figure 2.3.  A third Millar pressure-volume catheter, SPR-878 (Figure 2.3B(i)) 
was used for calibration experiments (see Section 2.3.2) but was not included in the 
isolated working heart setup. 
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Figure 2.3 Pressure-volume catheter technology.  A.  Millar rabbit PV catheter.  Typical pressure-volume 
catheter features are highlighted.  B (i) Millar 12 mm rat PV catheter and (ii) Scisence VSL rabbit PV 
catheter.  C.  Control units for (i) Millar and (ii) Scisense PV catheters. 
2.2.3 Pressure sensor calibration 
Prior to each experiment catheters were connected to their respective pressure amplifiers, 
with each catheter tip left soaking in separate saline filled bijous floated in a water bath at 
37 ºC.  Catheters were left for at least 45 minutes prior to experiments to warm up.  This 
ensured maximum stability of the pressure signal and prevented drift over long periods.  
Signal calibration was based on a 2-point linear calibration technique.  Briefly, the input 
settings menu for each pressure channel was accessed individually within LabChart and 
the software displayed output voltages from each sensor with respect to time.  Both the 
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Scisense and Millar pressure amplifiers were equipped with a calibration control switch 
that allowed output of preset voltage values corresponding to 0 and 100 mmHg.  With the 
catheter tip bathed in 37ºC Tyrode’s solution the calibration control switch was turned 
from ‘Transducer’ to ‘0’.  After ensuring this 0 pressure voltage reference was captured by 
Labchart, the switch was then turned to ‘100’.  The voltage values along with their 
corresponding pressure value were then entered into a units calibration interface.  Using 
these two values Labchart would then create a linear calibration by drawing a straight line 
between the two points and calculating the slope.  Calibration of both Scisense and Millar 
pressure sensors was performed in the same manner as described above, however it should 
be noted that the Scisense amplifiers have preset outputs of -2.86 V and -0.56 V for 0 and 
100 mmHg respectively, while the Millar amplifier had preset outputs of 0 V and +1V for 
0 and 100 mmHg respectively.  Once a calibration curve was established, pressure sensors 
were balanced to 0 using a balance adjustment control switch found on the pressure 
amplifier.  Sensors were balanced to 0 by holding the catheter with the sensor dipped under 
a meniscus of double distilled water at 37 ºC and adjusting the balance control switch until 
the Labchart output read 0 mmHg.  At this point the pressure sensor was ready to be used. 
2.2.4 Pressure sensor linearity and stability 
The voltage-pressure linear relationship for both Millar and Scisense pressure sensors was 
tested using a Delta-Cal pressure transducer tester (Utah Medical; Midvale, UT).  This 
handheld electronic device contains a built-in pre-calibrated solid state pressure transducer 
linked to an LCD display.  Following calibration of the pressure sensors as described 
above in section 2.2.3, the catheters were placed inside a haemostasis valve which was 
then attached to the Delta-Cal via a side-port connector.  A pneumatic pump within the 
Delta-Cal was used to generate a pressure that was applied to both the built-in transducer 
and the pressure sensor attached to the side port.  The pressure applied to the internal 
transducer was increased from 0 to 100 mmHg in 10 mmHg steps and compared with the 
pressure output generated by the catheter.  Figure 2.4 shows the results of the pressure 
generated by the Delta-Cal versus the pressure output from both Scisense and Millar 
catheters.  Both sensors demonstrated excellent linearity and were in agreement with the 
independently generated pressures of the Delta-Cal.  Provided catheters were warmed for 
45 min to 1 hour before balancing, the Scisense and Millar pressure sensors were also 
stable over extended periods of time, demonstrating signal drifts of less than 1 mmHg per 
hour.  These findings were in agreement with those of a previous study confirming the  
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Figure 2.4 Pressure sensor linearity.  A.  Scisense VSL catheter attached via haemostasis valve to the 
Delta-Cal.  B.  Delta-cal pressure reading vs. Millar and Scisense catheters 
 
accuracy and stability of solid-state pressure transducers from four separate manufacturers 
including Scisense and Millar (Hartley et al., 2008). 
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2.3 Volume measurement by conductance catheter 
Conductance catheter technology, originally developed by Jan Baan and colleagues (Baan 
et al., 1981; Baan et al., 1984) involves the insertion of a catheter with at least 2 pairs of 
ring electrodes, longitudinally into the left ventricle.  Pressure-volume catheters used in 
this study are shown in Figure 2.3, with electrodes for the single segment Millar SPR-851 
labeled E1 to E4.  E4 is the proximal electrode (located closest to the catheter handle), with 
E1, the distal electrode located closest to the tip of the catheter.  E2 and E3 lie in between 
E1 and E4 and comprise the volume sensing component of the catheter.  A constant current 
is passed through E4 with E1 acting as a ground reference.  This results in the generation 
of an electric field within the ventricular chamber.  As blood is a conductive medium, the 
voltage between the inner pair of electrodes E2 and E3 can be measured throughout the 
cardiac cycle.  Conductance (G) is related to voltage by the equation 
     
V
I
R
G  1      (1) 
Where I is current (amps) V is voltage (volts) and R is resistance (Ω).  The voltage 
measured between two recording electrodes is inversely proportional to the volume of 
blood surrounding the electrodes (Pacher et al., 2008).  As volume within the ventricle 
increases during diastole, the resistance (and therefore voltage) measured by the catheter 
decreases, and conductance increases.  As blood is ejected during systole, the measured 
resistance of the blood pool increases and conductance decreases.  Using this method it is 
therefore possible to measure instantaneous changes in conductance during the cardiac 
cycle.  In order to convert this conductance signal into true volume the length of the 
recording segment, as well as the specific resistivity of blood must also be taken into 
account.  The original equation proposed by Baan was 
     GLVol 2           (2) 
Where Vol is the instantaneously measured volume (ml), ρ is the specific resistivity of 
blood (Ω-cm), and L is the length of the recording electrode segment (mm).  Two elements 
were incorporated into (2) to yield 
          )(1 2 PGGLVol  
         (3) 
Where α is a dimensionless constant used to correct the volume signal for non-uniformity 
of the electric field and Gp, also known as parallel conductance, is a term used to describe 
conductance measured by the catheter owed to structures other than the blood within the 
left ventricle.  Calculation of these two parameters is discussed in detail later in this 
chapter. 
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2.3.1 Volume signal calibration  
Calibrating the conductance signal to achieve actual volume measurements was performed 
by creating a 2 point calibration curve in the data acquisition software similar to the 
method previously described for the pressure sensor.  This could be performed in two 
ways.  The first utilizes solutions of equal volume but different known conductance values 
to create a linear relationship between voltage output and conductance, with the resulting 
conductance values then being applied directly to Baan’s equation to obtain true volume.  
The second method requires the use of a conductance cuvette (pictured in Figure 2.5 A (i)), 
an acrylic block with precisely machined wells of matching depth but increasing diameter, 
and hence volume.  Cuvette wells were filled with a saline solution matching the specific 
conductivity of the blood of the animal being studied.  In the case of the isolated working 
heart, the Tyrode’s solution made for each experiment was used directly.  The catheter was 
placed in a well to display a voltage reading on the data capturing software being used.  
Great care was taken to ensure the catheter was central within the well as this was where 
the highest voltage signal was obtained.  Slight deviation from centre would result in 
underestimation of the voltage signal.  The purpose of this calibration was to establish a 
linear relationship between the raw analogue signal and measured volume, and then 
establish the slope of this line.  Provided that the relationship is indeed linear, all points in 
between the 2 calibration values used will fall on this line.  The total volume of solution 
that each well held was inconsequential, as the catheter only recorded volumes lying 
between the recording electrode segment (denoted by the symbol L in Baan’s equation).  
The relationship between measured volume and cuvette diameter for some commonly used 
recording electrode segments can be seen in Figure 2.5 A(ii).  Several factors were taken 
into account before commencing calibration using this method:  
  
(1)  The specific resistivity, ρ, of the solution being used is heavily temperature dependent, 
increasing by 2.1 % per degree Celsius as it cools from body temperature to room 
temperature.  Calibrating cuvettes were fixed to the inside of the isolated working heart 
water bath, heating the solution within to 37 ºC.  This eliminated the possibility of 
differences in solution conductivity between calibration and during the working heart 
experiment.  
 
(2)  The conductance signal measured by the catheter depends on the position of the 
catheter within the well, with the largest signal being achieved when the catheter was 
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central in a given well.  To maintain the accuracy of the calibration care was taken when 
moving between wells to achieve the highest conductance signal possible. 
2.3.1.1 Choosing lower and upper volume calibration limits   
A custom design 3F Scisense variable segment length (VSL) catheter and two Millar 
pressure volume catheters (SPR-878, 12 mm spacing; SPR-852, 18 mm spacing) were 
calibrated using the 2-point calibration described above.  The Scisense catheter permitted 
selection of the length of the recording segment from 14, 17, 20 and 23 mm in order to 
accommodate rabbit hearts of varying ventricular long axis (VLA) dimensions.  A smaller 
Scisense VSL catheter featuring 12, 15, 17 and 19 mm electrode spacing was also 
available.  Two cuvette wells of known diameter were chosen for an initial 2-point 
calibration using the LabChart software.  The cuvette wells were chosen to represent the 
highest and lowest volumes expected from the isolated working rabbit heart, which were 
estimated from preliminary experiments.  Cuvette wells of diameter 8.0 mm and 14.0 mm 
were chosen to represent the low and high volume limits of the linear relationship.  Since 
the calibration volume varied depending on the segment length chosen the rationale for 
selecting these calibration volumes was based on the most commonly used electrode 
spacing segment, 19 mm, such that the low calibration volume was 955.04 µl, and the 
highest calibration volume 2925.82 µl.  
2.3.1.2 Volume signal calibration procedure 
The Scisense VSL pressure-volume control unit allowed adjustment of the volume signal 
gain and offset, a feature not available on the Millar MPVS-400.  This permitted control of 
the voltage range or ‘swing’ that the catheter would operate within during a typical 
experiment.  The Scisense control unit had a voltage range of +/- 5 V, and voltage swing 
used throughout the study was -2 V to + 1 V, corresponding to the 8 mm and 14 mm 
diameter cuvette wells respectively.  This afforded plenty of room on the positive side of 
the control units’ operational range without compromising signal resolution.  Just prior to 
calibration, the temperature of solution within the cuvette wells was monitored using a 
2000T electronic thermistor (Digitron; Devon, UK).  Desired segment length was chosen 
using a control switch on the front of the Scisense control unit, labelled S1 for the shortest 
segment, up to S4 for the largest.  With Labchart recording, the catheter tip was submerged 
in the largest cuvette well, ensuring all electrodes were enclosed within the well.  The tip  
was positioned as centrally as possible and the voltage reading on the control units’ digital 
display was noted.  The catheter was then moved into the small well, centred, and the 
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voltage noted.  To achieve the desired voltage swing of -2V to +1V, the gain and offset 
balance controls were adjusted using a simple rule of moving between each well and 
adjusting the offset when the catheter is in the smallest well, while adjusting the gain in the 
largest well.  Eventually a reading of -2V and +1V was achieved by submerging the 
catheter tip in the 8 mm and 14 mm diameter cuvette wells respectively.  To complete the 
2-point calibration, the voltage values were entered into the LabChart units calibration 
interface and associated with a specific volume.  The volume associated with this measured 
voltage was dependent upon the recording segment length chosen and calculated using the 
equation describing the volume of a cylinder 
     LrVol 2      (4) 
Where Vol is volume (µl), r is the cuvette radius (mm) and L is the recording segment 
length (mm).  Calibration using this method was advantageous in that the values of ‘ρ’ and 
‘L’ from Baan’s equation were automatically incorporated into the calibration being 
intrinsic properties of the calibration solution and the catheter being used, respectively.  
Conversion of measured volume to true volume was simplified to  
           )(1 PCT VVV  
                           (5) 
Where VT is the true volume (ml), Vc is the volume measured by the catheter (ml) and Vp is 
the volume owed to parallel conductance (ml). 
 
Calibration of the Millar pressure-volume catheter was performed in a different manner to 
the Scisense equipment.  The MPVS-400 control unit was equipped with preset calibration 
values for volume similar to the in-built pressure calibration settings found on both 
systems, the units of which were expressed in RVU or relative volume units.  The 
calibration procedure for this was identical to that of the pressure sensor calibration 
described above. 
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Figure 2.5 Cuvette volume calibration.  A(i). Acrylic calibration cuvette and calibration wells.  A(ii).  
Cuvette diameter vs. volume relationship for several recording segments. Linearity and range of volume 
measurement of Millar (B) and Scisense (C) catheter systems using either rabbit blood (B (i) and C (i)) or 
Tyrode’s solution (B (ii) and C (ii)). 
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2.3.2 Volume range and linearity by the cuvette calibration 
method 
2.3.2.1 Comparison of Millar vs. Scisense volume measurement 
The control units for the volume portion of the Millar and Scisense catheters described 
above were based on the same technology, however the capabilities of the two systems 
were unknown prior to initiation of the experimental study.  Direct comparison of the two 
systems was undertaken by the cuvette calibration method described in the previous 
section using two different calibration media; Tyrode’s solution and heparinised rabbit 
blood.   
2.3.2.2 Resistivity of Tyrode’s solution and rabbit blood 
The specific resistivity of rabbit blood and Tyrode’s solution was measured using an 
electronic conductivity meter (Amber Science; Eugene, Oregon).  It was found that while 
rabbit blood at 37 ºC had a measured resistivity of 163.93 Ω.cm-1, Tyrode’s solution 
resistivity was lower, measuring 68.49 Ω.cm-1.  The effect this difference in conductivity 
between the two media had on the performance of the Millar and Scisense catheter systems 
was investigated by performing a cuvette volume linearity experiment. 
2.3.2.3 Cuvette well linearity calibration 
The calibration cuvette provided by Scisense was secured in the isolated working heart 
water bath at 37 ºC, and each cuvette well was filled with the calibration solution of 
interest.  Cuvette wells ranged from 3.0 to 14.0 mm in diameter, in 1 mm increments.  To 
extend the range of testing permitted by the cuvette wells, a cylindrical well of diameter 15 
mm was included.  Starting from the smallest cuvette well and moving in sequence to the 
largest well, catheter tips were fully submerged and centred in each cuvette well with the 
voltage output recorded on LabChart.  This procedure was repeated with each segment 
length of the Scisense VSL and for both Millar PV catheters using Tyrode’s solution and 
heparinised rabbit blood.   
2.3.2.4 Millar PV system has a limited range using Tyrode’s solution 
Using heparinised rabbit blood (Figure 2.5 B(i)) both Millar catheters were capable of 
recording values across the range of cuvette well diameters provided.  The 12 mm SPR-
878 (black filled squares) was linear only over a limited range (between 4 and 10 mm 
cuvette well diameter) while the 18 mm SPR-851 remained linear up to the 15 mm 
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diameter cuvette.  The non-linear behaviour of the SPR-878 was the result of the electric 
field generated by the catheter reaching its theoretical limits and becoming insensitive to 
further increases in volume.  This concept is discussed in more detail in the next section.  
Figure 2.5B(ii) shows the same experiment performed using the 18 mm Millar catheter 
bathed in Tyrode’s solution, with the output gain of the MPVS control unit set to four 
different values; 0.25, 0.5, 0.75 and 1.0.  The voltage signal of the 18 mm catheter at a gain 
of 1.0 (blue filled triangles) reaches a maximum in the 7 mm diameter cuvette using 
Tyrode’s solution, as demonstrated by the voltage remaining constant in the larger cuvette 
wells.  This problem persisted even when the gain on the MPVS was reduced to as little as 
¼ its original value (black filled squares).  This observation was due to the increased 
electrical conductivity of Tyrode’s solution in comparison to heparinised rabbit blood.  
From Figure 2.5A(ii), using an 18 mm catheter the highest volume capable of being 
measured would be ~ 1.4 ml which is unsuitable for an isolated working rabbit heart where 
stroke volume alone may exceed this value.  Preliminary experiments with the Millar 
catheter confirmed this limitation, with the volume signal reaching the limits of the control 
units’ operational range before end diastole, resulting in a truncated volume signal and PV 
loop.   
2.3.2.5 Scisense PV system remains within operational range using either 
blood or Tyrode’s solution 
Figure 2.5C(i) and (ii) show the cuvette well calibrations performed with the Scisense VSL 
catheter using heparinised rabbit blood and Tyrode’s solution, respectively.  Each segment 
length was calibrated using the voltage span of -2V to +1V as described above.  All 
segment lengths demonstrated linearity up to and including the 15 mm diameter cuvette.  
An additional cylinder with a diameter of 22 mm was included to extend the range of 
testing with this system.  The sensitivity of all but the 23 mm recording segment was 
reduced using the 22 mm cuvette (Figure 2.5B(i) and (ii), black squares, green circles and 
blue triangles), however the recording segments all remain within the operational voltage 
range of the Scisense control unit.  The range of cuvette diameters (and hence volumes) 
that the Millar system could work within was therefore restricted when using Tyrode’s 
solution.  In contrast, the Scisense VSL catheter remained within its operational range of 
+/- 5V in all cuvette wells, using all four recording segments.  The ability to fine tune gain 
and offset values using the Scisense control unit proved this system had superior utility 
compared to the Millar volume measurement technology in our isolated working heart 
setup and was therefore used for all subsequent volume measurements. 
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2.3.2.6 Limitations of electric field generated by conductance catheter 
Panels C(i) & (ii) in Figure 2.5 illustrate the limitations of the electric field generated by 
the Scisense VSL catheter when placed within a relatively large cylindrical well of 
diameter 22 mm.  Although the chosen recording segment lengths demonstrated linearity 
in cuvette wells up to 15 mm in diameter, all segment lengths except for the 23 mm 
become non-linear at the last well used.  Of note from Figure 2.5C(i) and (ii) is that non-
linearity decreased as segment length increased, indicating that in larger diameter wells the 
sensitivity of the catheter is increased with increasing segment length.   
2.3.2.7 Electric field heterogeneity in conductance catheter studies 
For the 2-point volume calibration to remain valid, it is critical that linearity exists between 
the volume measured by a conductance catheter and the actual volume present.  A number 
of studies have established that while Baan’s equation assumes a homogenous electric field 
distribution within the ventricle by the conductance catheter, in reality does not hold true in 
vivo (Steendijk et al., 1993; Wei et al., 2005; Wu et al., 1997).  While this heterogeneity 
could potentially lead to error in the estimation of true volumes within the ventricle, Baan 
et al. (1984) demonstrated there was no significant deviation in catheter volume estimation 
compared to cine-angiography and stroke volume estimation via electromagnetic flow 
probe (Baan et al., 1984).  While it can be seen that electric field heterogeneity does 
contribute as a source of error, conductance catheter measurements demonstrate linearity 
over a range of volumes in a number of publications using different species (Abe et al., 
1995; Burkhoff et al., 1985; Ito et al., 1996; Yang et al., 2001) and provided the correct 
catheter spacing is employed this may not be a significant problem.  To assess the 
relationship between volume measured by the catheter and true volume, the 2-point 
calibrations established prior to assessment of the voltage/cuvette well diameter 
relationships above and stored in LabChart were applied to all previously generated 
voltage data to obtain the calibrated volume measurement for each segment length using 
Tyrode’s solution.  The results in Figure 2.6 demonstrate that each recording segment 
demonstrates linearity over a large range of measured volumes, such that the effects of 
electric field heterogeneity do not create a significant source of error in volume estimation 
by conductance catheter within the range of volumes expected in the rabbit working heart. 
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Figure 2.6 Catheter volume linearity.  Relationship between true cuvette volume and cuvette volume as 
estimated by conductance catheter for (i) 14 mm, (ii) 17 mm, (iii) 20 mm and (iv) 23 mm recording segments 
2.3.3 Estimation of parallel conductance 
Two correction terms which had to be estimated for calculation of the true volume signal 
were parallel conductance and alpha.  Parallel conductance arises from the observation that 
the myocardial tissue as well as structures surrounding the heart will conduct electricity, 
and a significant offset of the conductance signal will occur as a result.   Since only the 
blood conductance signal is desired, the offset owing to parallel conductance must be 
estimated and subtracted from the total conductance (or volume) signal measured by the 
catheter.  The most common method of estimating parallel conductance in vivo involves 
injection of a bolus of hypertonic saline (10 to 30 %) into the pulmonary artery (Pacher et 
al., 2008; Steendijk et al., 2001; Steendijk & Baan, 2000).  The highly conductive saline 
washes into the left ventricle leading to a transient increase in the conductivity of the blood 
over several beats that will be recorded by the catheter.  The saline bolus must be of 
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sufficient volume such that it leads to a transient increase in the measured left ventricular 
volume signal without altering pressure within the chamber.  Calculation is performed 
offline and yields a single value for the parallel conductance.   
2.3.3.1 Verification of the hypertonic saline method for parallel conductance 
estimation 
The merits of the hypertonic saline bolus for parallel conductance estimation lie in the ease 
with which it can be performed as well as its reproducibility, however it relies on the 
assumption that parallel conductance remains constant throughout the cardiac cycle.  
Under normal circumstances parallel conductance is estimated from just 2 points on the 
volume signal, the maximum and minimum volume points.  Lankford et al. (1990) noted 
that potential errors could emerge if the value for parallel conductance at these 2 points 
was not the same (Lankford et al., 1990).  The group therefore investigated this claim by 
dividing the systolic period of each cardiac cycle during the saline injection into 20 equal 
time intervals (demarcated by dP/dtmax and dP/dtmin from the ventricular pressure trace), 
and obtaining time varying parallel conductance (Vp(t)) values by linear extrapolation of 
each of these time points between successive cardiac cycles (Lankford et al., 1990).  Using 
both isolated supported canine hearts and in vivo canine measurements the investigators 
demonstrated that parallel conductance determined from multiple points in the cardiac 
cycle correlated very highly with determination from just a single estimation, concluding 
that parallel conductance does not vary to a significant degree during the cardiac cycle.   
2.3.3.2 Ideal conditions for parallel conductance estimation 
Hypertonic saline bolus remains the most routinely used method of parallel conductance 
estimation and is still recommended for current conductance catheter studies (Pacher et al., 
2008).  To improve reproducibility and minimize error between studies optimal 
experimental conditions for saline bolus calibration have been investigated.  Herrera et al. 
(1999) investigated the effect of saline temperature and concentration on parallel 
conductance estimation by performing three injection manoeuvres in closed-chest dogs 
(Herrera et al., 1999).  They found that the saline bolus yields better results when kept as 
close to body temperature as possible, as the temperature gradients induced by cold (22 ºC) 
saline may increase blood resistivity by as much as 10%.  Bolus concentrations that caused 
the greatest dispersion of the volume signal (4.5 M and 6 M NaCl, approximately 26 and 
35 % respectively) yielded more consistent Vp estimations between injections, and were the 
concentrations recommended by the study (Herrera et al., 1999).   
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2.3.3.3 Saline bolus injection in the isolated working heart 
In the isolated working heart setup described here, only the left side of the heart was 
perfused.  This immediately limited the injection sites for saline bolus to two locations on 
the working heart system; i) The haemostasis valve located on the left atrial cannula, or ii) 
the preload chamber.  Injection via the preload chamber was chosen as it was more 
successful in yielding 5 – 7 cardiac cycles where solution conductivity changed without 
eliciting a change in peak pressure.  Using a thin plastic French catheter attached to a 1 ml 
syringe, a 0.15 ml bolus of 20 % saline bolus was injected at the entrance to the left atrial 
inflow line such that injection of the bolus did not alter the filling pressure during the 
manoeuvre.       
2.3.3.4 Calculation of parallel conductance 
So far the offset in the volume signal owing to structures other than the solution within the 
heart has been termed parallel conductance.  However the calibration procedure described 
above takes into account the blood resistivity, ρ and electrode segment length, L, from 
Baan’s original equation, allowing the parallel conductance term (Gp) to be exchanged for 
parallel volume (Vp) in the conversion to absolute volumes.  As described in Section 
2.3.1.2 the equation for estimation of true volume becomes 
           )(1 PCT VVV  
                           (5) 
Where VT is the true volume (ml), Vc is the volume measured by the catheter (ml) and Vp is 
the volume owed to parallel conductance (ml).  The term parallel volume will be used from 
this point onwards to describe the volume offset due to structures other than perfusion 
solution within the left ventricle.  A plastic bijou was filled with 5 ml of 20 % saline 
solution and held at 37 ºC in a water bath.  Vp estimation was performed after establishing 
stable baseline function.  Timing of the saline bolus was necessitated by the terminal 
nature of many experiments during this study which prevented post-experimental 
determination.  A 1 ml syringe was partially filled with 20 % saline solution.  A plastic 
French catheter attached to the syringe was primed with saline and fed into the working 
heart preload chamber just inside the left atrial inflow line.  0.15 ml of saline was injected 
into this line while pressure and volume traces were carefully monitored to ensure the 
injection had worked correctly.  The concentration of saline injected is not taken into 
account during calculation of Vp and is therefore not critical in that respect.  However bolus 
concentration, along with the volume injected, will impact on the success of the 
manoeuvre; too low a concentration and the volume dispersion will not be sufficient to 
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correctly estimate Vp, too high and there is an increased risk of causing irreversible 
depression of contractile function.  An example of pressure-volume loops obtained 
following a saline bolus injection in the isolated working heart, along with the resultant Vp 
estimation is shown in Figure 2.7, with mean Vp and r-values for 7 control isolated working 
hearts displayed in Table 2.1.  The aim was to achieve the largest number of cycles where 
Vc was changing without any alteration in left ventricular pressure.  0.15 ml of 20 % saline 
solution injected into the left atrial inflow line allowed consistent achievement of a period 
of 5 – 7 beats where alteration in Vc was visible while peak pressure remained stable.  Vp 
was estimated offline using PVAN pressure-volume analysis software version 3.6.  Parallel 
conductance was calculated as follows:  
1) The maximum (Vmax) and minimum (Vmin) volumes determined by the catheter during 
the wash-in phase of the hypertonic saline injection were displayed by PVAN with Vmin 
plotted as a function of Vmax, as shown in Figure 2.7 B.  
2)  Vp is solved using the observation that volume measured by the catheter, Vc, is linearly 
related to Tyrode’s solution conductivity (σT - the reciprocal of resistivity).  The hypertonic 
saline bolus causes a transient increase in Vc on a beat to beat basis owed exclusively to an 
increase in solution conductivity, however the actual volume within the ventricle remains 
constant.   
3)  PVAN establishes a linear relationship between successive Vmin and Vmax points for each 
cardiac cycle where σT is increasing. This relationship is then extrapolated to the point 
where it crosses the line of identity, where Vmax = Vmin.  Where these two lines meet the 
volume within the left ventricle is 0, and therefore the volume measured by the catheter at 
this point must be due to surrounding structures, or Vp.   
 
  
             
 
       Table 2.1 Mean values for parallel conductance and correction factor α 
 
Measured volume calibration constants  - Control group (n = 7) 
Vp                               R-value                          α 
1150.4 ± 187.13                0.94 ± 0.03                 0.87 ± 0.04 
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Figure 2.7 Parallel volume estimation.  A.  Conductivity change after saline bolus injection.  B.  Parallel 
volume estimation from maximum and minimum volumes by linear extrapolation 
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2.3.4 Estimation of α  
The effects of electric field heterogeneity have already been described in this chapter as a 
possible source of error when estimating absolute left ventricular volumes.  An associated 
source of error stems from the chosen catheter recording electrode segment length and its 
relation to the ventricular long axis (VLA) length.  Ideally the recording electrode segment 
would encompass the entire long axis of the ventricle but if an inappropriate recording 
segment length is chosen this may not be the case and may contribute to underestimation 
of absolute volumes.  The original equation proposed by Baan and colleagues (1984) 
included a calibration term known as α, a dimensionless constant used to correct the 
measured volume signal for the errors introduced by electric field heterogeneity as 
described above (Baan et al., 1984).  In practice α is calculated by forcing the stroke 
volume measured by the catheter, SVc to equal stroke volume as measured by an 
independent means, most commonly an electromagnetic flow probe.  Therefore: 
     
True
C
SV
SV
           (6) 
Where SVc is the volume measured by the catheter, and SVTrue is the independently 
measured true stroke volume.  In the isolated working heart setup, α was measured in this 
manner by independent assessment of cardiac output.  In the isolated working heart cardiac 
output was defined as the sum of aortic flow and coronary flow.  Coronary flow was 
assessed by timed measurement of perfusate dripping from the heart.  Aortic flow was 
measured continuously throughout the experiment using an ultrasonic in-line flow meter. 
2.3.4.1 Ultrasonic flow meter calibration 
The flow meter utilized two in-built piezoelectric transducers located at either end of the 
flow probe tubing.  When electrically stimulated they produced a vibration that alternately 
propagates along the length of the tubing both with and against the flow of liquid.  The 
velocity with which the wave propagates is proportional to the flow and was therefore used 
to calculate flow.  The measured flow value was then transmitted to a control unit and 
displayed on a 5 digit LCD output that updated once every 1 s.  The output voltage of the 
ultrasonic flow meter changed linearly with measured volume and continuous recording of 
flow was made through LabChart by connecting the flow meter to the 8-channel Powerlab 
A/D board and performing a 2-point linear calibration similar to that described for pressure 
and volume.  After priming of the working heart system afterload line the peristaltic pump 
was stopped briefly dropping flow to 0.  LabChart software was set to record the baseline 
voltage output from the flow meter when flow was 0 ml/min.  The pump was then 
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switched on and flow commenced.  Flow was adjusted via the dial on the peristaltic pump 
such that the flow meter would display a reading of 200 ml/min.  Both low and high 
voltages recorded by LabChart were then entered into the units calibration interface and 
associated with 0 and 200 ml/min respectively, creating the appropriate linear calibration. 
2.3.4.2 Calculation of heart rate for assessment of stroke volume 
Heart rate was calculated from the left ventricular pressure trace by measuring the interval 
between the cyclical rise and fall of the pressure waveform with respect to time.  Stroke 
volume was then calculated using the formula 
      
HR
COSVTrue       (7) 
Where SVTrue is the true stroke volume (ml), CO is cardiac output (ml.min-1) and HR is 
heart rate (beats.min-1).  Values recorded for SVTrue and SVc during each experiment were 
entered into equation (6) to obtain α. 
2.3.5 Selection of catheter segment length 
The correction term α allows for conversion of relative volume to absolute volume.  
However, steps were taken to avoid reliance on α and ensure the absolute volume 
measurements obtained were as representative of volume within the entire left ventricle as 
possible.  This was achieved through selection of a catheter whose recording segment 
length matched as closely as possible the VLA distance of the animal being studied.  
Isolated rabbit heart VLA distances were assessed during the initial setup of the working 
heart system.  Upon completion of an isolated working heart experiment, hearts were 
removed from the system and a cut was made longitudinally along the left ventricular wall 
to reveal the chamber.  The distance from apical endocardium to the aortic valve leaflets 
was measured using a small plastic measuring device fashioned from a millimeter ruler.  
Figure 2.8A shows the spread of VLA distances recorded from 39 hearts isolated from 
stock animals with a mean body weight of 3.41 ± 0.06 kg and mean age of 152 ± 3 days.  
VLA distances ranged from 20 to 24 mm, with a mean value of 22.00 ± 0.20 mm, 
representing a potential error of 4 mm between animals.  The most suitable VSL catheter 
available was defined as one which could match the 20 – 24 mm range closest.  Initially 
this appeared to be the VSL catheter with 14, 17, 20 and 23 mm recording segments.  The 
largest electrode segments almost completely span the range of measured VLA distances in 
isolated hearts.  Dead space at the catheter tip however was 4.25 mm.  Factoring this into 
the total distance spanned by the catheter the 23 mm spacing was unsuitable for isolated  
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Figure 2.8 Isolated rabbit heart VLA measurements.  A.  Spread of VLA lengths in isolated rabbit hearts 
(n = 39).  B.  Correlation between measured VLA versus (i) animal age and (ii) body weight (n = 39) 
 
working heart experiments, at least on stock animals.  A second VSL catheter with 
recording segments of 12, 15, 17 and 19 mm was manufactured.  The dead space at the tip 
of this catheter was 2 mm, meaning the largest segment did not become redundant.  While 
there was argument for use of the larger VSL catheter in bigger hearts, with the majority of 
isolated hearts having a VLA of less than 24 mm the 19 mm spacing of the smaller catheter 
would offer greater accuracy in most cases.  The lengthy warm-up time of the catheters and 
lack of a second PV control unit meant that swapping between the two was not feasible.  
VLA distances of each heart were plotted against the age and body weight of the donor 
animal to investigate existence of a correlation that could be used to predict the VLA of an 
isolated heart prior to the experiment.  Results are shown in Figure 2.8B(i) and (ii).  
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Neither parameter demonstrated correlation with VLA distance meaning selection of 
recording segment length could not be made on that basis.  The catheter recording segment 
chosen for each experiment was set at 19 mm.  Where a smaller segment length was 
appropriate the catheter was removed from the isolated working heart system and the 
volume signal quickly recalibrated in LabChart to accommodate the new segment.  Mean 
values for 7 control isolated working hearts are shown in Table 2.1.  Mean values for α 
using this approach were 0.87, with values as high as 0.95 being recorded in some cases, 
demonstrating very good representation of volumes within the entire left ventricular cavity 
prior to correction with α. 
2.3.6 Multi-segmental volume measurement 
Due to size of the ventricular cavity in large animals and humans, volume estimation in 
these species is performed using a conductance catheter with multiple sets of recording 
segments.  This allows the volume signal to be split up into discrete segments, each 
representing a particular portion of the left ventricular cavity.  The resulting segmental 
volumes are then summed to obtain the total volume signal for the entire left ventricle.  
The advantage of this technique is that it may permit assessment of regional changes in 
cardiac function following a localized intervention.  Size limitations (due to minimum 
electrode segment lengths possible) prevent assessment of segmental volumes in small 
animals such as rats and mice, where VLA dimensions are in the order of 4 to 12 mm.  
Rabbit hearts however are of adequate size to allow measurement of at least 3 discrete 
segments within the left ventricle through conductance catheter technology, and the multi-
segmental approach has been used previously in this species  in vivo (Pinsky et al., 1996; 
Royse & Royse, 2005; Solda et al., 1990).  Discrete segmental volume estimation within 
the left ventricle of isolated working rabbit hearts was performed with the use of a 3F 6 – 
electrode multi-segmental pressure-volume catheter (Scisense. London, Ontario).  The two 
outermost electrodes designated the excitation electrodes and were used to generate the 
electric field within the LV, while four inner electrodes spaced equally apart delineated 3 
discrete recording segments 5.5 mm in length.  The total recording segment length of the 
catheter was 16.5 mm with a dead space at the distal portion of the tip measuring 2 mm.  
Setup and calibration of pressure and volume portions of this catheter was almost identical 
to that of the Scisense VSL catheters.  Deviations from the calibration procedure specified 
earlier in the chapter are described in detail.  The catheter was connected to a GX5 
pressure-volume control unit and the catheter tip left soaking in 37 ºC Tyrode’s solution 
for 45 minutes prior to use.  Output from each recording electrode segment occupied a 
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single channel on the PowerLab A/D board allowing continuous monitoring of individual 
segment volumes.  Pressure and volume calibration within LabChart was performed 
almost identically to that of the VSL catheters, except that each volume segment on the 
multi-segmental catheter was calibrated separately.  The issue of electric field 
heterogeneity was addressed by taking into consideration recording electrode sensitivity.  
When exposed to a static volume in a cylindrical well, segments closer to the electric field 
source electrodes will report a higher voltage than those further away, despite being 
exposed to the same volume.  The Scisense multi-segmental system allowed adjustment of 
individual segment gain and offset values such that each segment displayed the same 
voltage when exposed to the same volume, compensating for the non-uniform distribution 
of the electric field.  A voltage swing of -2V to +1V was employed, using cylindrical wells 
of 4 mm and 6 mm radius (276.46 µl and 622.04 µl, respectively when using a recording 
segment of 5.5 mm) to represent the low and high portions of the voltage span, 
respectively.  An arithmetic channel was created in LabChart to display total measured 
volume, which was defined as the sum of the measured volumes from each recording 
segment.  Catheter insertion and positioning was performed as described in section 2.1.4 
and parallel conductance was estimated using the hypertonic saline bolus method.  
Absolute ventricular volume was calculated as 
      PVVVVVol  321
1

    (8) 
Where Vol is absolute left ventricular volume (ml), α is a dimensionless calibration factor, 
V1, V2 and V3 are the instantaneous volumes measured by each recording segment (ml), and 
Vp is the parallel volume (ml). 
2.3.7 How are left ventricular pressure-volume relationships 
obtained? 
To obtain load-independent measures of ventricular relaxation in the isolated working 
heart, loading conditions were altered transiently following a stable steady state period by 
brief occlusion of the left atrial inflow line.  This method was carried out as a surrogate to 
preload reduction by transient inferior vena caval occlusion, a recommended manoeuvre 
for determination of pressure-volume relations in vivo (Burkhoff et al., 2005; Pacher et al., 
2008).  Determination of the end diastolic pressure volume relationship is carried out by 
fitting a mono-exponential relationship to the end diastolic pressure-volume points from 
the resultant family of loops.  This mono-exponential fit describing the end diastolic 
pressure volume relationship is denoted by  
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    )*(exp EDVCEDP       (9) 
Where EDP is end diastolic pressure (mmHg), C is a curve-fitting constant term, β is the 
diastolic stiffness constant and EDV is the end diastolic volume (ml).  Pressure-volume 
loops obtained during a typical atrial inflow occlusion are shown in Figure 2.9A with the 
red line indicating the mono-exponential curve fit for this example.  The diastolic stiffness 
constant, β could be visualized by plotting chamber stiffness (rate of pressure increase for a 
given increase in volume, or dP/dV) against pressure and calculating the slope of the 
resultant linear relationship (Figure 2.9 B).  Mean values for the exponential fitting terms 
are found in Table 2.2.   
 
EDPVR fitting terms  - Control group (n = 7) 
                         β                              R-value 
                 3.55 ± 0.47                  0.99 ± 0.001 
                       Table 2.2 Mean stiffness constant and r-value of EDPVR fit 
2.3.8 Data Analysis 
All data were recorded as described in section 2.1.4 and analysed offline following the 
experimental period.  An example of typical pressure and volume recordings from the 
isolated working rabbit heart during a single cardiac cycle is shown in Figure 2.10.  A 
number of functional indices highlighted on the left ventricular pressure and volume traces 
in the upper panel of Figure 2.10A, were obtained from these individual signals, while 
Figure 2.10B, shows the pressure-volume loop obtained by plotting pressure as a function 
of volume for the same cardiac cycle from which stroke volume, stroke work (denoted by 
the area within the PV loop), and ejection fraction (stroke volume as a % of end diastolic 
volume) are assessed from steady state pressure volume loops.  Steady state values were 
obtained at pre-defined time points for each set of experiments by analyzing 10 
consecutive cardiac cycles and recording the mean values for each measured variable.  
Indices of steady state ventricular contractility, maximum rate of rise and fall in pressure 
(dP/dtmax and dP/dtmin, respectively) were obtained by calculating the first derivative of 
pressure, as shown in Figure 2.10A.  The ventricular relaxation constant τ was calculated 
from the ventricular pressure trace using LabChart’s Blood Pressure Module (described in 
greater detail in Section 2.3.9.  Logistic τ was calculated by fitting a three parametric 
exponential decay function, starting at the point of maximal rate of fall of the ventricular 
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pressure trace, dP/dtmin, and ending when pressure reaches a value 5 mmHg above the end 
diastolic pressure of the following beat.  This function is of the form  
      )()/exp()()0()(  PtPPtP       (10) 
Where P(t) is the time varying pressure (mmHg), P(0) is the initial pressure at start of fit 
(mmHg), P(∞) is the asymptotic equilibrium pressure (mmHg), t is time (ms) and τ is a 
constant describing relaxation (ms) (Langer, 2002). 
2.3.9 Analysis programs used 
Data were analysed using a number of pressure-volume analysis programs whose 
calculation methods were confirmed by analysis using Origin 6.1 and by comparison of 
results between programs. 
 
(1) LabChart.  Many simple calculations could be performed using the LabChart 
interface.  Sections of trace could be manually highlighted and a number of simple 
calculations performed.  Mean aortic flow was calculated in this manner by taking the 
average value over 10 selected beats at predetermined intervals.  A low pass digital filter 
with a cut-off frequency of 50 Hz was applied to remove this noise and ensure more 
accurate calculation of maximum and minimum volumes by data analysis programs.  This 
filter was sufficient to remove electrical noise without significantly altering the shape of 
the volume trace.  Calculated α and Vp values could be applied to the raw volume trace 
with the result being displayed in a separate channel.      
 
(2) Blood pressure module.  Calculation of parameters associated with the pressure trace 
were analysed using the blood pressure module (BPM) provided with LabChart.  All 
steady state parameter calculations, excluding cycle duration, were calculated within a 
domain known as the cycle region, defined as the period from one end diastolic pressure 
point to the next.  End diastolic pressure was calculated using an algorithm based on the 
observation that the overall shape of the ventricular pressure waveform will remain 
consistent despite variation commonly existing around the end diastolic pressure point.  A 
detection algorithm was then applied to the ventricular pressure waveform allowing 
automated estimation of end diastolic pressure.  For each cardiac cycle the blood pressure 
module was used to calculate end diastolic pressure (mmHg), minimum pressure (mmHg), 
peak pressure (mmHg), dP/dtmax (mmHg.s-1), dP/dtmin (mmHg.s-1), heart rate (beats.min-1) 
and the relaxation constant τ (ms). 
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Figure 2.9 Determination of EDPVR.  A.  Typical family of pressure-volume loops following occlusion.  
B.  Ventricular stiffness (dP/dV) varies linearly with pressure.  
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Figure 2.10 Pressure and volume during the cardiac cycle.  A.  Typical pressure and volume recordings 
for a single cardiac cycle.  B.  The pressure-volume loop, illustrating the 4 main phases of the cardiac cycle.     
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(3) PVAN.  The pressure-volume analysis module (Millar Instruments) version 3.6 was 
used to estimate parallel conductance.  PVAN integrated into LabChart allowing recorded 
data to be imported directly into the program by associating the specific pressure and 
volume channels with PVAN, manually highlighting the selection of trace to be analysed 
and importing the selection.  PVAN calculates end diastolic pressure by analyzing the 
entire pressure trace and assigning a value (for example, x) to each point.  The rate of 
change in pressure is calculated progressively until the rate of change reaches a threshold.  
PVAN assumes the r-wave (the deflection on the ECG associated with ventricular 
depolarisation) has occurred just before this point and moves back 4 time points, assigning 
the end diastolic pressure.  The parallel conductance is estimated by PVAN in exactly the 
same manner described in section 2.3.3 and a single value for Vp, along with an r-value for 
the linear fit for the data points are reported. 
 
(4) Labscribe.  Data acquisition and analysis software was available through Labscribe 
version 2.0 (iWorx; New Hampshire, US), which contained built-in modules specifically 
for analysis of pressure-volume relationships.  Labscribe was designed specifically for use 
with iWorx A-D boards and as such was not compatible with PowerLab.  Data could be 
imported into Labscribe from LabChart however, by saving selected portions of data as 
text.  Labscribe detected a cardiac cycle using a pressure threshold detection method.  The 
pressure trace was then normalized and a pressure volume ratio was calculated by dividing 
normalized pressure by normalized volume.  The end diastolic point was calculated as a 
point just prior to the minimum of the pressure/volume ratio, while the end systolic point 
was determined as the point just after the maximum of this ratio.  Labscribe was used to 
calculate the EDPVR following atrial inflow line occlusion.  The software used the same 
mono-exponential curve fit described in section 2.3.7, and the accuracy of this fit was 
confirmed using Origin 6.1.      
 
(5) Heart Rate Variability.  A final module available within LabChart was the heart rate 
variability (HRV) module, used to calculate mean RR-intervals between successive beats 
from a selected portion of the pressure trace.  R-waves were detected from the pressure 
trace using a method similar to EDP detection by the blood pressure module.  The HRV 
module allowed user specification of a normal RR interval range, along with calculation of 
ectopic beats based on this range. 
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2.3.9.1 Pressure waveform parameters 
Pressure variables calculated using the blood pressure module and Labscribe were very 
closely matched, but demonstrated a significant deviation compared with PVAN.  This was 
found to be related to the manner in which PVAN calculates end diastolic pressure.  In 
some experiments, a pressure rise associated with atrial contraction would appear on the 
left ventricular pressure trace.  If the slope of the pressure rise associated with this event 
was of sufficient magnitude PVAN would incorrectly determine EDP at this point.  The 
EDP detection algorithms used by Labscribe and BPM were superior in this respect in that 
EDP was determined more accurately at a point after this pressure inflection.  Labscribe 
determined end-diastolic and end-systolic pressure and volume points by calculating the 
ratio of instantaneous pressure and volume for each cardiac cycle.  End systole was located 
just after the maximum of the pressure-volume ratio, and end-diastole just before the 
minimum of the pressure-volume ratio.  This method was in consistent agreement with 
BPM.  dP/dtmax and dP/dtmin calculated by PVAN also differed significantly from values 
obtained from Labscribe and BPM, as well as manual calculation of these parameters using 
Origin 6.1.  This occurred because PVAN differentiates the pressure signal then applies a 
smoothing algorithm to the resultant values.  
2.3.9.2 Volume signal parameters 
End diastolic volume determined manually from the raw volume signal correlated with the 
values reported by Labscribe confirming that this program was appropriate for calculating 
the end diastolic pressure volume relation.  Both Labscribe and PVAN were capable of 
estimating Vp by plotting end systolic volume as a function of end diastolic volume, 
however, due to the shape of the pressure volume loop in the isolated working heart 
experiments around the point of end systole, neither program would accurately determine 
Vp using this method.  PVAN allowed estimation of Vp using maximum and minimum 
volumes instead, which permitted estimation of Vp for isolated working rabbit heart 
experiments.  All of the above parameters were obtained manually using Origin 6.1 and 
compared to the above analysis programs to ensure their accuracy.  While it was possible 
to use solely Origin 6.1 for most data analysis, this required much more time for manual 
computation.  Once determination of various parameters using the above analysis programs 
was confirmed to be accurate these were used for the remainder of the study. 
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2.4 Optimising the isolated working heart preparation 
Loading conditions imposed on the isolated working heart are crucial in determining the 
work performed by the heart, its peak output, and ultimately the longevity of the 
preparation (Sutherland & Hearse, 2000).  Previous studies with the working rabbit heart 
preparation commonly used an initial preload of 10 to 15 cmH2O (7.4 - 11 mmHg) (Itoi & 
Lopaschuk, 1996; Leitch & Patterson, 1994; McCabe et al., 2005; Pye et al., 1996).  
Afterload pressures utilized in the above studies however were far more variable, ranging 
from 41 (Leitch & Patterson, 1994) to 105 cmH2O (Itoi & Lopaschuk, 1996).  Perhaps 
more crucial than the baseline preload settings is the aortic impedance determined by the 
design of the aortic outflow line.  The term impedance describes the interaction between 
pressure and flow pulses in the aortic outflow tract, which is influenced by the viscoelastic 
properties inherent to the arterial wall, the fluid moving through the arterial system, and 
their interaction (Milnor, 1975)  Aside from the design of the aortic cannula already 
discussed, two common factors determining aortic impedance in the isolated working heart 
are the (i) afterload, and (ii) the volume of air within the compliance chamber providing an 
aortic Windkessel (Podesser et al., 1993; Van Bilsen et al., 1991).  While the isolated 
working heart is likely to perform stably and consistently over a range of different 
conditions, no two experimental setups are identical, and it was important to establish the 
capabilities of the current experimental setup to determine optimal conditions for a 
prolonged study.   
2.4.1 Aortic outflow design and pressure-volume loop shape 
Studies investigating instantaneous pressure-volume relations in rodents using conductance 
catheter technology typically describe either a square or auxotonic configuration of the PV 
loop (Joho et al., 2007; Pacher et al., 2004; Pacher et al., 2008; Segers et al., 2005) 
however this is not always reported (Pinsky et al., 1996; Solda et al., 1990).  How et al. 
(2005) using an ex vivo murine working heart preparation found that PV loop shape was 
highly influenced by the length of the aortic cannula and the compliance air volume, noting 
that a longer cannula (positioning the heart further from the compliance chamber) altered 
the shape of the PV loop such that peak systolic pressure occurred soon after opening of 
the aortic valves, with pressure falling thereafter throughout ejection (How et al., 2005).  
Use of a short (3 mm) aortic cannula achieved a rectangular PV loop configuration.  
Therefore, the effects of a range of compliance air volumes as well as distance from the 
aortic cannula to the compliance chamber were investigated to determine the optimal 
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conditions for an isolated working heart preparation.  The ultimate aim of this investigation 
was to define a set of conditions for the isolated working rabbit heart which would produce 
the greatest mechanical function and cardiac output. 
2.4.2 How does compliance volume influence working heart 
mechanical function? 
The volume of air in the compliance bubble trap sufficient to act as an aortic Windkessel in 
the working rabbit heart has not been well characterized.  Van Bilsen et al. (1991) 
attempted to quantify the minimum air volume required in this chamber in a working rat 
heart system by setting pressure drop (the decrease in pressure from one end of a flow 
system to the other) of less than 4 kPa as the limiting factor in their calculations (Van 
Bilsen et al., 1991).  Fluid turbulence within the aortic conduit is a major determinant of 
aortic impedance, and increases as pressure drop increases.  Using this they determined a 
volume of at least 5.5 ml was required.  In mouse working hearts volumes quoted are 
normally significantly smaller, in the order of 1-2 ml (de Windt et al., 1999; How et al., 
2005).  While very little information is available on the specific compliance chamber 
volumes used in isolated working rabbit heart preparation, the significantly greater muscle 
mass and cardiac output of the rabbit heart in comparison to the rat would predict a 
minimum volume even greater than the 5.5 ml suggested by Van Bilsen and colleagues 
(Van Bilsen et al., 1991).   
2.4.2.1 Experimental protocol for investigation of compliance volume on 
isolated working heart function 
Seven isolated working rabbit hearts were used to study the influence of compliance 
volume on working heart function in the current experimental setup (Figures 2.11, 2.12 and 
2.13).  Baseline working heart function was established using a left atrial filling pressure of 
7.4 mmHg and an afterload pressure of 60 mmHg.  From initial experiments it was found 
that hearts could not sustain an output in working mode when no air was present.  The 
volume of air in the compliance chamber was initially set at 15 ml of air as this was found 
to result in a stable steady state function in preliminary experiments.  Hearts were paced at 
200 beats.min-1 throughout the experiment.  After establishing baseline left ventricular 
function, compliance was lowered to a starting value of 5 ml by removal of air with a 
graduated syringe through a two-way stopcock on top of the compliance chamber.  The 
protocol then involved obtaining steady state functional measurements before increasing 
compliance volume in 5 ml increments up to 20 ml. 
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Figure 2.11 Compliance volume and the pressure-volume loop.  Typical pressure volume loops from 
working rabbit hearts using two different compliance chamber positions with compliance air volume set at (i) 
5 ml (ii) 10 ml and (iii) 15 ml. 
2.4.2.2 Distance from aortic cannula to compliance chamber   
The effect of altering the distance between the compliance chamber and aortic cannula on 
working heart function was also investigated.  Constraints in the design of the aortic 
outflow tract meant that this variable remained fixed during experiments and could not be 
altered.  The experiments were split into 2 groups; in the first, distance from aortic cannula 
to the compliance chamber was 13 cm (n = 3), the shortest length achievable, while in the 
second this length was increased to 39 cm (n = 4).  Mean values at 5 and 15 ml compliance 
volumes were compared within groups by repeated measures ANOVA with Tukey’s test 
for multiple comparisons performed as a post test.  Mean data between groups at each 
compliance volume were compared using two-sample student’s t-test.  A P-value < 0.05 
was considered significant.  The diagrams in Figure 2.11 demonstrate the difference in PV 
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loop shape between the 13 cm and 39 cm configurations, with 13 cm demonstrating a more 
rectangular shape in comparison.  Stroke volume however is larger at all compliance 
volumes using the 39 cm configuration.  Stroke volume in both groups is increased with 
increasing compliance air volume.  No further alterations in the PV loop were apparent at 
20 ml compliance volume (data not shown).   
2.4.2.3 Effect of compliance on systolic functional parameters 
Increasing compliance volume had no effect on peak pressure in either group (Figure 2.12 
(i)) however peak pressure was significantly greater in the 39 cm group at 10 and 15 ml 
compliance volumes by 20.44 and 20.28 % respectively.  The maximum rate of rise of 
pressure (Figure 2.12 (ii)) was 32.98 ± 0.34 % higher at 15 ml compliance vs. 5 ml 
compliance in the 39 cm group, but there were no differences apparent in the 13 cm group.  
Additionally, dP/dtmax did not significantly differ between groups at any compliance 
volume.   
2.4.2.4 Effect of compliance on diastolic functional parameters 
Left ventricular end diastolic pressure was not significantly affected by increasing 
compliance volume in either group, nor were there any significant differences present 
between groups (data not shown).  The maximum rate of left ventricular pressure fall in the 
13 cm group however was significantly increased by 79.58 ± 24.87 % at 15 ml compliance 
vs. 5 ml (Figure 2.12 (iv)).  The relaxation time constant τ was also significantly decreased 
at the higher compliance volume of 15 ml vs 5 ml, by 54.43 ± 1.69 % (13 cm group) and 
42.92 ± 9.34 % (39 cm group), respectively.  There was also a trend for τ to be faster in the 
39 cm group at all compliance volumes but this only reached significance at 10 ml 
compliance volume. 
2.4.2.5 Effect of compliance on volume parameters 
As can be seen from the representative pressure-volume loops in Figure 2.11 (i-iii) and the 
mean data in Figure 2.13, increasing compliance had a marked effect on volume 
parameters of the isolated working heart in both the 13 cm and 39 cm groups.  Aortic flow 
(Figure 2.13 (i)) was significantly increased in both groups between 5 ml compliance and 
15 ml compliance (13 cm; 89.60 ± 32.29 %; 39 cm; 120.87 ± 72.58 %) although coronary 
flow remained unchanged at all compliance volumes (Figure 2.13 (ii)).  Additionally, 
aortic flow was significantly higher in the 39 cm group at 10 (57.35 %) and 15 ml (65.65 
%) compliance air volume compared to the 13 cm group.  Stroke volume (Figure 2.13 (iii))  
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Figure 2.12 Compliance volume and working heart contractility.  Influence of compliance distance on 
indices of contractility under varying compliance volumes in isolated working hearts.  Values expressed as 
mean ± SEM.  13 cm group, n = 2; 39 cm group, n = 4.  * P < 0.05 13 cm vs. 39 cm, students unpaired t-test; 
5 ml vs. 15 ml, repeated measures ANOVA with Tukey-Kramer multiple comparisons test. 
as expected followed the same pattern as aortic flow, appearing significantly higher at 15 
ml compliance vs. 5 ml compliance in both the 13 cm group (by 63.54 ± 14.82 %) and the 
39 cm group (by 84.16 ± 42.14 %).  This was due to significantly higher end diastolic 
volumes in the 39 cm group at all compliance volumes vs. the 13 cm group (30.62 % 
higher at 15 ml compliance - Figure 2.13 (iv)), without a significant difference in end 
systolic volumes (Figure 2.13 (v)) between groups at any compliance volume.  End 
systolic volume (ESV) was significantly lower in both the 13 cm group and 39 cm group at 
15 ml compliance vs. 5 ml compliance.  Ejection fraction (Figure 2.13 (vi)) was also 
significantly greater at 15 ml vs. 5 ml compliance in the 13 cm (by 67.41 ± 15.28 %) and 
39 cm group (by 94.87 ± 47.54 %), owing to a significant reduction in ESV with no change 
in EDV. 
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2.4.2.6 Distance from aortic cannula to compliance chamber influences 
working heart function 
Various indices of cardiac function appeared improved when the length of tubing between 
the aortic cannula and compliance chamber was set to 39 cm, rather than the shortest 
distance of 13 cm.  LV peak pressure (Figure 2.12 (i)), aortic flow and stroke volume 
(Figure 2.13 (i) and (iii)) were all shown to be elevated in the 39 cm configuration.  The 
increased stroke volume was a consequence of higher end diastolic volumes using the 39 
cm configuration (Figure 2.13 (iv)).  This may be explained by the trend towards faster 
relaxation using this configuration, which at a fixed heart rate would allow for more 
complete filling of the left ventricle during diastole.  The PV loops shown in Figure 2.11 
demonstrate that a rectangular PV loop configuration could be achieved with the 
compliance chamber closer to the aortic cannula.  Ultimately however a compromise was 
made between PV loop shape and working heart performance.  In order to optimise the 
function of the working rabbit heart preparation, the 39 cm configuration was chosen. 
2.4.2.7 Compliance volume and working heart function 
From the data described above, the volume of air within the compliance chamber has a 
marked influence on cardiac function.  As is demonstrated in Figure 2.12, increasing the 
volume of air in the compliance chamber from 5 ml to 15 ml led to a significant 
improvement in the maximum rate of ventricular pressure rise and decreased the relaxation 
constant τ.  Aortic flow, stroke volume and ejection fraction (Figure 2.13) were also 
significantly elevated with 15 ml compliance volume in comparison to 5 ml.  A 
compliance volume of 5 ml air was therefore considered unsuitable for working rabbit 
heart experiments as function could be vastly improved with the use of 15 ml air.  It was 
found that increasing compliance volume to 20 ml induced no further changes in 
ventricular performance (data not shown).  One possible explanation for the relatively poor 
function observed using 5 ml air as compliance volume is elevation of arterial impedance.  
Impedance is determined in vivo by the compliance of the arterial system and the resistance 
of the systemic vascular bed (Urschel et al., 1968).  Urschel et al. (1968) increased 
compliance in the aorta of unconscious dogs by directing aortic blood flow through a stiff 
glass bypass (Urschel et al., 1968).  When alterations in preload were controlled for an 
increase in aortic impedance and a decline in  
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Figure 2.13 Compliance volume and working heart volume parameters. 
Influence of compliance distance on volume and flow measurements under varying compliance volumes in 
isolated working hearts.  * P < 0.05 13 cm vs. 39 cm, students unpaired t-test; 5 ml vs. 15 ml, repeated 
measures ANOVA with Tukey-Kramer multiple comparisons test.  Values expressed as mean ± SEM. 
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stroke volume was found to occur, suggesting a decline in compliance can significantly 
reduce output.  Leite-Moreira and Gillebert (1994) demonstrated that large increases in 
afterload, induced by clamping the aorta in early systole, significantly slowed left 
ventricular pressure fall (Leite-Moreira & Gillebert, 1994).  Relatively large increases in 
afterload induced by aortic clamping have also been shown to elevate end diastolic 
pressures, potentially impairing left ventricular filling (Leite-Moreira et al., 1999).  The 
authors explained this phenomenon in terms of ‘relative load’ (the ratio of baseline systolic 
pressure to isovolumic pressure) demonstrating that hearts under a high relative load 
experience a decline in the rate of left ventricular pressure fall when exposed to elevations 
in systolic pressure (Gillebert et al., 1997; Leite-Moreira et al., 1999).  Although there 
were no significant differences between 10 and 15 ml of air, 15 ml tended to show the 
highest mean values for dP/dtmax, aortic flow, stroke volume and ejection fraction.  The 
remainder of isolated working heart experiments therefore used a compliance volume of 15 
ml.     
2.4.3 How does afterload pressure affect working heart 
mechanical function? 
The influence of afterload pressure on working rabbit heart mechanical function was 
evaluated by exposing isolated working rabbit hearts to stepwise increases in afterload 
pressure from 50 mmHg to 80 mmHg in 10 mmHg increments.  These experiments were 
used to establish optimal loading conditions for the isolated working heart in terms of 
stroke volume and coronary flow reserve using the current setup.  Crystalloid perfusates 
such as Krebs-Henseleit and Tyrode’s solution have been shown to have poor oxygen-
carrying capacity compared to blood (Masuda et al., 1994; Sutherland & Hearse, 2000).  
Furthermore use of such solutions has been shown to limit coronary reserve in isolated 
working heart preparations (Masuda et al., 1994).  Therefore the ability to increase 
coronary flow with increasing afterload was also investigated.  The protocol was 
completed using the hearts from the 39 cm group reported above.  Following the 
completion of the compliance alterations, compliance volume was once again set to 15 ml 
of air to ensure steady state values returned to baseline and the preparation was stable.  
Preload remained at 7.4 mmHg and hearts were paced at 200 beats.min-1 throughout.  
Mean values of measured functional parameters at 50 and 80 mmHg afterload were 
compared within groups by repeated measures ANOVA with Tukey’s test for multiple 
comparisons performed as a post test.  A P-value < 0.05 was considered significant. 
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Figure 2.14 Influence of afterload on working heart contractile function.  A.  Representative PV loops at 
increasing afterload pressures.  B(i – iv) Effect of increasing afterload on isolated working heart contractile 
and relaxation parameters (n=4).  All values expressed as mean ± SEM.    
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2.4.3.1 Afterload and systolic functional parameters 
As can be seen from the representative pressure-volume loops in Figure 2.14A, elevation 
of afterload in a stepwise manner between 50 and 80 mmHg led to incremental elevation of 
peak systolic pressure with little change in stroke volume over the range.  Peak pressure 
(Figure 2.14 B(i)) significantly increased by 28.56 ± 2.55 % between 50 and 80 mmHg, 
and was significantly elevated with each afterload increment.  Similarly, dP/dtmax (Figure 
2.14 B(ii)) was 33.16 ± 5.39 % higher at 80 mmHg compared with 50, and each step 
increase in afterload led to a significant increase in dP/dtmax.  
2.4.3.2 Afterload and diastolic functional parameters  
Maximum rate of ventricular pressure fall (dP/dtmin - Figure 2.14 B(iii)) was significantly 
increased between 50 and 80 mmHg by 55.93 ± 4.37 %, with each elevation of afterload 
inducing a significant increase.  The relaxation constant τ (Figure 2.14 B(iv)) however did 
not change significantly within the range of afterload pressures investigated, although there 
was a trend for τ to be fastest at 60 mmHg.  Increasing afterload between 50 and 80 mmHg 
had no effect on end diastolic pressures. 
2.4.3.3 Afterload and volume parameters 
Aortic flow (Figure 2.15 (i)) was not significantly altered with each afterload increment 
within the range studied, but a significant reduction of 11.55 ± 5.31 % was evident at 80 
mmHg vs, 50 mmHg.  Aortic flow also fell significantly between 80 and 60 mmHg (not 
shown on graph).  Coronary flow however had a tendency to increase with increasing 
afterload pressure but this was only significant between 50 vs. 60 mmHg (23.72 ± 4.42 % 
increase), and 50 vs. 80 mmHg (31.04 ± 7.58 %).  The combination of increasing coronary 
flow with decreasing aortic flow at higher afterload pressures resulted in no significant 
changes evident in stroke volume (Figure 2.15 (iii)).  End diastolic and end systolic 
volumes were not different between any of the afterload settings investigated (data not 
shown).  Ejection fraction (Figure 2.15 (vi)) tended to be greatest at 60 mmHg also, but no 
significant differences were observed. 
2.4.3.4 Afterload pressure influences myocardial contractility and coronary 
flow 
Optimal afterload pressure for the current isolated working heart set up was studied by 
varying afterload between 50 and 80 mmHg, with the aim of selecting an afterload which 
produced maximal cardiac output and working heart performance.  In addition, it was  
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Figure 2.15 Influence of afterload pressure on working heart volume parameters.  (i-v) Volume and 
flow parameters at varying afterload pressures (n=4).  All values expressed as mean ± SEM.   
 
hoped that some coronary flow reserve would still be evident and that coronary flow could 
increase if work demand (load) was increased.  As shown in Figure 2.14 increasing 
afterload pressure in the current study led to stepwise elevations in peak systolic pressure, 
dP/dtmax and dP/dtmin.  The relaxation constant τ was not significantly altered between any 
of the afterload pressures investigated, although relaxation tended to be fastest at 60 
mmHg.  In terms of systolic pressure parameters 80 mmHg provided the greatest level of 
performance, however it was found that aortic flow began to decline significantly at this 
afterload pressure in comparison to 50 and 60 mmHg (Figure 2.15 (i)).  This was offset by 
an increased coronary flow vs. 50 mmHg, but not vs. 60 mmHg.  Selection of optimal 
afterload was a compromise between peak cardiac output and maximal systolic parameters. 
In terms of cardiac output (sum of aortic flow and coronary flow), stroke volume and 
ejection fraction 60 mmHg tended to show the greatest performance (Figure 2.15).  In 
addition relaxation also tended to be quickest at 60 mmHg.  The afterload pressures 
achievable by the perfusion apparatus were restricted by height limitations within the 
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laboratory, such that the system was working close to its limit at 80 mmHg.  The in vivo 
afterload of healthy mature rabbits has been reported by Baker et al. (1988) as 86 ± 14 
mmHg (Baker et al., 1988) which would suggest 80 mmHg as the most appropriate choice.  
Preliminary longevity studies with 80 mmHg afterload however (data not shown) 
suggested that functional decline after 60 min was   10 % which is generally what is 
accepted in isolated working heart studies ((Sutherland & Hearse, 2000), see also section 
2.4.3.1 below).  For these reasons 60 mmHg was chosen as afterload perfusion pressure for 
the remainder of the investigation.   
2.4.3.5 Increased contractility with increasing afterload may be explained by 
Gregg’s phenomenon 
The initial response of the heart to acute increases in arterial resistance (and hence 
afterload) in vivo is elevation of peak ventricular and aortic pressures with a concomitant 
decline in stroke volume (Milnor, 1975).  The relationship between ventricular wall stress 
and the contractile element velocity (the force-velocity curve) is altered following a change 
in arterial resistance in favour of increased force production at any given velocity (Bove & 
Lynch, 1970; Milnor, 1975).  Changes that occur upon increasing afterload in isolated 
heart preparations result in an increase in contractility through several recognized 
regulatory effects, though their relevance to contractile regulation in vivo remains unclear.  
One such effect is known as Gregg’s phenomenon, where changes in coronary perfusion 
(elicited by alteration of afterload) alter contractile strength and myocardial oxygen 
consumption (Feigl, 1983)  While several mechanisms have been proposed to try and 
explain this effect it is still not clear which is responsible.  One such mechanism, proposed 
by Arnold et al. (1968) known as the ‘garden-hose’ effect suggests that the increase in 
transmural pressure causes distension of the coronary vessels leading to increased stretch 
of the myocardial fibers which could increase contraction by the Frank-Starling 
mechanism (increased fibre length) (Arnold et al., 1968).  Evidence to support this comes 
from studies which demonstrate that increasing coronary distension while keeping 
coronary flow constant can elicit this effect (Feigl, 1983).  Abel and Reis (1970) however, 
reported that coronary flow was more important than coronary distension pressure for 
dictating this effect (Abel & Reis, 1970).  Using isovolumically contracting canine hearts, 
they found that the maximum velocity of contractile element shortening (Vce) could be 
increased by increasing flow at a constant pressure, but that altering pressure while keeping 
flow constant would have no effect on contractility (Abel & Reis, 1970).  In line with 
previous investigations, perfusion pressure had a marked influence on contractility and 
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coronary flow in the present study that may be attributable to this phenomenon (Masuda et 
al., 1994).     
2.4.4 Isolated working heart longevity 
Of critical importance to the validity of any results obtained from the isolated working 
heart is the stability of the preparation over time.  To assess this using the optimized 
working heart setup, the mechanical performance of 7 isolated working rabbit hearts was 
recorded over a period of 90 min.  Preload was set to 7.4 mmHg and afterload to 60 
mmHg.  Compliance volume was held constant at 15 ml air.  Settings were chosen based 
on the data shown in sections 2.4.2 and 2.4.3 above.  Hearts were paced at constant rate, as 
close to 200 beats.min-1 as possible (average = 204.10 ± 3.81 beats.min-1).  Following 
establishment of steady state baseline function, hearts were given a period of 5 minutes to 
stabilize before the experiment commenced.  Data at predefined intervals throughout the 
90 minute perfusion protocol were compared to control values (mean values at 0 min) 
using a paired student’s t-test.  P-values of < 0.05 were considered significant. 
2.4.4.1 Stability of working heart contractile parameters during prolonged 
perfusion 
Over the 90 min perfusion period in working heart mode, left ventricular peak pressure 
(Figure 2.16 (i & ii)) and the maximum rate of left ventricular pressure rise (Figure 2.16 
(iii & iv)) remained stable.  There was a tendency for both parameters to increase over the 
first 30 min relative to baseline but this did not reach significance.  Cardiac output (Figure 
2.16 (v & vi)) was also stable over the 90 min, falling by 3.14 ± 2.24 % (not significant).  
End diastolic pressure (Figure 2.17 (i & ii)) was stable over the first 60 min of perfusion 
but became significantly elevated by 90 min (27.15 ± 13.27 % above baseline).  While the 
maximum rate of left ventricular pressure fall did not significantly differ from baseline 
after 90 min (Figure 2.17 (iii & iv)), the relaxation constant τ (Figure 2.17 (v & vi)) was 
significantly prolonged after this time, increasing by 26.22 ± 10.44.  Coronary flow was 
not significantly different from baseline at any point.  
2.4.4.2 Expected longevity of the isolated working heart preparation 
Long term stability of an ex vivo working heart preparation is dependent on a number of 
factors, including composition of the perfusion medium, work load imposed on the heart,  
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Figure 2.16 Systolic function of the working heart during prolonged perfusion.  Left ventricular peak 
pressure, dP/dtmax and cardiac output during 90 min of working heart perfusion (n=7).  Panels on left indicate 
mean ± SEM values, panels on right indicate values as % of control (0 min)   
 
and the presence of exogenous drugs or compounds (Sutherland & Hearse, 2000).  In 
addition, the specific design of the aortic outflow tract may significantly influence the 
stability of working heart preparations over time (Van Bilsen et al., 1991).  Values for 
functional decline over prolonged periods have been suggested to be around 5 – 10 % per 
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hour (Sutherland & Hearse, 2000) using left ventricular developed pressure or cardiac 
output as the comparative functional index.  In agreement with this, Lewandowski et al. 
(1987) reported a 5 % drop in cardiac output of isolated working rabbit hearts 65 min after 
recording of baseline measurements, widening to 14.1 % after 79 min (calculated from 
mean reported values) (Lewandowski et al., 1987). DeWindt et al. (1999) reported a non-
significant decline in isolated murine heart cardiac output of 8 ± 10% after 100 min 
antegrade (working heart) perfusion compared with 20 min after initiation of working heart 
(de Windt et al., 1999).  Chemnitius and colleagues (1985) reported that cardiac outputs of 
a rabbit working heart preparation increased (non-significantly) by 6.4 % between initial 
control values and following 60 min, however it should be noted that an equilibration 
period of 2-3 min was reported following initiation of working heart perfusion compared 
with 30 min in the present study (Chemnitius et al., 1985).  A non-significant decrease in 
cardiac output was found in the current investigation following 90 min of perfusion in 
isolated working rabbit hearts, in good agreement with previously reported values for 
isolated working heart preparations following 60 min of perfusion with crystalloid 
perfusion media.  Although end diastolic pressure (Figure 2.17 (i & ii)) and τ (Figure 2.17 
(v & vi)) were significantly elevated after 90 min of perfusion in the current study, no 
significant differences were apparent after 60 min of perfusion. 
2.4.4.3 Improving stability of the isolated working heart preparation 
The isolated working heart setup described in this chapter was used in conjunction with a 
crystalloid perfusion medium.  While this is the most commonly used perfusate for isolated 
heart studies (Podesser et al., 1999) the oxygen carrying capacity of such solutions is much 
lower than that of blood (Sutherland & Hearse, 2000).  In addition, prolonged perfusion 
periods are associated with increasing levels of oedema and tissue swelling which may 
adversely affect coronary perfusion by inducing compression of the microvasculature 
(Segel & Ensunsa, 1988).  In the current study it may have been possible to improve 
stability even further with the addition of exogenous substrates to the perfusion medium.  
Increased tissue water content has been demonstrated to be reduced in isolated, non-
ejecting rabbit hearts by addition of bovine serum albumin to the perfusion medium 
(Mann, 1981).  Addition of albumin is also associated with preserved coronary vascular 
resistance and reduced leakage of creatine kinase in working rabbit hearts perfused with a 
perfluorochemical-based buffer (Segel & Ensunsa, 1988).  Inclusion of albumin to the 
perfusion medium in the present study may have helped to improve longevity, although the  
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Figure 2.17 Diastolic functional parameters of the working heart during prolonged perfusion.  End 
diastolic pressure (LVEDP), dP/dtmin and τ during 90 min perfusion in working heart mode.  Panels on left 
indicate mean ± SEM values, panels on right indicate values as % of control (0 min) 
 
method of perfusate oxygenation would have to be altered to accommodate this, as direct 
gas bubbling of solutions containing free fatty acids results in significant foaming 
(Sutherland & Hearse, 2000).  Pyruvate is another metabolic substrate that is commonly 
included in crystalloid buffer solutions alongside glucose (de Windt et al., 1999; Gillis et 
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al., 1996; Schmidt, 2001; Van Bilsen et al., 1991).  Pyruvate has been demonstrated to 
influence intracellular Ca2+ cycling, SR Ca2+ load and myofilament Ca2+ sensitivity 
(Hasenfuss & Pieske, 2002; Hermann et al., 2000a).  Hermann et al. (2000) demonstrated 
that pyruvate potentiated the increased force development induced by isoproterenol in 
isolated ventricular muscle preparations (Hermann et al., 2000b).  Pyruvate also increased 
SR Ca2+ load, time to peak developed tension, and time from peak tension to half-maximal 
relaxation, an observation the authors suggested was indicative of an alteration in Ca2+ 
cycling and/or myofilament cross-bridge kinetics.  In ventricular myocardium from failing 
human hearts pyruvate led to an increase in systolic force and a decrease in diastolic force, 
attributable to i) increased SR Ca2+ cycling and ii) elevated pHi effecting an increase in 
myofilament Ca2+ sensitivity.  As the main focus of this thesis is Ca2+ cycling with respect 
to SR function the decision was made not to include pyruvate as a metabolic substrate to 
avoid complication of subsequent results.       
2.4.4.4 Alternative perfusion media 
Crystalloid perfusion solutions are the most frequently used for isolated working heart 
experiments, however other possibilities exist for perfusion of the isolated heart, including 
perfluorochemical emulsion (Chemnitius et al., 1985) and erythrocyte-washed solutions 
(Chen et al., 1987; Gillis et al., 1996; Masuda et al., 1994; Podesser et al., 1999).  Both 
have superior oxygen carrying capacity in comparison to crystalloid perfusates and have 
been demonstrated to improve contractile performance (elevated dP/dtmax and dP/dtmin) and 
reduce the loss of high energy phosphates over time in the working rabbit heart 
(Chemnitius et al., 1985; Chen et al., 1987; Podesser et al., 1999).  Significantly greater 
contractile reserve, measured by assessment of reactive hyperaemia after transient 
ischaemia, is also evident when using perfluorochemical emulsion (Chemnitius et al., 
1985) or erythrocyte-enriched solutions (Masuda et al., 1994) in comparison to crystalloid 
perfusion solutions.  For these reasons such preparations are recommended over crystalloid 
perfusates in studies of ischaemia and reperfusion injury.  A compromise must be made 
with regard to cost and preparation time however, especially with erythrocyte enhanced 
solutions.  Membrane oxygenation is a requirement for any perfusion solution containing 
erythrocytes as directly gassing the solution with a glass bubbler results in significant 
foaming.  In addition, recirculation of solution through the system via peristaltic pump 
motion is associated with erythrocyte haemolysis and subsequent accumulation of free 
haemoglobin (Podesser et al., 1999).  In the present study, a crystalloid perfusion medium 
(modified Tyrode’s solution) was adequate for sustaining working heart function over a 
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prolonged period with only minimal decline in contractile and relaxation parameters.  
Solution preparation was relatively swift and large quantities (15-20 L) could be made at 
little cost.  Had preparation longevity been in doubt, perfluorochemical emulsion or 
erythrocyte-enriched perfusion solutions may have been investigated, however the ease of 
preparation in addition to the above data regarding longevity meant that in the current 
study modified Tyrode’s solution was an adequate choice for working heart perfusion. 
   
 
 
 
 
 
 
 
 
3 The effects of K201 (JTV-519) on left ventricular 
mechanical function in the isolated working 
rabbit heart 
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3.1 Introduction 
Coordinated regulation of Ca2+ release from the sarcoplasmic reticulum (SR) is critical to 
normal cardiomyocyte function.  In the ventricular myocyte, SR Ca2+ release is visualised 
as unitary local release events known as Ca2+ sparks, which represent activation of a 
cluster of ryanodine receptors (RyR2s) opening in concert to release Ca2+ (Cheng et al., 
1993).  These events occur at a low frequency (~100 s-1) and do not necessarily require a 
triggering influx of Ca2+ to occur (Bers, 2002; Cheng et al., 1993).  Under normal 
conditions, synchronised SR Ca2+ release via the cardiac ryanodine receptor (RyR2) is 
triggered by the inward Ca2+ current, and the rising phase of the intracellular Ca2+ transient 
is believed to reflect the temporal and spatial summation of thousands of Ca2+ sparks (Bers, 
2002).  Excessive spontaneous SR-mediated Ca2+ release during diastole however, has 
been demonstrated to occur in situations where RyR2 function is altered.  Mutations in the 
RyR2 channels (Liu et al., 2008) as well as changes in channel function evident in various 
disease states such as congestive heart failure (Tateishi et al., 2009) have been shown to 
result in an increased frequency of Ca2+ release during the diastolic period.  Excessive 
spontaneous Ca2+ release during diastole has been identified as a potential mechanism in 
the genesis of triggered arrhythmias (Bers et al., 2006; Hove-Madsen et al., 2004).  
Moreover, diastolic Ca2+ leak has also been proposed to lead to increased diastolic tone 
and incomplete relaxation, as well as potentially contributing to decreased SR content 
(Shannon et al., 2003).  In the search for potential therapeutic strategies, attention has 
focused on agents or treatments which can specifically target the RyR2 and restore normal 
function.  One such drug which has emerged in the literature in recent years is K201 (JTV-
519).  First described for its cardioprotective properties against myocardial over-
contraction and necrosis (Kaneko, 1994), K201 has since been shown to possess potential 
as both a cardioprotective and anti-arrhythmic agent (Hasumi et al., 2007; Inagaki et al., 
2000b).  Most recently, it has been demonstrated using a mouse myocardial infarction 
model (Wehrens et al., 2005), as well as a canine model of pacing induced heart failure 
(Yano et al., 2003) that K201 is able to significantly attenuate development of cardiac 
dysfunction and ventricular remodelling.  In these models, K201 was proposed to stabilise 
the RyR2 in the closed state, preventing SR Ca2+ leak and potentially arrhythmogenic 
events from occurring (Tateishi et al., 2009; Wehrens et al., 2005; Yano et al., 2003).         
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3.1.1 Initial investigations with K201 and myocardial preservation 
The chemical formation of K201 is depicted in Figure 3.1.  K201 is a 1, 4-benzothiazepine 
derivative, initially developed as a cardioprotective agent to inhibit cellular damage and 
myocardial over-contraction associated with ischaemia-reperfusion injury and myocardial  
 
Figure 3.1 Chemical structure of K201. 4-[3-{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-
tetrahydro-1,4-benzothiazepine.  From Inagaki et al. (2000) 
infarction (Kaneko, 1994).  At concentrations of 1.0 µM and above the compound was 
shown to significantly suppress cellular necrosis and myocardial over-contraction in a rat 
Langendorff model induced by perfusion of epinephrine (0.1 mg, administered as 546 µM 
bolus) and/or caffeine (10 mg, administered as 52 mM bolus) (Kaneko, 1994).  K201 was 
also shown to inhibit the binding of F-actin to the calcium binding protein Annexin V, 
however this was only achievable using a minimum concentration of 10 µM.  Further 
detailing of K201’s cardioprotective effects were made using experimental models of 
ischaemia-reperfusion injury (Hachida et al., 1999; Inagaki et al., 2000a; Inagaki et al., 
2000b; Kawabata et al., 2000).   
3.1.1.1 K201 influences recovery of mechanical function in models of 
ischaemia-reperfusion and prolonged myocardial preservation 
Hachida and colleagues (1999) studied K201’s cardioprotective effects in the setting of 
prolonged myocardial preservation with Bretschneider’s histidine-tryptophan-ketoglutarate 
(HTK) cardioplegic solution (Hachida et al., 1999).  Rat hearts preserved for 6 hours with 
an HTK solution containing 10 µM K201 demonstrated a significantly greater recovery of 
left ventricular developed pressure and coronary blood flow following normothermic 
perfusion in comparison with untreated controls.  Elevation of [Ca2+]i, as assessed by the 
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Ca2+-sensitive dye Fura-2/AM, was also significantly attenuated in hearts perfused with 
K201 (Hachida et al., 1999).  Inagaki et al. (2000) assessed contractile function of the 
isolated rat heart following 30 min of global ischaemia and 30 min reperfusion (Inagaki et 
al., 2000a).  They discovered that a 5 min perfusion period with K201 (0.3, 1.0 or 3.0 µM) 
prior to 30 min global ischaemia led to a reduction in the level of myocardial stunning in 
comparison to untreated control hearts, as evidenced by left ventricular developed pressure 
recovering to levels significantly greater than controls 30 min after reperfusion.  No 
significant differences were seen in left ventricular end diastolic pressure (LVEDP) 
between K201 treated and control hearts.  This protective effect was also observed when 
1.0 µM K201 was perfused either prior to the ischaemic period, or during the initial 5 min 
of the reperfusion phase.  The authors concluded that this effect was mediated by 
activation of PKC-δ, as the protective effect was abolished in the K201 groups by 
treatment with the PKC inhibitor GF109203X (Inagaki et al., 2000a).  In a follow up study 
by the same group, hearts were loaded with the fluorescent Ca2+ indicator Indo-1, allowing 
the authors to determine that prolonged (> 10 min) ischaemia and subsequent reperfusion 
was associated with an increase in [Ca2+]i (Inagaki et al., 2000b).  This rise in [Ca2+]i was 
significantly attenuated by K201 at 1.0 µM and above, while preservation of myocardial 
contractile function could be achieved using even lower concentrations (0.3 µM) (Inagaki 
et al., 2000b).    Kawabata et al. (2002) investigated the role of nitric oxide (NO) in the 
protective action of K201 following ischaemia and reperfusion by simultaneously 
perfusing hearts with K201 and the NO synthase inhibitor NG-nitro-L-arginine methyl ester 
(L-NAME) for 40 min prior to 20 min global ischaemia (Kawabata et al., 2002)  Ischaemia 
induced a rise in diastolic tension (assessed from LVEDP) in untreated control hearts 
which was significantly inhibited by pre-treatment with 1.0 µM K201. NO synthase 
inhibition had little effect on the ability of K201 to inhibit elevation in diastolic tension 
during the ischaemic period suggesting increased cytosolic calcium levels associated with 
ischaemic contracture are more effectively impeded by K201 than by NO synthase alone.  
Interestingly in this investigation neither LVEDP or developed pressure in the K201 
groups were significantly different from control following the 30 min reperfusion period, 
contrary to the findings of Inagaki and colleagues in the rat heart, who reported a 
significant recovery of developed pressure 30 min after reperfusion (Inagaki et al., 2000a). 
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3.1.1.2 K201 preserves high energy phosphates in ischaemia-reperfusion 
models 
Inagaki et al. (2000) determined efflux of creatine phosphokinase (CPK) and lactate 
dehydrogenase (LDH) by measuring levels of each in coronary effluent samples of rats 
following ischaemia and subsequent reperfusion (Inagaki et al., 2000a).  Perfusion of K201 
prior to ischaemia resulted in a significant reduction in the levels of both CPK and LDH 
present in coronary effluent samples at 30 min of reperfusion in comparison to samples 
from untreated control hearts.  Beneficial metabolic effects of K201 were also reported by 
Kawabata et al. (2000) following 20 min ischaemia then reperfusion in the isolated rabbit 
heart (Kawabata et al., 2000).  The investigators found that while ischaemia resulted in a 
decline in ATP and increase in inorganic phosphate (Pi) in control hearts, pre-perfusion 
with K201 significantly attenuated both of these effects.  In a follow-up investigation, 
simultaneous pre-perfusion with K201 and the NO synthase inhibitor L-NAME abolished 
the influence of K201 on ATP and Pi levels during ischaemia and reperfusion (Kawabata et 
al., 2002).  Thus K201 appears to preserve high energy phosphate levels following 
myocardial ischaemia and reperfusion injury, with evidence suggesting this effect may be 
mediated in part by stimulation of NO synthase.  
3.1.2 Effect of K201 on membrane currents and its anti-arrhythmic 
potential 
A number of investigations have reported on the potential of K201 as an anti-arrhythmic 
agent, ascribed mainly to its inhibitory actions on a number of ionic currents (Kumagai et 
al., 2003; Nakaya et al., 2000).  From the work of Kimura and colleagues (1999) using 
guinea pig ventricular myocytes it was established that K201 possessed an inhibitory effect 
on several ionic currents, including the inward sodium current, INa, the inward calcium 
current, ICa, and the inwardly rectifying potassium current IK1.  The action potential 
duration was significantly shortened in the presence of concentrations as low as 1.0 µM, an 
effect that could not be explained by inhibition of these three ionic currents alone (Kimura 
et al., 1999).  Further investigation of K201’s channel blocking action was carried out 
using guinea pig atrial cells (Nakaya et al., 2000).  Both IK-ACh and IKr were potently 
suppressed by K201, with an IC50 of 2.29 µM and 2.42 µM respectively.  As current 
pharmacological treatments for AF possess similar channel blocking actions (Wettwer et 
al., 2007), it was postulated that K201 may possess anti-arrhythmic properties in such a 
setting.  Indeed, in a guinea-pig Langendorff model of AF, 1.0 µM K201 led to a reversal 
of the reduction in monophasic action potential (MAP90) and effective refractory period 
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(ERP) durations induced by carbachol chloride (CCh), and completely prevented AF 
induction by a train of stimuli, despite the presence of CCh (Nakaya et al., 2000).  Sole 
application of K201 (0.3 and 1.0 µM) to atrial myocytes did not significantly alter APD, in 
contrast to the significant shortening reported by Kimura et al. (Kimura et al., 1999). K201 
was also shown to be effective in preventing AF using the canine sterile pericarditis model 
(Kumagai et al., 2003).  Treatment with K201 completely prevented induction of AF by 
rapid atrial pacing in this model, and while it was still possible to generate sustained atrial 
flutter, the number and duration of these episodes was significantly reduced.  Atrial 
effective refractory period for any given cycle length was also significantly prolonged by 
K201, although conduction time within the right atrium itself was not significantly altered 
(Kumagai et al., 2003).  Hasumi et al. (2007) studied the anti-arrhythmic potential of K201 
in the setting of pharmacologically-induced ventricular Torsades de Pointes (Hasumi et al., 
2007).  Treatment with clofilium in the presence of α1-adrenoceptor blockade led to 
induction of Torsades de Pointes, an effect which was completely blocked by 
administration of 400 µg.kg-1 K201 (~12.85 µM) (Hasumi et al., 2007). 
3.1.3 K201 and the cardiac ryanodine receptor 
Since the discovery of the binding protein FKBP12.6 (calstabin2) and its relationship with 
the cardiac ryanodine receptor (Lam et al., 1995; Timerman et al., 1996), attempts have 
been made to characterise this relationship in various cardiac disease states, including heart 
failure.  It has been reported that the stoichiometry of FKBP12.6 binding to RyR2 is 
significantly reduced in ventricular tissue from failing hearts (Marx et al., 2000; Ono et al., 
2000; Yano et al., 2000) which has been proposed to occur as a direct consequence of 
‘hyperphosphorylation’ of RyR2 by protein kinase A (PKA) in heart failure (Marx et al., 
2000; Reiken et al., 2003).  Yano and colleagues (2003) demonstrated that a canine 
chronic right ventricular pacing model of heart failure was associated with increased PKA 
phosphorylation of RyR2, dissociation of FKBP12.6 from the channel and an apparent 
increase in diastolic calcium leak (Yano et al., 2003).  Treatment with K201 throughout the 
period of chronic pacing significantly attenuated the decline in systolic and diastolic 
function and prevented remodelling of the left ventricle.  These effects were attributed to 
the ability of K201 to restore normal FKBP12.6-RyR2 stoichiometry and inhibit diastolic 
Ca2+ leak (Yano et al., 2003).  In normal SR vesicles prepared from canine left ventricular 
homogenates, treatment with FK506 (dissociating FKBP12.6 from RyR2) led to a decline 
in the rate and magnitude of Ca2+ release to levels comparable with failing SR vesicles.  In 
normal and failing SR vesicles both parameters could be restored towards control levels 
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using 1 µM K201 (Kohno et al., 2003).  K201 treatment was also effective in preventing 
exercise-induced arrhythmias in FKBP12.6 +/- mice, although this was not the case in 
FKBP12.6 -/- mice, suggesting that FKBP12.6 is a prerequisite for K201’s antiarrhythmic 
action in this setting (Wehrens et al., 2004).   
3.1.4 Is FKBP12.6 the critical mediator of K201 RyR2 channel 
stabilisation? 
While some studies have shown that K201’s actions are mediated via the RyR2 to some 
extent, investigators have challenged a number of observations regarding the action of the 
drug.  It has been suggested that the initial trigger for dissociation of FKBP12.6 from 
RyR2 occurs as the result of disruption of normal receptor interdomain interaction (Oda et 
al., 2005).  Through the use of peptide constructs that correspond to subdomains of the 
RyR2 previously shown to harbour mutations in CPVT, unzipping of the N-
terminal/Central domain interactions led to cAMP-dependent hyperphosphorylation of 
RyR2, dissociation of FKBP12.6 from the channel complex and Ca2+ leak.  Of note was 
that domain unzipping was already present in failing hearts.  The specific binding site of 
K201 was identified by Yamamoto et al. (2008) using synthetic peptides corresponding to 
specific regions of RyR2 (Yamamoto et al., 2008).  They identified an amino acid 
sequence in the RyR2 that shared sequence homology with Annexin V, a protein known to 
bind with K201 (Kaneko et al., 1997). This region, known as domain2059-2156, included a 
smaller domain (domain2114-2149).  The domain peptide2114-2149 (DP2114-2149) was synthesised 
by the group and found to bind K201.  Inclusion of larger RyR2 fragments in the search 
revealed that K201 did not bind fragments that contained no sequence homology with 
DP2114-2149.  DP2114-2149 was shown to interact with the RyR2 in SR vesicles and prevent 
Ca2+ leak induced by application of FK506.  This effect could be achieved in the presence 
of 30 µM FK506 which binds FKBP12.6 completely, suggesting that stabilisation can 
occur without re-association of FKBP12.6 to the channel complex (Yamamoto et al., 
2008).  Investigations by Hunt et al (2007) led to the conclusion that FKBP12.6 was not 
essential for suppression of SR Ca2+ leak in cells exhibiting spontaneous SR Ca2+ release 
(termed store overload induced Ca2+ release, or SOICR) from the following observations; 
(a) K201 suppressed spontaneous release events in intact ventricular myocytes to the same 
degree, regardless of the presence or absence of 2 µM FK506, (b) the level of K201’s 
inhibition of spontaneous Ca2+ release from human embryonic kidney (HEK-293) cells co-
expressing RyR2 and FKBP12.6 were the same as HEK-293 cells expressing RyR2 alone  
(Hunt et al., 2007).  Evidence is therefore accumulating which suggests FKBP12.6 is not a 
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requirement for restoration of normal RyR2 gating function in the presence of K201, 
although this issue remains to be fully resolved.          
3.1.5 What is the effect of K201 on E-C coupling in normal cardiac 
preparations? 
The beneficial effects of K201 in the setting of ischaemia-reperfusion injury, experimental 
heart failure, as well as in various models of atrial fibrillation have all been well 
documented.  Little effort however has been made to characterise the influence of K201 on 
normal cardiac function with regards to excitation-contraction coupling.  From the work of 
Kimura and colleagues (1999) it is clear that K201 treatment leads to a concentration 
dependent suppression of ICa,L, INa and IK1 in guinea pig ventricular myocytes (Kimura et 
al., 1999).  Inagaki et al. (2000) noted depression of L-type Ca2+ current in isolated rat 
ventricular myocytes using 1.0 µM (by 22 %) and 3.0 µM (by 59.6 %) K201 but concluded 
that interaction with the L-type Ca2+ channel did not play a significant role in the 
cardioprotective effect of K201, as the concentration of K201 required to elicit protection 
against ischaemia-reperfusion  injury (0.3 µM) did not significantly inhibit ICa,L (Inagaki et 
al., 2000b).  Furthermore, although ICa,L was significantly inhibited at both 1.0 and 3.0 µM 
K201, only 3.0 µM demonstrated a significant depression of left ventricular developed 
pressure prior to onset of ischaemia.  More recently, Loughrey et al. (2007) explored in 
depth K201’s influence on E-C coupling mechanisms in rabbit cardiomyocytes.  K201 at 
1.0 µM was shown to significantly reduce Ca2+ leak from the SR without altering SR Ca2+ 
content, and at this concentration diastolic Ca2+ waves induced by Ca2+ overload were 
significantly attenuated (Loughrey et al., 2007).  Application of 3.0 µM K201 effectively 
abolished Ca2+ waves however this was also associated with a reduction in SR content 
(Loughrey et al., 2007).  They also found that, in contrast to previous findings, ICa,L was 
inhibited at 3.0 µM but not 1.0 µM K201, and that the maximal rate of SR Ca2+ uptake by 
SERCA (Vmax) was significantly reduced to 88 % and 77 % of control values using 1.0 and 
3.0 µM respectively, an observation in disagreement with those of Yano et al., who 
reported that SR Ca2+ uptake was not altered by K201 (Yano et al., 2003).  Taken together, 
the results of these previous studies suggest that there are marked alterations in E-C 
coupling mechanisms in the presence of 3.0 µM K201 that would favour a depression of 
cardiac inotropy in normally functioning hearts (decreased ICa,L, RyR2 open probability 
and SR Ca2+ uptake), but the implications for 1.0 µM K201 are not so clear due to the 
aforementioned disparities between results of individual investigations.            
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3.1.6 Aims 
The aim of the work described in this chapter was to establish the effects of different 
concentrations of K201 on cardiac inotropy and mechanical function in an isolated 
working rabbit heart preparation.  Contractile function in the isolated working heart 
preparation is more physiological than that measured in previous Langendorff-based 
investigations, allowing more thorough characterisation of mechanical function, including 
assessment of ventricular volumes.  Based on the results of previous studies looking at the 
actions of this drug on EC coupling, it was hypothesised that K201 would demonstrate a 
depressive effect on contractile function in the isolated working heart that would become 
apparent at concentrations of 3.0 µM and above.   
3.2 Methods 
3.2.1 Isolated working heart setup 
Hearts from 8 male New Zealand White rabbits were excised and perfused initially in 
Langendorff mode on the isolated working heart apparatus as described in the General 
Methods chapter section 2.1.3.  After cannulation of the left atrium and initiation of 
working heart mode, perfusate solution was recirculated to establish working heart 
recirculating mode with a fixed volume of 540 ml.  Preload was set at 7.4 mmHg and 
afterload set to 60 mmHg.  These settings remained constant throughout the experimental 
protocol. 
3.2.2 Left ventricular function by pressure-volume catheterisation 
A 3F Scisense VSL catheter with a recording electrode segment of 19 mm was advanced 
slowly past the aortic valves into the left ventricle to obtain pressure-volume measurements 
throughout the experimental protocol.  Estimation of Vp was made by injection of a 20 % 
hypertonic saline bolus into the left atrial inflow line 5 min prior to the beginning of the 
protocol. 
3.2.3 Solutions 
Perfusion of the isolated working heart was performed using Tyrode’s solution, the 
composition of which is described in General Methods section 2.1.3.  K201 was created by 
dissolving K201 (molecular weight 461 g.mol-1) in a 10% dimethyl sulfoxide (DMSO) 
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solution to yield a stock K201 concentration of 1 mM.  The 10% DMSO acted as vehicle 
solution in control experiments  
3.2.4 Experimental Protocol 
The effect of increasing concentrations of K201 on mechanical function was investigated 
in 8 isolated working rabbit hearts.  After recording of baseline function 162 µl of a 1 mM 
K201 stock were added to the recirculating perfusate via the recirculation reservoir, 
yielding a final concentration of 0.3 µM K201.  The concentration of K201 was increased 
to 1.0 µM 4 min after this point by addition of 378 µl, with a final increase in 
concentration to 3.0 µM performed once again 4 min later by addition of 1080 µl.  Hearts 
were not paced throughout the protocol. 
3.2.5 Data Recording and statistical analysis 
All data were recorded on a Dell PC using LabChart software version 5.5.6 at a sampling 
rate of 1000 Hz, and analysed offline using LabChart’s Blood Pressure Module and 
LabScribe2.0 software.  Vp estimation was performed offline using PVAN.  Student’s t-test 
or Repeated Measures ANOVA and Tukey-Kramer multiple comparisons test were used to 
compare the effect of each addition of K201 on a number of functional parameters.  A P-
value of < 0.05 was considered statistically significant. 
3.3 Results 
The protocol for incremental addition of K201 to the isolated working heart perfusate is 
shown in Figure 3.2A.  Arrows along the top represent the point where the drug was added 
to the perfusion reservoir, with labeled bars showing the concentration of drug perfusing 
the heart.  Time delay between addition of drug to the reservoir and the drug reaching the 
heart was estimated based on the preliminary calculations discussed in General Methods 
Chapter section 2.1.1.  Before 4 min of perfusion with 3.0 µM K201, 3 of the 8 hearts were 
no longer able to maintain a cardiac output sufficient to sustain working heart function and 
did not last the full 4 min at this concentration.  For this reason, subsequent functional 
mean data comparisons were therefore made at 90 s after addition of 3.0 µM to the 
perfusate when all hearts produced a measurable aortic flow.  Left intra-ventricular (LV) 
pressure and volume recordings at each concentration of K201 are depicted in Figure 3.2B 
(i–iv) and corresponding pressure volume loops in Figure 3.2C.  Whilst 0.3 µM K201 did 
not affect heart rate (HR), 1.0 and 3.0 µM K201 induced a concentration-dependent  
Allen Kelly - 2010  Chapter 3 
 118
   
 
Figure 3.2 K201 concentration response.  A.  Diagram of the experimental protocol.  B(i–iv).  
Representative pressure and volume traces taken from points denoted in A.  C.  Representative pressure-
volume loops at each of the time points indicated in A.  D.  Heart rate in K201 (n=8) and paced vehicle 
control (n=4) groups, expressed as a % of control. 
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reduction in HR (to 92.99 ± 1.74 % and 87.75 ± 1.74 % of pre-K201 value (204.58 ± 3.19 
beats.min-1) - Figure 1D).  This reduction in HR did not occur in the vehicle control (198.4 
± 6.6 beats.min-1 (steady state) vs. 200.2 ± 6.4 beats.min-1 (90 s post-1080 µl vehicle); 
n=3).  Therefore, to enable assessment of cardiac functional parameters at equivalent heart 
rates with timed controls, a subset of hearts were perfused with the corresponding 
concentration of vehicle and paced at rates equivalent to the mean values achieved with 
each concentration of K201 (Figure 3.2D). 
 
Pre-K201 0.3 µM K201 1.0 µM K201 3.0 µM K201
Parameter
HR (beats.min-1) 203.72 ± 3.17 200.79 ± 3.85 189.58 ± 5.36 177.29 ± 7.54
AF (ml.min-1) 177.06 ± 13.87 166.04 ± 15.63 135.35 ± 20.79* 99.57 ± 23.71*
CF (ml.min-1) 67.50 ± 4.50 67.75 ± 4.64 67.88 ± 4.63 67.75 ± 4.71
SV (ml) 1242.92 ± 92.45 1192.31 ± 96.64 1079.60 ± 122.92* 921.84 ± 121.72*
Systolic
PSP (mmHg) 98.11 ± 1.45 97.28 ± 2.09 93.35 ± 2.19* 89.37 ± 1.89*
dP/dtmax (mmHg.s-1) 1916.10 ± 72.67 1830.76 ± 109.58 1501.20 ± 114.81* 1276.68 ± 93.12*
ESV (ml) 632.33 ± 68.33 686.06 ± 76.05 865.24 ± 127.30 1055.54 ± 140.00
EF (%) 66.27 ± 3.28 63.47 ± 3.48 56.27 ± 5.08* 46.78 ± 4.85*
Diastolic
EDP (mmHg) 8.15 ± 1.38 9.12 ± 1.50 9.83 ± 1.62 10.15 ± 1.45
dP/dtmin (mmHg.s
-1) -2077.03 ± 144.54 -1986.55 ± 145.67 -1787.33 ± 137.12 -1522.80 ± 149.91
EDV (ml) 1875.24 ± 102.78 1878.37 ± 108.91 1944.84 ± 135.71 1977.38 ± 155.61
Tau (ms) 27.38 ± 2.77 29.03 ± 3.06 37.68 ± 4.56* 49.11 ± 7.05*
Table 1 Left Ventricular Functional Indices from Isolated Working Rabbit Hearts
 
Table 3.1 Effect of K201 on haemodynamic parameters of the isolated working rabbit heart.  HR, heart 
rate; PSP, LV peak systolic pressure; EDP, end diastolic pressure; ESV, end systolic volume; EDV, end 
diastolic volume; SV, stroke volume; AF, aortic flow; CF, coronary flow; EF, ejection fraction.  Values 
expressed as mean ± SEM. * P < 0.05 vs. previous K201 concentration. 
3.3.1 Effect of K201 on systolic functional parameters in the 
isolated working rabbit heart 
Mean functional parameters from hearts perfused with K201 are shown in Table 3.1.  As 
demonstrated by the representative trace and PV loop in Figure 3.2B(ii) and 3.2C, 
respectively, application of 0.3 µM K201 did not significantly effect any systolic 
functional parameter measured (Table 3.1 & Figure 3.3).  However, as can be seen from 
example traces in Figure 3.2B, and PV loops in Figure 3.2C, 1.0 and 3.0 µM K201 led to a 
significant concentration dependent reduction in LV peak systolic pressure (PSP) which 
when normalised for the negative chronotropic effect and DMSO decreased to 92.16 and  
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Figure 3.3 Influence of K201 on working heart function.  (i-iiiv).  Effect of K201 on functional 
parameters of unpaced isolated working hearts (black squares, n=8) in comparison to paced vehicle controls 
(red circles, n=4).  All values are non-normalised and expressed as % of pre-K201 values.  
 
87.78% of control values, respectively (Figure 3.3(i)).  Similarly, the maximum rate of rise 
of intra-ventricular pressure was significantly reduced to 80.93 and 69.11% of control 
respectively (Figure 3.3(ii)).  
3.3.2 Effects of K201 on diastolic functional parameters in the 
isolated working rabbit heart 
Normalising for the effect of negative inotropy and DMSO, the relaxation of the 
myocardium was also impaired by 0.3, 1.0 and 3.0 µM K201 as assessed by the end 
diastolic pressure (EDP) which was significantly increased to 113.79, 119.68 and 123.10% 
of control values (Figure 3.3(iii)).  Similarly, 1.0 and 3.0 µM K201 decreased the 
maximum rate of LV pressure fall (dP/dtmin – Figure 3.3(iv)) to 83.45 and 71.64% of the 
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control value and increased the time for the relaxation constant (τ) to 125.19 and 158.58% 
of the control value (Figure 3.3(v)). 
3.3.3 Effects of K201 on volume parameters in the isolated 
working rabbit heart 
As can be observed in the PV loops shown in Figure 3.2C and mean data in Table 3.1 and 
Figure 3.3(vi), 1.0 and 3.0 µM K201 led to a decline in stroke volume (SV) to 83.62 and 
70.18% of control values.  This was due to an increase in end-systolic volume (ESV) to 
150.71 and 185.56 % of control, shown in Figure 3.3(vii) as opposed to the any significant 
alteration in end-diastolic volume (mean data in Table 3.1, percentage data not shown). As 
a result of these volume changes the ejection fraction was reduced by 1.0 and 3.0 µM 
K201 to 80.44 and 66.63% of control values (Figure 3.3(viii)).  K201 did not alter 
coronary flow which at steady state was 67.50 ± 4.50 ml.min-1.     
3.3.4 Comparison of the effects of K201 in paced vs. non-paced 
hearts 
Due to the negative chronotropy induced by K201 the control hearts had to be paced at 
equivalent heart rates.  This led to a situation where the control hearts were paced but the 
hearts exposed to K201 were not paced.  It is possible that the pacing in control hearts had 
altered the electrical activation pattern and therefore the subsequent mechanical function 
therefore making direct comparison complex.  To ensure that the effect of K201 on 
systolic, diastolic and volume parameters is the same between paced and non-paced hearts 
a subset of hearts were paced at a set rate (201.98 ± 2.26 bpm) and then perfused with 1.0 
µM K201 during continued pacing.  Figure 3.3B compares the effects of a 4 min period of 
K201 perfusion in paced and non-paced hearts.  The non-paced hearts were comprised of 
the same group as shown in Figure 3.3A and table 3.1, however pre-1.0 µM values were 
expressed as a % of values 4 min after perfusion with 0.3 µM K201, as this allowed for 
direct comparison of the same time period in 1.0 µM K201 for both groups.  As can be 
seen from Figure 3.4(i) & (ii), all parameters measured, with the exception of the 
relaxation constant were altered significantly in the same direction as when not paced 
demonstrating that the mechanical effects of K201 on the normal heart is due to a direct 
effect of K201 rather than any pacing induced modulation.                        
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Figure 3.4 Influence of K201 on working heart function.  (i-ii).  % change in functional parameters of 
unpaced (white bars, n=8) and paced (grey bars, n=4) hearts exposed to 1.0 µM K201 for 4 min.  Paced 
hearts expressed as a % of pre-K201 values.  Non-paced hearts expressed as a % of post-4min 0.3 µM K201 
values to compare identical perfusion times in 1.0 µM K201 for both groups   
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3.4 Discussion 
3.4.1 K201 has a negative inotropic effect on the intact isolated 
ejecting heart 
The potential cardioprotective effects of K201 have been demonstrated in a number of 
investigations utilizing different stress-inducing protocols.  Kaneko et al. (1994) 
demonstrated that K201 could protect against myocardial over-contraction and cell 
necrosis following administration of epinephrine and/or caffeine (Kaneko, 1994), while 
preservation of left ventricular function was achieved in ischaemia-reperfusion studies 
when K201 was perfused both before the onset of ischaemia (Ito et al., 2000) and during 
reperfusion (Inagaki et al., 2000b).  Little is known however about the effects of K201 on 
contractile function in the normally functioning heart.  The results from this investigation 
demonstrate that K201 has a negative inotropic effect on the isolated working heart at 
concentrations of 1.0 µM and above.  These results may have implications for the use of 
K201 as a therapeutic treatment in various cardiac disease states, as the dosage required to 
effectively treat such conditions may alter heart function.  Aside from LVEDP none of the 
parameters measured during this study were significantly altered at a concentration of 0.3 
µM, but depression of a number of contractile indices, including dP/dtmax, left ventricular 
developed pressure, stroke volume and ejection fraction, became apparent at 1.0 µM.  At a 
concentration of 3.0 µM K201 proved to be particularly cardio-depressive and indeed 3 of 
the 8 hearts used during this investigation were not able to sustain aortic flow after several 
minutes of perfusion with this concentration, leading to a drop in perfusion pressure and a 
decline in left ventricular contractility.  These findings suggest K201 may possess a narrow 
therapeutic window. 
3.4.2 The influence of heart rate on the negative inotropic effect 
of K201 
Increasing stimulation rate is well known to influence myocardial contractility (by the so-
called force-frequency relationship (Endoh, 2004; KOCH-WESER & BLINKS, 1963)).  A 
positive force-frequency relationship has been demonstrated in mammalian ventricular 
myocytes from a number of species including the rabbit, and is explained by a) elevated 
SR Ca2+ content at higher stimulation frequencies and b) an increase in [Na]i causing a shift 
in the SR Ca2+ uptake/Ca2+ extrusion balance by favouring reduced Ca2+ efflux via the 
Na+/Ca2+ exchange (NCX) (Maier et al., 2000).  The observation that SR Ca2+ content is 
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not appreciably altered with increasing stimulation frequency in rat cardiac myocytes 
explains the negative force-frequency relationship in this species, where the dominant 
effect of increased stimulation frequency is the time encroachment on full restitution of EC 
coupling mechanisms (Maier et al., 2000).  In the isolated working rabbit heart therefore, a 
decrease in heart rate may be expected to have a negative influence on left ventricular 
inotropy and in part explain the effects of K201.  Using hearts from a subset of 
experiments where heart rate was fixed throughout the protocol, the % change from 
baseline in a number of functional indices after 4 min of perfusion with 1.0 µM K201 was 
compared with the equivalent perfusion period used in the initial protocol where heart rate 
declined (mean HR values are displayed in Table 3.1).  From this it was possible to assess 
the effects of heart rate on left ventricular inotropy in the isolated working heart during 
perfusion with K201.  As shown in Figure 3.4, in both sets of hearts the direction of the 
change in every parameter was the same, and aside from the relaxation constant τ there 
were no significant differences in the magnitude of change in any parameter between 
groups.  This suggests that the decline in heart rate caused by K201 does not explain the 
drugs’ negative inotropic action at 1.0 µM. 
3.4.3 What are the main factors contributing to the negative 
inotropic effect of K201? 
Previous investigations looking at the mechanisms of K201’s actions in normally 
functioning heart preparations are somewhat limited.  Kaneko (1994) found that K201 
inhibited the Ca2+-dependent binding of Annexin-V to F-actin, a protein which comprises 
the microfilaments of the cytoskeleton.  This effect however required concentrations of 10 
µM or higher (Kaneko, 1994; Kaneko et al., 1997).  Kimura et al. (1999) using guinea pig 
ventricular myocytes, found that K201 inhibited ICa,L by 20% and 50% using 1.0 and 3.0 
µM respectively (Kimura et al., 1999).  A similar result was also reported by Inagaki et al. 
(2000) who demonstrated 1.0 and 3.0 µM led to a 22 % and 59 % inhibition of ICa,L 
respectively in rat ventricular myocytes (Inagaki et al., 2000b).  They also reported that left 
ventricular developed pressure in the rat Langendorff setup was significantly depressed 
after administration of 3.0, but not 1.0 µM K201 prior to ischaemia (Inagaki et al., 2000a).  
Loughrey et al. (2007) found that 1.0 µM K201 decreased the Ca2+ transient in normal 
rabbit ventricular myocytes by 17 % and inhibited SR Ca2+ uptake by SERCA but that 
concentrations of 3.0 µM were required to inhibit ICa,L amplitude significantly (Loughrey 
et al., 2007).  The negative inotropic action of K201 could most likely be explained by the 
above observations of K201’s action on intracellular Ca2+ handling.  The reduction in ICa,L 
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amplitude at 3.0 µM coupled with a reduction in SR Ca2+ uptake, and subsequent reduction 
in SR Ca2+ content would be expected to significantly reduce cardiomyocyte inotropy.  Our 
results suggest 1.0 µM K201 is enough to significantly inhibit contractile function in the 
working heart, albeit by a small amount.  This effect cannot be explained by a significant 
reduction in L-type Ca2+ current which was found to be unaltered by 1.0 µM in isolated 
rabbit ventricular myocytes (Loughrey et al., 2007).   
 
Several studies have shown that K201 restores normal channel function to RyR2s from 
failing hearts by reducing channel Po and inhibiting Ca2+ leak from the channel (Kohno et 
al., 2003; Wehrens et al., 2005; Yano et al., 2003).  In addition, increased spontaneous SR 
Ca2+ release events in intact ventricular myocytes evoked by elevated [Ca2+]o are 
significantly attenuated in the presence of 1.0 µM K201 (Hunt et al., 2007; Loughrey et 
al., 2007).  Loughrey et al. (2007) made several observations regarding the action of 1.0 
µM K201 on Ca2+ release characteristics in rabbit ventricular myocytes; 1) Application of 
1.0 µM to permeabilised rabbit ventricular myocytes resulted in a significant decline in 
Ca2+ spark duration (to 82% of control) and Ca2+ spark frequency (to 63% of control) 
without altering spark amplitude or width, and 2) the rate of Ca2+ leak from the SR of 
permeabilised myocytes was significantly reduced to 84% of control in the presence of 1.0 
µM K201.  Inhibition of RyR2 alone however would not be expected to result in steady 
state alteration of contractility and by itself is unlikely to explain the negative inotropic 
effects of K201.  Addition of agents such as caffeine or BDM to enhance CICR only result 
in transient changes in the systolic Ca2+ transient and do not result in a sustained increase 
in contractility (Trafford et al., 1998).  While decreasing RyR2 sensitivity to activation by 
Ca2+ would be predicted to increase SR Ca2+ content, similar to the effect seen with 
application of tetracaine (Overend et al., 1997), this was not shown to occur with 1.0 or 3.0 
µM K201, indicating the presence of alternative mechanisms of K201’s actions at these 
concentrations.  This was confirmed by the observation that K201 also leads to inhibition 
of SR Ca2+ uptake via SERCA at 1.0 µM and above (Loughrey et al., 2007).  The 
combination of RyR2 and SERCA inhibition at 1.0 µM significantly inhibited the ability 
for Ca2+ waves to propagate, decreases Ca2+ spark duration and frequency, and together 
could potentially explain some of the negative inotropic action of K201 at this 
concentration.         
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3.4.4 The influence of ion current inhibition by K201 on cardiac 
inotropy 
Inhibition of ion currents critical to maintenance of resting membrane potential (Em) and 
action potential characteristics may influence contractile function and cardiac inotropy.  INa 
inhibition with anti-arrhythmic agents such as lidocaine has been shown to shorten the 
action potential duration (APD), which leads to a reduction in the duration of Na+ and Ca2+ 
influx during the action potential and ultimately a reduction in Ca2+ transient amplitude 
(Pankucsi et al., 1996; Sheu & Lederer, 1985).  While K201 has been shown to inhibit fast 
INa current (Kimura et al., 1999) and shorten APD (Kimura et al., 1999; Kiriyama et al., 
2000) in isolated guinea pig ventricular myocytes, slow inward Na+ current was not found 
to be inhibited by K201 (Kimura et al., 1999).  In addition, Em was not significantly 
different between K201 treated cells and untreated control myocytes.  Kiriyama et al. 
(2000) found that application of 1.0 µM K201 significantly inhibited the delayed rectifier 
K+ current, IKr in isolated guinea-pig ventricular myocytes.  Kimura also reported that in 
addition to its inhibitory action on INa and ICa.L, K201 irreversibly inhibited IK1 (to 
approximately 70% of control values at 1.0 µM).  Inhibition of repolarising K+ currents 
would be expected to result in prolongation of the action potential and induce a positive 
inotropic effect, which is believed to be mediated by a net increase in Ca2+ influx via the L-
type Ca2+ channel (Bouchard et al., 1995).   Kaprielian et al. (1999) found that APD was 
significantly prolonged in right ventricular myocytes from rats that had undergone 
coronary artery ligation 8 weeks previously in comparison to myocytes from sham 
operated controls (Kaprielian et al., 1999).  This was attributed to a reduction in 
repolarising K+ current density, specifically ITO and IK1.  Stimulating sham ventricular 
myocytes with MI-derived action potentials resulted in a significantly increased [Ca2+] 
transient amplitude with no change in diastolic [Ca2+]i.  While peak ICa.L was reduced by 
stimulating sham myocytes with the post-MI waveform, the net Ca2+ influx through L-type 
Ca2+ channels was significantly increased (Kaprielian et al., 1999). 
 
From the results of studies on isolated guinea-pig ventricular myocytes the overall effect of 
K201 is a significant shortening of the ventricular action potential despite inhibition of the 
repolarising K+ currents IKr and IK1 (Kimura et al., 1999; Kiriyama et al., 2000).  A 
significant contributor to the shortened APD is undoubtedly inhibition of INa, however the 
degree of inhibition demonstrated may not be enough to account for the degree of APD 
shortening and modulation of ion currents as yet unreported may contribute (Kimura et al., 
1999).  In addition, the influence of K201 on APD in rabbit ventricular myocytes has not 
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been investigated, and in order to fully elucidate the mechanisms contributing to the 
negative inotropic effect of K201 in the current investigation further study is warranted.    
3.4.5 Implications for use in therapeutic treatment strategies 
In order to work as a potentially viable treatment for conditions such as heart failure or 
atrial fibrillation an optimal range of concentrations in which K201 is effective must be 
established.  In light of the results of this study, due caution may have to be paid to the 
concentration of K201 used due to its negative inotropic influence.  Both Inagaki et al. 
(2000) and Ito et al. (2000) found that 0.3 µM K201 was sufficient to elicit a protective 
effect on left ventricular mechanical function in ischaemia-reperfusion injury models, with 
no further preservation of function evident using 1.0 µM (Inagaki et al., 2000b; Ito et al., 
2000).  Loughrey et al. (2007) reported that 1.0 µM suppressed spontaneous Ca2+ waves in 
permeabilised rabbit ventricular myocytes but 3.0 µM was able to abolish them completely 
(Loughrey et al., 2007).  Store overload-induced Ca2+ release (SOICR) in rat ventricular 
myocytes was also significantly attenuated using 3.0 µM K01 and eliminated at higher 
concentrations (Hunt et al., 2007).  The concentration of K201 required to confer a 
beneficial response appears therefore to be dependent on the experimental conditions in 
which the drug is used, as well as the species investigated.  While in the above examples 
higher concentrations of K201 were more effective in abolishing spontaneous Ca2+ release 
events, results from this investigation suggest that significant depression of cardiac 
mechanical function may occur at such concentrations.   The importance of such 
knowledge to the therapeutic potential of K201 was highlighted in a recent publication by 
Toischer et al. (2009) who investigated the influence of K201 on contractile performance 
of isolated muscle preparations from end-stage heart failure patients (Toischer et al., 
2009).  While K201 was shown to confer some beneficial effects on post-rest potentiation 
and frequency-dependent changes in systolic and diastolic tension (force-frequency 
relations) at a concentration of 0.3 µM under conditions believed to promote increased SR 
Ca2+ leak (5 mM [Ca2+]o), 1.0 and 3.0 µM were not acutely beneficial to systolic 
contractile function, and indeed at 1.0 µM inhibited developed tension by 9.8 % in 
comparison to control.  The authors concluded that initial investigations with K201 in 
human patients should begin using sub-micromolar concentrations of the drug to avoid 
potentially adverse effects of further depressed contractile function in heart failure patients.    
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3.5 Summary 
The data presented in this chapter demonstrate that perfusion of the isolated working rabbit 
heart with K201 leads to a concentration-dependent depression of heart rate and left 
ventricular function that becomes prominent at 1.0 and 3.0 µM.  The negative inotropic 
effects may be explained by previously documented action of K201 on excitation-
contraction coupling and intracellular Ca2+ handling mechanisms which promotes a 
concentration-dependent reduction in L-type Ca2+ current amplitude (at 3.0 µM in rabbit 
ventricular myocytes), SR Ca2+ uptake (via SERCA) and consequently SR Ca2+ content, 
and an inhibition of the SR Ca2+ release channel, RyR2.  In addition, previous findings 
describing shortening of the ventricular action potential due in part to inhibition of INa may 
also explain a portion of the negative inotropic effects of this compound in isolated 
working rabbit hearts, although the contribution of this mechanism in rabbit myocardium 
requires further investigation.  A reduction in intrinsic heart rate was also shown to occur 
but the contribution to the overall negative inotropic effects of K201 appear to be small.  
Given that cardioprotection in previous studies requires concentrations of up to 1.0 µM yet 
3.0 µM significantly depresses left ventricular function, K201 appears to have a very 
narrow therapeutic window. 
   
 
 
 
 
 
4 Calcium loading and β-adrenergic stimulation: 
Influence on left ventricular mechanical function 
in the isolated working rabbit heart 
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4.1 Introduction 
Cardiac inotropy and lusitropy is influenced on a beat-to-beat basis by a large number of 
factors, including loading conditions imposed on the heart, myofilament Ca2+ sensitivity, 
energy availability and intracellular Ca2+ fluxes.  Interventions which increase the available 
levels of Ca2+ within the cell will, initially, lead to an increase in cardiac inotropy (Scholz, 
1983).  In physiological situations, activation of the β-adrenergic system (via sympathetic 
stimulation) permits control of the inotropic state of the heart.  Many inotropic agents work 
by increasing intracellular Ca2+ levels, either directly by stimulating an increase in 
intracellular Ca2+ levels (in this way Ca2+ itself can be considered an inotropic agent as 
increasing [Ca]o elicits a positive inotropic response) (Scholz, 1983), or indirectly as in the 
case of phosphodiesterase inhibitors such as milrinone, which prevent the enzymatic 
inactivation of cyclic adenosine monophosphate (cAMP) allowing a more sustained β-
adrenergic response (Alousi & Johnson, 1986).  While increasing intracellular Ca2+ load is 
essential in regulation of physiological positive inotropic responses, such as in exercise or 
during the so-called ‘fight or flight’ response, an increase beyond threshold levels 
eventually leads to a decline in cardiac inotropy and the development of mechanical and 
electrical abnormalities, also known as Ca2+ overload (Vassalle & Lin, 2004). 
4.1.1 Catecholamine excess causes Ca2+ overload and myocardial 
damage   
Activation of β1-adrenergic receptors by endogenous catecholamines results in stimulation 
of an intracellular signaling cascade resulting in the phosphorylation of a number of 
intracellular proteins involved in Ca2+ regulation within the cardiomyocyte.  Initiation of 
the β1-adrenergic receptor pathway results in a stimulatory protein, Gs, activating Adenylyl 
Cyclase which in turn increases production of cAMP.  This results in stimulation of 
cAMP-dependent protein kinase A (PKA) which phosphorylates a number of intracellular 
targets, including L-type Ca2+ channels, the cardiac ryanodine receptor (RyR2), the SR 
Ca2+ uptake inhibitory protein phospholamban and cardiac troponin I (Bers, 2002).  The 
net effect is a significant enhancement of cardiac inotropy and lusitropy.  While these 
effects are of importance in the physiological regulation of cardiac inotropy, it has been 
suggested that excessive stimulation of the β1-adrenergic receptor pathway is detrimental 
for cardiac function, leading to Ca2+ overload and the formation of myocardial lesions in 
conjunction with depletion of high energy phosphate reserves (Fleckenstein et al., 1983; 
Rona, 1985).  It has been hypothesized that Ca2+ homeostasis during β-adrenergic 
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stimulation involves a preferential reliance on glycolysis rather than oxidative 
phosphorylation.  Nakamura and colleagues (1993) tested this hypothesis by inhibiting 
glycolysis in isolated rabbit hearts exposed to isoproterenol (ISO) (Nakamura et al., 1993).  
Treatment with iodoacetate (IAA) to inhibit glycolysis produced no depression in cardiac 
function and had little effect on overall ATP or phosphocreatine (PCr) levels.  Subsequent 
addition of ISO however resulted in a marked depression of function (lower systolic 
pressure, elevated end diastolic pressure) and high energy phosphate levels.  This effect 
was attributed to accumulation of intracellular Ca2+ and Ca2+ overload as exposure to low 
[Ca2+]o (0.6 mM) resulted in prevention of ATP depletion and decline of contractile 
function (Nakamura et al., 1993).  Excessive β-adrenergic stimulation is known to be 
cardiotoxic, leading to the formation of myocardial lesions and tissue damage (Goldspink 
et al., 2004; Haft, 1974; Mann et al., 1992; Rona, 1985).  Studies by Mann et al. (1992) 
showed that in isolated ventricular myocytes from dogs, cats and rats, continuous exposure 
to > 10 nM norepinephrine led to a marked increase in spontaneous contractile behaviour 
and eventually (> 24hrs) irreversible hypercontracture of cells, both of which could be 
inhibited by treatment with the β-antagonist propanolol (1 µM) (Mann et al., 1992).  48-72 
hrs exposure to 0.1 µM isoproterenol resulted in an almost identical decline in the % of 
viable rod-shaped cardiomyocytes to that achieved with 1 µM norepinephrine.  The 
investigators found that these effects were a direct result of cAMP-mediated [Ca2+]i 
overload, as evidenced by both specific upregulation of cAMP inducing spontaneous 
contraction and hypercontracture, and pretreatment with the L-type Ca2+ channel blocker 
verapamil prevented these effects.                
4.1.2 Ca2+ overload may be ameliorated by K201 
Ca2+ overload represents a dysfunction in intracellular Ca2+ handling that results in 
decreased inotropy and an increased propensity for triggered arrhythmias.  
Pharmacological interventions which target specific intracellular Ca2+ handling 
components, in particular those associated with the sarcoplasmic reticulum may therefore 
prove beneficial in alleviating the detrimental effects of Ca2+ overload.  The 
cardioprotective effects of K201 have already been discussed in the previous chapter.  A 
number of studies utilizing different species have demonstrated that K201 appears to have 
a protective effect in ischaemia-reperfusion injury (Inagaki et al., 2000b; Ito et al., 2000; 
Kawabata et al., 2000).  Inagaki et al., (2000) concluded that K201 reduced the levels of 
Ca2+ overload associated with ischaemia-reperfusion, as evidenced by a significantly 
reduced systolic and diastolic Indo-1 fluorescence (indicative of [Ca2+]i) during reperfusion 
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in K201 treated hearts compared to controls (Inagaki et al., 2000b).  K201 was shown also 
to inhibit apoptosis and necrosis induced by single injections of isoproterenol in rats, an 
effect the authors attributed to the inhibition of diastolic Ca2+ leak mediated by 
hyperphosphorylation of RyR2 (Ellison et al., 2007).  Spontaneous SR-mediated release 
events induced by elevation of extracellular Ca2+ levels have also been shown to be 
inhibited in single cell studies with K201, using both rat (Hunt et al., 2007) and rabbit 
(Loughrey et al., 2007) ventricular myocytes loaded with Ca2+-sensitive fluorescent 
probes.  Recently, Elliott et al. (2008) investigated the effect of K201 on diastolic SR Ca2+ 
release in intact field-stimulated rat ventricular myocytes in the presence of elevated 
[Ca2+]o and the β-agonist isoproterenol (Elliott et al., 2008).  The diastolic Ca2+ release 
events, and subsequent contractile activation associated with β-adrenergic stimulation were 
significantly inhibited using 1.0 µM K201. How such results translate to the overall 
mechanical function of the whole heart however is still not clear.  Kaneko and colleagues 
(2006) attempted to address this question using a Ca2+-loading protocol (elevated [Ca2+]o + 
norepinephrine administration) in an in vivo rat model (Kaneko et al., 2006).  While 
elevated [Ca2+]o alone did not induce any abnormalities in left ventricular pressure, 
simultaneous infusion of Ca2+ (12 mg.kg.min-1) and norepinephrine (30 µg.kg.min-1) 
resulted in elevated left ventricular end diastolic pressures and the appearance of diastolic 
contractures which, when of sufficient magnitude exceeded aortic pressure and induced 
aortic valve opening during diastole.  Pre-infusion of K201 prior to administration of 
norepinephrine significantly attenuated the rise in EDP, prevented diastolic aortic valve 
opening and improved mortality, effects that were not observed with diltiazem (Kaneko et 
al., 2006).  From these investigations it is clear that K201 possesses the potential to prevent 
the deleterious effects of Ca2+ overload (contractile dysfunction, apoptosis and necrosis, 
electrical abnormalities) which may be mediated, at least in part, by its ability to prevent 
diastolic Ca2+ release in conditions of elevated [Ca2+]i and β-adrenergic stimulation.  The 
exact mechanism of action under such conditions however is still unclear.   
4.1.3 Non cardiac-specific effects of K201 
The action of K201 on cardiac function in the above study by Kaneko et al. (2006) may be 
mediated in part by systemic effects of the drug.  Lisy & Burnett. (2006) reported that 
administration of K201 in healthy anaesthetized dogs resulted in enhancement of renal 
haemodynamics, glomerular filtration rate and urinary sodium excretion (Lisy & Burnett, 
Jr., 2006).  A mild reduction in mean arterial pressure was also observed.  It is possible that 
additional vascular effects in vivo may play a role in the protective action of K201. 
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4.1.4 Aims 
The aims of the work described in this chapter were to investigate the functional 
consequences of combined elevation in Ca2+ loading and β-adrenergic stimulation in the 
isolated working rabbit heart, and further, to examine how addition of K201 alters the 
contractile profile of isolated working hearts exposed to these conditions.  The isolated 
working heart provides a model for examining the direct actions of K201 on cardiac 
function in the face of a pathological situation simulated using elevated [Ca2+] and β-
adrenergic stimulation, allowing determination of the direct effects of K201 on whole heart 
function without the confounding influence of systemic variables.  It was hypothesized that 
the combination of Ca2+ loading and β-adrenergic stimulation would result in a decline in 
contractile performance ultimately detrimental to working heart function, and that 
application of 1.0 µM K201 would result in a rescue of contractile function as a result of 
its direct influence on the myocardium. 
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4.2 Methods 
4.2.1 Isolated working heart setup 
Hearts from 20 male New Zealand White rabbits were excised and perfused initially in 
Langendorff mode on the isolated working heart apparatus as described in the General 
Methods chapter section 2.1.3.  After cannulation of the left atrium working heart mode 
was initiated.  Preload was set at 7.4 mmHg and afterload set to 60 mmHg.  These settings 
remained constant throughout the experimental protocol.  Hearts were not paced and were 
allowed to beat spontaneously throughout the experiment. 
4.2.2 Left ventricular function by pressure-volume catheterisation 
A 3F Scisense VSL catheter with a recording electrode segment of 19 mm was advanced 
slowly past the aortic valves into the left ventricle to obtain pressure-volume measurements 
throughout the experimental protocol. 
4.2.3 Solutions 
Perfusion of the isolated working heart was performed using Tyrode’s solution, the 
composition of which is described in General Methods section 2.1.3.  Drugs were made 10 
minutes prior to the beginning of each experiment and stored in light-shielded containers.  
Stock K201 solution was created by dissolving K201 in a 10% dimethyl sulfoxide 
(DMSO) solution to yield a concentration of 1 mM.  Isoproterenol hydrochloride was 
dissolved in de-ionized water and diluted to yield a stock concentration of 1 mM.   
4.2.4 Experimental Protocol 
The protocol used was similar to that described by Kaneko et al (2006) in an in vivo rat 
model (Kaneko et al., 2006).  All hearts perfused in working heart mode underwent a 
protocol involving an increase in extracellular calcium concentration from 2.5 mM to 4.5 
mM by addition of CaCl2 to the perfusate.  5 min later hearts were then additionally 
perfused with 150 nM isoproterenol (ISO), a β-adrenergic agonist.  Hearts were then split 
into two groups; the first received no further intervention (4.5 mM [Ca2+]/ISO) whilst the 
second group were perfused with 1.0 µM K201 30 s after addition of ISO (4.5 mM 
[Ca2+]/ISO + K201).  The end of the experiment was reached when hearts were no longer 
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able to produce an aortic flow, resulting in a decline in coronary perfusion pressure and a 
precipitous decline in mechanical function as a direct result. 
4.2.5 Measurement of lactate release from the isolated working 
heart 
In a subset of hearts from each group (4.5 mM [Ca2+]/ISO; n = 5.  4.5 mM [Ca2+]/ISO + 
K201; n =3) coronary effluent samples were collected in duplicate from hearts for 
assessment of lactate levels.  Samples were collected prior to perfusion with elevated 
extracellular Ca2+, during the 5 minute period of perfusion with 4.5 mM [Ca2+]o, and at 1 
minute intervals for 10 minutes following addition of ISO.  All samples were collected in 
numbered 1.5 ml Eppendorff tubes, which were immediately sealed and snap frozen in 
liquid nitrogen.  At the end of each experiment, samples were stored at -80 ºC.  Lactate 
levels were assessed spectrophotometrically based on the method of Maughan (1982) 
(Maughan, 1982).  Briefly, coronary effluent samples were thawed on the day of analysis 
and 20 µl of each sample diluted in 200 µl of 0.4 mM perchloric acid (PCA) to de-
proteinize the sample.  1.1 M hydrazine buffer was prepared the day before using 1.3 g 
hydrazine sulphate, 5.0 g hydrazine hydrate and 0.2 g EDTA dissolved in 100 ml double 
distilled water, pH 9.0.  The reaction mixture was prepared prior to each experiment using 
a combination of 10 ml hydrazine buffer, 0.5 ml NAD+ (final concentration 5.0 mM) and 
0.1 ml lactate dehydrogenase (LDH).  Lactate standards of the following concentrations 
were prepared by dilution of an 8 mM L-lactate standard calibration solution; 0.25 mM, 
1.0 mM, 2.0 mM and 3.0 mM.  All standards were diluted in PCA to yield the same 1/11 
dilution factor as the coronary effluent samples.  20 µl of each sample, in duplicate, was 
added to a 96-well plate, along with duplicates of each standard, a blank sample, and a 
control sample (3 mM L-lactate).  200 µl of reagent was then added to each of the wells 
containing a sample, and the plate was loaded into a SPECTRAmax M2e (Molecular 
Devices, US) for spectrophotometric measurement of L-lactate levels using light 
absorbance at 340 nm wavelength.  The principle is based on the notion that conversion of 
L-lactate to pyruvate is linked to NAD+ by the following reaction: 
 
   HNADHpyruvateNADlactateL LDH  
 
Inclusion of hydrazine in the mixture ensures the ketone (pyruvate) is removed from the 
reaction.  By addition of excess NAD+ the reaction can proceed to completion (from left to 
right).  The level of NADH assessed by absorbance at 340 nm is directly proportional to 
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the L-lactate levels in each sample.  The SPECTRAmax M2e created a linear calibration 
curve between the known lactate concentrations, with the lactate concentration of each 
standard calculated by the SPECTRAmax using the measured absorbance values of NADH 
at 340 nm.  Values from all samples were calculated relative to the linear calibration 
established from the lactate standards.  Samples were analysed in duplicate with the mean 
value of the two samples reported. 
4.2.6 Determination of arrhythmogenicity 
Arrythmogenicity in isolated working hearts was assessed by analysis of the ventricular 
pressure trace using the Heart Rate Variability (HRV) module in LabChart 5.5.6.  HRV 
was set to detect a peak in the pressure trace greater than 30 mmHg as the occurrence of an 
electrical event synonymous with R-wave detection.  Arrhythmogenicity was assessed by 
calculating the mean interval between successive pressure peaks (mean inter-peak interval) 
as well as the standard deviation of the mean interval (SD of mean inter-peak interval) 
from a selection of 10 consecutive pressure peaks 0, 10, 20, 50 and 200s after perfusion 
with isoproterenol, then at 100s intervals after this up to 600s.      
4.2.7 Data recording and statistical analysis  
All working heart functional data were recorded on a Dell PC using LabChart software 
version 5.5.6 at a sampling rate of 1000 Hz, and analysed offline using LabChart’s Blood 
Pressure Module and LabScribe2.0 software.  Quantification of ectopic electrical activity 
and arrythmogenicity was performed using the HRV module in LabChart.  Coronary 
effluent samples were assessed for L-lactate using SoftMax Pro software version 5.3.  All 
results were saved to an external hard drive. Two-sample Student’s t-test was used to 
compare values between groups on a number of functional parameters.  A P-value of < 
0.05 was considered statistically significant. 
4.3 Results 
4.3.1 Transient effects of elevated [Ca2+]o and isoproterenol 
A schematic of the experimental protocol is depicted in Figure 4.1A.  Figure 4.1 shows 
typical traces and PV loops demonstrating the transition from 2.5 mM to 4.5 mM [Ca2+]o  
(Figure 4.1B(i) & (ii)) and addition of ISO (Figure 4.1C(i) & (ii)).  Elevation of [Ca2+]o 
from 2.5 mM to 4.5 mM (Figure 4.1B) was associated with an increase in both developed    
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Figure 4.1 Pressure-volume traces during elevated [Ca2+]o and β-adrenergic stimulation.  A.  Protocol 
diagram. Arrows on both diagrams represent the direction of change, with first and last loop in sequence 
colour-highlighted.  B(ii) & C (ii).  Representative pressure, volume and heart rate traces following elevation 
of [Ca2+]o and addition of ISO, respectively.  D.  Representative steady state PV loops in 2.5 mM [Ca2+]o 
(yellow trace), 4.5 mM [Ca2+]o (red trace) and 4.5 mM [Ca2+]o plus 150 nM ISO (10 s (green trace) and 50 s 
(black trace) after addition).  Volume values were not corrected for parallel volume offset (Vp).     
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pressure and stroke volume.  The effect was biphasic, with developed pressure rising to a 
peak before dropping slightly to reach a new steady state value greater than the steady state 
in 2.5 mM [Ca2+]o.  Similarly addition of 150 nM ISO (Figure 4.1C) resulted in a positive 
inotropic response albeit of greater magnitude in comparison to that exhibited by the 
increased [Ca2+]o.  Elevated [Ca2+]o had no effect on heart rate (Figure 4.1B(ii); top panel) 
however addition of ISO was associated with an immediate increase in heart rate (Figure 
4.1C(ii); top panel, mean values in Figure 4.5B(i & ii)).  Representative PV loops from the 
steady state, elevated [Ca2+]o perfusion, 10s and 50s after ISO perfusion are shown in 
Figure 4.1D.  Mean data for contractile indices before and up to 50s after ISO perfusion are 
shown in the left hand panels of Figures 4.3B and 4.4A. 
4.3.2 Effect of elevated extracellular calcium on systolic 
functional parameters 
As shown from the example traces in Figure 4.1B(i) & (ii) and the mean data in Figure 4.2, 
increasing extracellular Ca2+ from 2.5 mM to 4.5 mM initially led to a transient increase in 
left ventricular functional parameters.  LV peak pressure (Figure 4.2(i)) rose significantly 
by 10.69 ± 2.09 % shortly after increasing [Ca2+]o before settling to a new steady state that 
was significantly higher than steady state peak pressure in 2.5 mM [Ca2+]o (by 4.39 ± 1.88 
%).  Similarly, the maximum rate of rise of LV pressure was significantly increased by 
23.55 ± 4.22 %, and remained significantly elevated by 20.12 ± 3.89 % in steady state vs. 
2.5 mM [Ca2+]o steady state (Figure 4.2(ii)).  Heart rate was not significantly altered after 
elevation of [Ca2+]o (data not shown). 
4.3.3 Effect of elevated extracellular calcium on diastolic 
functional parameters 
LV end diastolic pressure (LVEDP – Figure 4.2(iii)) was significantly reduced by 14.11 ± 
2.84 % initially after increasing [Ca2+]o but was not significantly different at higher [Ca2+]o 
in steady state.  Similarly, in comparison to steady state 2.5 mM [Ca2+]o, the maximum rate 
of LV pressure fall was significantly increased initially by 16.98 ± 6.13 % but declined 
back to levels comparable to 2.5 mM [Ca2+]o.  Ventricular relaxation therefore was not 
significantly different once steady state was achieved. 
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Figure 4.2 Elevation of [Ca2+]o and working heart mechanical function.  Indices of mechanical function 
during steady state 2.5 mM [Ca2+]o perfusion (left bar), at peak developed pressure during the transient 
increase in left ventricular function following 4.5 mM [Ca2+]o perfusion (middle bar), and in steady state 4.5 
mM [Ca2+]o (right bar).  All values expressed as mean ± SEM.  Significance evaluated using paired Student’s 
t-test.   
Allen Kelly - 2010  Chapter 4 
 140
4.3.4 Effect of elevated extracellular calcium on volume 
parameters 
Aortic flow (Figure 4.2(v)) was increased significantly by 28.55 ± 5.32 % in the initial 
period following elevation of [Ca2+]o and remained significantly elevated in steady state by 
13.43 ± 4.75 %.  As coronary flow did not change in response to elevated [Ca2+]o (data not 
shown), stroke volume mirrored the response of aortic flow, increasing both in the initial 
phase after elevation of [Ca2+]o (by 18.31 ± 3.46 %) and in steady state (by 8.24 ± 3.24 %) 
in comparison to steady state 2.5 mM [Ca2+]o. 
4.3.5 The effect of prolonged β-adrenergic stimulation and 
elevated [Ca2+]o on mechanical function, and the influence of 
K201 
Changes in the mean functional indices in the subsequent sections are expressed relative to 
values 50s after addition of ISO when the transient phase of the ISO perfusion has passed.  
The data shown only includes surviving hearts still producing an aortic flow.  The number 
of hearts still producing an aortic flow is shown in Figure 4.3A(i) and expressed as a 
function of time post-ISO perfusion. 
 
While the addition of ISO produced a transient increase in cardiac performance (Figure 
4.3B(i-iv), left hand panels) that was similar in both groups, the net effect of ISO perfusion 
alone was an impaired cardiac function with only 5 out of 11 hearts still producing an 
aortic outflow within the first 600 s (Figure 4.3A(i)).  In contrast, addition of 1.0 µM K201 
led to all hearts sustaining an aortic flow within the first 600 s and prolonged the time 
before aortic flow ceased by 317.63 % (Figure 4.3A(ii)). 
4.3.5.1 The effect of K201 on systolic and diastolic parameters following 
elevated [Ca2+]o and β-adrenergic stimulation 
Hearts perfused solely with elevated [Ca2+]o and ISO demonstrated a decline in peak 
pressure and dP/dtmax relative to function at 50s post-ISO (Figures 4.3B(i) & (ii)).  K201 
prevented the subsequent decline in function in both parameters measured at 600s post-ISO 
(87.39 % vs. 66.48 %; with (n=9) vs. without K201 (n=5) and 97.37 % vs. 68.27 %; with 
vs. without K201 respectively, P<0.05).  The protocol did not result in a significant change 
in EDP (Figure 4.3B(iii)) but K201 improved relaxation as measured by dP/dtmin (Figure  
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Figure 4.3 Mechanical function during 600 s of elevated [Ca2+]o and ISO perfusion (± K201).  A(i).  
Survival plot showing % of hearts functioning in each group during 3000 s (50 min) of ISO perfusion with n-
value at each stage of protocol indicated. (ii)  Mean functional time during ISO perfusion in both groups.  
B(i-iv); Systolic and diastolic functional parameters 50s before and after perfusion with ISO (left panels) and 
up to 600s after perfusion with ISO (right panels). Hearts without K201 = black squares; with K201 = red 
circles.  All values expressed as mean ± SEM.  Significance between groups evaluated with unpaired 
Student’s t-test. 
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Figure 4.4 Volume indices during 600s of elevated [Ca2+]o and ISO perfusion (± K201).  A(i-iv); Volume 
parameters 50 s before and after perfusion with ISO (i) and up to 600s after perfusion with ISO (ii).  B.  
Coronary flow at several stages throughout the protocol.  C.  Lactate concentration measured from coronary 
effluent samples. All values expressed as mean ± SEM.  Significance between groups evaluated with 
unpaired Student’s t-test.     
4.3B(iv)) thus preventing a decline in dP/dtmin at 600s post-ISO (105.27 % vs. 64.97 %; 
with (n=9) vs. without K201 (n=5), P<0.05). 
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4.3.5.2 The effect of K201 on volume parameters during -adrenergic 
stimulation and elevated [Ca2+]o  
Subsequent to a transient rise 15s post-ISO, aortic flow (Figure 4.4A(i)) decreased 600s 
post-ISO, however, K201 limited the degree to which aortic flow declined at 600s post-
ISO (78.61 % vs. 37.52%; with (n=9) vs. without K201 (n=5), P<0.05).  This pattern was 
similar to the assessment of stroke volume (Figure 4.4A(ii)) 600s post-ISO (93.55 % vs. 
60.62%; with (n=9) vs. without K201 (n=5), P<0.05).  Coronary flow (Figure 4.4B) was 
not significantly different between groups at 600s post-ISO (66.67 ± 2.96 vs. 68.67 ± 5.21 
ml.min-1).  Similarly lactate concentrations (Figure 4.4C) measured from the coronary 
perfusate were not significantly different between groups 600s post-ISO (0.100 ± 0.023 
mM vs. 0.061 ± 0.028 mM; with (n=3) vs. without K201 (n=3). 
4.3.6 Arrythmicity following elevated extracellular Ca2+ and β-
adrenergic stimulation, and the influence of K201 
Prior to ISO perfusion, contraction appeared regular under sinus rhythm (Figure 4.5A(i)) 
and inter-peak interval variability was low.  At 600s post-ISO irregular contractile function 
was present (Figure 4.5A(ii)) which was reduced in K201 (Figure 4.5A(iii)).  There were 
no significant differences in mean inter-peak interval between groups at any point in the 
protocol (Figure 4.5B(i) & (ii)).  The standard deviation of the mean inter-peak interval 
(Figure 4.5C) was however significantly lower at 600s post-ISO in hearts perfused with 
K201 (27.29 ± 7.91 ms vs. 66.07 ± 17.91 ms; with (n=9) vs. without K201 (n=5); P < 
0.05).  This result suggests that K201 was able to partially reduce the increase in mean 
inter-peak interval variability.   
4.3.7 Investigating the difference in the timing of addition of K201 
on cardiac function 
In a separate subset of hearts, K201 was applied at a later time point during the protocol 
(300s vs. 30s post-ISO).  This was performed in order to establish whether K201 prevented 
deterioration of cardiac functional parameters if applied at a later stage of the protocol 
where decline in cardiac function had already begun.  Similar to application of K201 at 30s    
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Figure 4.5 Arrhythmicity following perfusion with elevated [Ca2+]o and β-adrenergic stimulation.  A.  
Representative pressure recordings 40s prior to ISO perfusion (i), 600s after ISO perfusion without (ii) and 
with K201 (iii).  B.  Mean inter-beat interval during the 600s of ISO perfusion in K201 treated vs. untreated 
hearts.  C.  Standard deviation of the mean inter-peak interval in K201 treated vs. untreated hearts.  All data 
expressed as mean ± SEM.  Significance between groups evaluated with unpaired Student’s t-test.         
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Figure 4.6 Cardioprotection Preservation of mechanical function after perfusion with K201 at 30s or 
300s.  Mechanical function and volumes after 600s ISO perfusion expressed as % of values following 20s 
ISO perfusion.  4.5 mM [Ca2+]o + ISO; n=4; + K201 (30s); n=9; + K201 (300s); n=3.  All values expressed as 
mean ± SEM.  Significance between groups evaluated with unpaired Student’s t-test. 
post-ISO, application of K201 at 300s post-ISO significantly limited the decline in peak 
pressure, aortic flow and SV when compared to hearts without K201 (81.49 ± 1.48 % vs. 
64.53 ± 4.20 %, 45.67 ± 5.97 % vs. 25.10 ± 2.49 %, and 58.29 ± 3.79 % vs. 40.29 ± 4.72 
%; P<0.05, Figure 4.6) but had no effect on the decline in dP/dtmax or dP/dtmin induced by 
the protocol. 
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4.4 Discussion 
4.4.1 K201 attenuates the negative inotropic effects associated 
with elevated [Ca2+]o and simultaneous β-adrenergic 
stimulation 
The present study aimed to assess the ability of K201 to preserve contractile function in a 
whole heart model of left ventricular dysfunction induced by elevated [Ca2+]o with β-
adrenergic stimulation.  The use of an isolated working heart model allowed the 
assessment of ventricular mechanical function without the possibility of confounding 
systemic effects of any of the compounds used.  Increasing perfusate [Ca2+]o from 2.5 mM 
to 4.5 mM led to a steady state increase in a number of functional parameters in the 
isolated working heart, including left ventricular peak pressure, dP/dtmax and stroke volume 
(Figure 4.2), and by itself improved left ventricular function.  Administration of 
isoproterenol in the isolated working rabbit heart following 5 min of increased [Ca2+]o 
perfusion in the present study initially caused a transient positive inotropic effect with a 
concomitant increase in cardiac output.  Following this initial (10-15s) phase, function 
declined quickly such that after 600s (10 min) of isoproterenol perfusion only 5 of the 11 
hearts perfused with elevated Ca2+ and ISO alone were able to sustain an aortic flow 
sufficient to maintain coronary perfusion pressure at 60 mmHg.  As shown in Figures 4.3 
and 4.4 however, in hearts perfused with K201 30s after ISO perfusion functional decline 
was significantly attenuated, allowing hearts to maintain aortic flow for a significantly 
longer period of time. 
4.4.2 Possible mechanisms of action of K201 following elevated 
[Ca2+]o with β-adrenergic stimulation 
There are a number of possible mechanisms by which K201 may have elicited its 
cardioprotective effects in the setting of elevated [Ca2+]o and β-adrenergic stimulation.  
K201 has been shown to attenuate the formation of myocardial lesions and development of 
contracture induced by administration of epinephrine or caffeine in a whole heart rat 
Langendorff preparation (Kaneko, 1994).  The use of Ca2+-sensitive fluorophores in 
isolated whole heart models of ischaemia-reperfusion injury and prolonged myocardial 
preservation indicated that K201 significantly attenuated the rise in [Ca2+]i associated with 
reperfusion (Hachida et al., 1999; Inagaki et al., 2000b).  K201 has also been shown to 
limit spontaneous SR-mediated Ca2+ release events in isolated myocytes from both rat and 
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rabbit left ventricle (Hunt et al., 2007; Loughrey et al., 2007), as well as eliciting 
significant attenuation of diastolic Ca2+ release events in field-stimulated rat myocytes 
subjected to perfusion with 4.5 mM [Ca2+]o and β-adrenergic stimulation (Elliott et al., 
2008).  Given that K201 has been demonstrated to have such potent effects in experimental 
models associated with elevation of [Ca2+]i it is likely that some of its cardioprotective 
effects in the current study may be attributed to a reduction in cellular Ca2+ overload.  
Consistent with this, K201 has been shown to target a number of intracellular Ca2+ 
handling components.  1.0 µM K201 significantly inhibits ICaL in guinea pig and rat 
ventricular myocytes by 20 and 22 % respectively (Inagaki et al., 2000b; Kimura et al., 
1999) and in rabbit pulmonary vein cardiomyocytes by 38 % (Chen et al., 2008), although 
in rabbit ventricular myocytes a significant inhibition was reported at 3.0 µM but not 1.0 
µM (Loughrey et al., 2007).  Loughrey et al. (2007) also demonstrated a significant 
inhibition of SR Ca2+ uptake via SERCA2a in rabbit ventricular myocytes at 1.0 µM (Vmax 
reduced to 88 % of control) although at this concentration SR Ca2+ content was not altered 
(Loughrey et al., 2007).  While the possibility exists that K201 interacts directly with the 
β-adrenergic receptor to inhibit the action of isoproterenol the findings of Ellison et al. 
(2007) would suggest this is not the case as 1.0 µM K201 was demonstrated to prevent cell 
apoptosis and necrosis in adult rat ventricular myocytes exposed to 10 µM ISO without 
significantly altering the ISO-induced activation of protein kinase A (Ellison et al., 2007).      
4.4.2.1 Stabilisation of the cardiac Ryanodine receptor by K201 may underlie 
the protective effect following elevated [Ca2+]o and β-adrenergic 
stimulation  
With respect to intracellular Ca2+ handling, one of the most widely documented effects of 
K201 is its ability to stabilize the cardiac ryanodine receptor (RyR2) in its closed state, 
thereby inhibiting potentially arrhythmogenic Ca2+ release from the SR (Chen et al., 2008; 
Kohno et al., 2003; Wehrens et al., 2004; Yano et al., 2003).  Increased spontaneous Ca2+ 
release during the diastolic period may produce heterogenous myocyte contraction, 
reducing the number of myocytes available for recruitment during the next stimulated beat 
and decrease the amplitude of contraction (Stern et al., 1988).  An increase in diastolic 
[Ca2+]i levels would also be expected, which may also result in an increased diastolic tone.  
Reduction of RyR2 open probability has been proposed as a mechanism for the prevention 
of diastolic Ca2+ release and the potentiation of systolic release (Venetucci et al., 2006).  
Venetucci et al. (2006) demonstrated that application of 1 µM ISO in rat ventricular 
myocytes was sufficient to cause spontaneous Ca2+ waves in steady state.  Stimulated Ca2+ 
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transients immediately proceeding a Ca2+ wave were significantly reduced in amplitude 
and decreasing RyR2 open probability (Po) with the pharmacological agent tetracaine (50 
µM) during ISO stimulation not only significantly attenuated Ca2+ waves but also 
increased the systolic Ca2+ transient (Venetucci et al., 2006).  Ellison et al. (2007) noted 
that hyperphosphorylation of the RyR2 appeared critical to the induction of apoptosis 
mediated by a single dose of isoproterenol (5 mg.kg-1, ~ 370 µM) in rat hearts (Ellison et 
al., 2007).  Treatment with 1.0 µM K201 led to a reduction in PKA and CaMKII 
phosphorylation of the RyR2 and a reduction in ISO-induced apoptosis.  Elliott et al. 
(2008) also demonstrated that a similar Ca2+ loading protocol to that used in the current 
investigation led to the appearance of Ca2+ waves and after-contractions in intact field-
stimulated rat cardiomyocytes which were significantly attenuated upon application of 1.0 
µM K201 (Elliott et al., 2008).  Taken together, the net effect of K201 in the present study 
may involve reduction of [Ca2+]i, and an inhibition of the negative inotropic effects 
associated with excessive [Ca2+]i loading.  In the present study elevated [Ca2+]o and β-
adrenergic stimulation led to the appearance of ventricular ectopic beats.  Application of 
K201 in this model resulted in a reduction in the mean inter-peak interval variability, as 
assessed by standard deviation of the mean inter-peak interval.   
4.4.2.2 Effects of late versus early K201 perfusion on cardioprotection 
In the current study, K201 was able to exert a cardioprotective effect when administered 
shortly (30s) after addition of isoproterenol, however it was unclear whether or not the 
predominant mechanism for the reduction in inotropy induced by elevated [Ca2+]o and ISO 
was due to the inhibition of reversible events such as Ca2+ wave production, or the result of 
irreversible cellular damage.  This was tested by administration of K201 in a subset of 
hearts already exposed to 5 minutes (300s) of ISO perfusion.  It was found that K201 
administered at this time point resulted in a significant rescue in some of the measured 
parameters including peak pressure and stroke volume.  Recovery of function was not 
significant in the rates of change in left ventricular pressure, indicating that 
cardioprotection was not as effective as it was in hearts perfused with K201 30 s after ISO 
addition.  Taken together this demonstrates that K201 was able to reverse some of the 
cellular dysfunction induced by elevated [Ca2+]o and ISO, suggesting that, up until 5 
minutes after perfusion of ISO at least, that irreversible cellular damage (mitochondrial 
membrane permeability transition, cellular apoptosis, cellular necrosis) was not the 
primary mechanism of left ventricular dysfunction.   
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4.4.3 Detrimental effects of isoproterenol administration include 
mechanisms independent of Ca2+ overload 
Ca2+ overload has been shown to be critical to the detrimental effects of excessive β-
adrenergic stimulation by catecholamines, as well as sympathomimetics such as 
isoproterenol (Fleckenstein et al., 1983; Mann et al., 1992; Rona, 1985).  Accompanying 
the negative inotropic effects of catecholamine-induced Ca2+ overload however is the 
development of myocardial lesions, cellular necrosis (Fleckenstein et al., 1983) and 
apoptosis (Shizukuda et al., 1998).  Studies of excessive β-adrenergic stimulation on 
isolated cultured myocytes and in whole heart preparations have revealed additional effects 
of excessive β-adrenergic stimulation that may contribute to myocardial injury (and 
ultimately loss of inotropy) independent of Ca2+ overload (Bloom & Davis, 1972; Dhalla et 
al., 1978; Mohan & Bloom, 1999; Ramos et al., 1984; Somani et al., 1970; Yates et al., 
1981).   
4.4.3.1 Hypoperfusion of the ventricular myocardium following isoproterenol 
treatment 
Somani et al. (1970) investigated the influence of ISO perfusion on capillary blood flow 
using an isolated supported canine heart preparation, in which an ex vivo heart is supplied 
with blood and nutrients from an anaesthetized support animal.  The extraction of the 
radio-labeled isotope Rubidium-86 from the blood was used as a marker for determining 
the proportion of total coronary blood flow that reaches the capillary beds.  The 
investigation demonstrated that ISO administration (0.05-0.1 µg.min-1) led to a drop in 
coronary artery perfusion pressure and a reduction in the extraction of Rubidium-86 from 
the coronary blood irrespective of total coronary blood flow (Somani et al., 1970).  This 
effect was attributable in part to the increase in heart rate and to a lesser extent the increase 
in left ventricular systolic pressure following ISO administration.  Because the inner layers 
of the myocardium are perfused primarily during diastole, decreasing the diastolic interval 
may reduce the total blood flow through these areas of the heart.  In addition, the authors 
suggested that the increase in left ventricular systolic pressure and heart rate increases 
extravascular resistance, leading to a redistribution of coronary blood flow to the detriment 
of the endocardial and sub-endocardial layers.  No alterations in global coronary flow were 
noted in the current study however this does not eliminate the possibility of inner 
myocardial layers becoming hypoperfused.     
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4.4.3.2 Oxidation of isoproterenol and free-radical damage 
Negative inotropic and necrotic effects of endogenous catecholamines, as well as 
isoproterenol have also been attributed to the formation of oxidation products (Rona, 1985; 
Yates et al., 1981).  Catecholamine’s (epinephrine, norepinephrine) as well as 
isoproterenol have the ability to oxidize to ο-quinones in the presence of oxidizing agents 
or alkalis (Bindoli et al., 1989; Remiao et al., 2002).  These intermediary products undergo 
an irreversible cyclisation reaction with the resultant leukoadrenochrome being further 
oxidized either by oxidizing agents or other ο-quinones to form adrenochrome (Bindoli et 
al., 1989).  Dhalla et al. (1978) demonstrated that spontaneously oxidized isoproterenol 
caused myocardial lesion formation and contractile dysfunction, the extent of which was 
exacerbated in a dose-dependent manner (Dhalla et al., 1978).  Ramos et al. (1984) found 
that toxic concentrations of ISO (> 24 µM) induced a biphasic increase in Ca2+ uptake in 
cultured rat cardiomyocytes, the secondary phase of which occurred between 7 and 10 min 
post-ISO addition (absent with treatment of 240 nM) and was attenuated by antioxidant 
treatment (ascorbic acid and sodium bisulfite) but not by propanolol or verapamil (Ramos 
et al., 1984).  Persoon-Rothert et al. (1989) demonstrated that isoproterenol-induced 
myocardial necrosis following 6 hour incubation with 0.5-2.5 mM isoproterenol in cultured 
neonatal rat cardiomyocytes, assessed by measurement of α-hydroxybutyrate 
dehydrogenase (α-HBDH) release from the cytoplasm, could be significantly attenuated 
with the use of free-radical scavengers and substances which inhibit isoproterenol 
oxidation (Persoon-Rothert et al., 1989).  Furthermore, β-adrenoceptor antagonism with 
propanolol did not reduce the levels of α-HBDH release, while exposure of cells to the 
non-oxidising β-adrenoceptor agonist fenoterol did not significantly alter α-HBDH release 
in comparison to control myocytes.  It is unclear to what extent this mechanism contributes 
to the contractile dysfunction seen in the current study.  In general studies investigating 
isoproterenol-induced myocardial injury have used single injections or continuous doses 
that are several orders of magnitude greater than those used in the current investigation 
(Bloom & Davis, 1972; Dhalla et al., 1978; Mohan & Bloom, 1999) and as such may not 
be expected to induce a significant level of oxidative stress through this mechanism.  In 
addition, studies such as those conducted by Persoon-Rothert et al. (1989) involve 
incubation periods of several hours, and are unlikely to account for the decline in 
mechanical function seen within a 10 min period in the current investigation.  This could 
have been investigated in the current experimental protocol by using agents which prevent 
oxidation of ISO and comparing functional indices against the heart treated with elevated 
[Ca2+] and ISO only.     
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4.4.4 Metabolism and mitochondrial function during Ca2+ loading 
and β-adrenergic stimulation – Influence of K201                
The mitochondria have been demonstrated to be susceptible to Ca2+ overload, resulting in a 
reduction in high energy phosphate production, intracellular ATP levels and exhaustion of 
intracellular energy stores (Fleckenstein et al., 1983; Miyata et al., 1992).  Moreover, 
mitochondrial Ca2+ overload occurring during ischaemia and reperfusion has been 
implicated in opening of the membrane permeability transition pore and the subsequent 
signaling cascade that leads to triggered cell death (apoptosis) and necrosis (Toda et al., 
2007).  In the current study lactate release from the isolated working heart was used as a 
measure of anaerobic respiration before and after the addition of isoproterenol.  It was 
found that lactate concentration increased in the initial 60 -120s following ISO perfusion, 
but that lactate release declined beyond this point back to pre-ISO levels in both groups, 
with no detectable difference between groups.  It is possible that lactate release was too 
indirect a measure of the respiratory state of the muscle and that other marker’s of energy 
metabolism may have revealed a difference between the groups.  Kawabata et al. (2000) 
measured changes in ATP, inorganic phosphate (Pi) and phosphocreatine (PCr) levels 
during ischaemia and reperfusion in the isolated rabbit heart by 31P-NMR spectrometry, 
revealing a preservation of ATP levels during ischaemia and reperfusion, as well as an 
attenuation of rising Pi during ischaemia following application of 1.0 µM K201 (Kawabata 
et al., 2000).  Direct measurement of ATP levels in the isolated working rabbit heart 
therefore may have revealed a significant effect of K201 on myocardial metabolism.  K201 
has been shown to exhibit cardioprotective properties in ischaemia-reperfusion studies, and 
this protective effect has been associated with an attenuation of intracellular Ca2+ overload 
(Inagaki et al., 2000b) as well as activation of protein kinase C (PKC) (Inagaki et al., 
2000a; Ito et al., 2000).  PKC has been implicated in the signaling cascade involved in 
ischaemic preconditioning (Ytrehus et al., 1994), and this may be related to the activation 
of mitochondrial ATP-sensitive K+ channels (KATP) (Korge et al., 2002; Liu et al., 1999).  
Ito et al. (2000) demonstrated that the cardioprotective effect of K201 could be 
significantly attenuated by application of the PKC inhibitor chelerythrine, or by selective 
blockade of mitochondrial KATP channels with 5-hydroxydecanoic acid (5-HD) (Ito et al., 
2000).  Inagaki et al. (2000) noted that translocation of PKC-δ to the plasma membrane 
was key to K201’s cardioprotective effect in a rat model of ischaemia reperfusion injury as 
selective blockade of this isoform prevented any myocardial protection by K201 (Inagaki 
et al., 2000a).  PKC was not investigated in the current study but provides a potential 
mechanism for future investigations using this protocol.  A number of inhibitors of PKC 
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(chelerythrine, GF109203X) previously used in isolated Langendorff-perfused heart 
preparations are available that could be applied to the isolated working rabbit heart to 
further investigate this potential mechanism.  K201 therefore may well exert at least an 
indirect protective effect on the mitochondria through activation of a specific PKC isoform 
however this was not investigated in the current study, and warrants further investigation.  
4.5 Summary 
Perfusion of isolated working rabbit hearts with high [Ca2+]o and the β-adrenergic agonist 
isoproterenol led to a decline in left ventricular contractility and cardiac output such that 
the majority of hearts could not maintain sufficient output to sustain function beyond 600s 
of ISO perfusion.  Application of K201 shortly after ISO perfusion (30s) led to a 
significant preservation of mechanical function and cardiac output allowing hearts to 
function for a significantly longer period of time.  Application of K201 at a later time in 
the protocol (300s) led to a significant rescue of function, indicating a reversible disruption 
of intracellular function was mainly responsible for the decline in inotropy.  From the 
effects of K201 documented in the literature an attenuation of cellular Ca2+ overload is one 
likely mechanism for this cardioprotective response, although the influence of 
mitochondria-specific effects have not been fully elucidated and may play a role.         
   
 
 
 
 
 
 
 
 
5 Acute effects of K201 on cardiac function in a 
rabbit model of left ventricular dysfunction 
following coronary artery ligation 
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5.1 Introduction 
Current definitions of heart failure describe the condition as an impairment of cardiac 
function resulting in an inability of the heart to maintain a cardiac output sufficient to meet 
the metabolic demands of the body (Braunwald E, 2008; Ritter & Neyses, 2003).  
Abnormalities in Ca2+ handling and E-C coupling mechanisms are a common finding in 
cardiac disease states, with key alterations in heart failure including a reduction in SR Ca2+ 
uptake (Beuckelmann et al., 1995; Hasenfuss & Pieske, 2002), upregulation of NCX 
(Pogwizd et al., 1999a), and altered RyR2 function (Yano et al., 2003), all of which are 
thought to contribute to a reduced SR Ca2+ content and a reduction in the size of the 
systolic Ca2+ transient (Bers et al., 2003; Houser et al., 2000).  Recently a great deal of 
attention has been focused on the concept of altered RyR2 function, and the enhancement 
of diastolic Ca2+ leak from the SR in heart failure although the contribution of this 
mechanism to the overall contractile dysfunction in heart failure remains controversial 
(Belevych et al., 2007; Bers et al., 2003; George, 2008; Tateishi et al., 2009).  The 1, 4-
benzothiazepine derivative K201 has, in a number of studies, been demonstrated to reduce 
RyR2-mediated SR Ca2+ leak and spontaneous SR-mediated triggered activity in 
ventricular myocytes (Hunt et al., 2007; Loughrey et al., 2007; Yano et al., 2003) and may 
therefore prove beneficial as part of therapeutic treatment strategies for heart failure.      
5.1.1 Beneficial effects of K201 in animal models of heart failure 
Several investigations have reported on the beneficial effects of K201 in animal models of 
heart failure (Kohno et al., 2003; Wehrens et al., 2005; Yano et al., 2003).  In a canine 
pacing-induced heart failure model, K201 was shown to be effective in preventing the 
development of left ventricular remodeling following a 4 week period of chronic right 
ventricular pacing, resulting in significantly improved left ventricular function compared to 
untreated, paced animals (Yano et al., 2003).  The study identified several critical elements 
of K201’s protective effects in this particular heart failure model; the pacing induced 
model of heart failure resulted in a dissociation of FKBP12.6 from the RyR2, leading to an 
increase in Ca2+ leak through the channel.  K201, by restoring the binding of FKBP12.6 to 
the RyR2 led to a reduction in the Ca2+ leak from failing SR vesicles.  In SR vesicles from 
failing hearts not treated with K201, there was an upregulation of RyR phosphorylation by 
PKA in comparison to unpaced controls.  In K201 treated SR vesicles from failing hearts 
however this ‘hyperphosphorylated’ state was reversed.  The study also found that while 
K201 had no effect on Ca2+ uptake in normal or failing SR vesicles when applied acutely, 
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SR vesicles from animals treated throughout the 4 week pacing period demonstrated a 
significantly greater level of SR Ca2+ uptake, as well as higher SERCA2a protein 
expression compared to those from untreated heart failure animals (Yano et al., 2003).  
The finding that K201 has no effect on SR Ca2+ uptake is in contrast to a recent report by 
Loughrey et al., (2007) who demonstrated a reduction in maximal SR Ca2+ uptake rate 
(Vmax) to 88 % of control at 1.0 µM K201 using rabbit ventricular myocytes (Loughrey et 
al., 2007).  Kohno et al. (2003) also found that in SR vesicles from failing hearts, as well 
as from normal control hearts treated with 30 µM FK506 (to dissociate FKBP12.6 from the 
RyR2), the rate of Ca2+ release induced by polylysine was significantly reduced compared 
to untreated controls (Kohno et al., 2003).  Treatment with K201 in both instances led to a 
restoration of Ca2+ release kinetics towards control values.  Increased Ca2+ spark frequency 
in SR vesicles from pacing-induced heart failure dogs in comparison to controls has been 
demonstrated by Tateishi et al. (2009) (Tateishi et al., 2009).  Application of 0.3 µM K201 
significantly reduced Ca2+ spark frequency and led to an increase in Ca2+ spark amplitude.  
The investigators concluded that this may be a crucial factor in the action of K201 to 
improve contractile function in the failing heart.  Boyden et al., (2004) reported that K201 
was effective in limiting the appearance of arrhythmogenic micro Ca2+ waves in Purkinje 
fibres from canine hearts 48 hours after myocardial infarction (MI) (Boyden et al., 2004).  
The effects of K201 on murine cardiac function were also investigated using a ligation 
induced myocardial infarction model (Wehrens et al., 2005).  Cardiac function in wild-type 
(WT) mice 4 weeks after MI was significantly improved following continuous infusion of 
K201 (0.5 mg.kg-1.h-1) compared to untreated WT MI mice.  In FKBP12.6 (calstabin2)-/- 
mice however K201 did not demonstrate any significant influence on left ventricular 
haemodynamics, with post-MI function in FKBP12.6-/- mice unchanged in comparison to 
WT MI mice.  The authors attributed this effect to stabilization of the RyR2 by K201 
which led to a reduced open probability and abolition of channel subconductance state.  
Additionally, as these effects were not observed in FKBP12.6-/- mice it was concluded that 
re-association of FKBP12.6 with the RyR2 is a prerequisite for the normal action of K201.  
To date no reports have been published describing the influence of K201 on cardiac 
function in healthy animals.         
5.1.2 Non-cardiac specific effects of K201 
K201 has been shown to affect function of non-cardiac tissues including skeletal muscle 
and in the kidney (Almassy et al., 2008; Lisy & Burnett, Jr., 2006; Wehrens et al., 2005).  
Wehrens et al. (2005) reported an improvement in skeletal muscle function (as assessed by 
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reduced rate of fatigue) in both wild-type and FKBP12.6-/- mice 4 weeks following MI, 
suggesting that K201 elicited a beneficial effect on skeletal muscle function independent of 
an improvement in cardiac function (Wehrens et al., 2005).  This study however did not 
address the influence of K201 treatment on cardiac function in non-failing wild type mice.  
The effects of K201 on RyRs in the kidney and renal function was investigated by Lisy & 
Burnett (2006) (Lisy & Burnett, Jr., 2006).  At the largest dose used in the investigation 
(0.5 mg.kg-1.min-1, approximately 13.5 µM) K201 led to a significant enhancement of 
glomerular filtration rate and renal blood flow.  These changes could not be attributed to an 
increase in cardiac output, as K201 at this dose significantly lowered cardiac output by 
~26% (Lisy & Burnett, Jr., 2006).  K201 was also found to be natriuretic and diuretic, 
leading to an increased urinary volume and sodium excretion. The authors suggested the 
combination of these effects may prove beneficial in the setting of congestive heart failure 
by limiting fluid retention and improving renal function, however this observation would 
seem counter-intuitive as doses required to illicit an acute response led to significant 
depression of cardiac output (Lisy & Burnett, Jr., 2006).  In this regard further 
investigation is warranted in order to clarify any long term benefit therapeutic doses of 
K201 may have on renal function, especially in the setting of congestive heart failure.  The 
effects of K201 therefore are not limited merely to the drugs’ previously reported actions 
on cardiac tissue.  Moreover, in the setting of heart failure K201 may indirectly improve 
cardiac function via its effects on other tissues in the intact animal.  Isolating the influence 
of K201 on whole heart mechanical function after MI, independent of systemic effects has 
not been attempted to date.  In addition, studies where K201 has been shown to improve 
cardiac function in models of heart failure have involved chronic administration of the 
drug at or close to the start of treatment to induce heart failure (Wehrens et al., 2005; Yano 
et al., 2003).  Therefore, there is currently no information available on the acute effects of 
K201 administration on ventricular mechanical function in an MI model of left ventricular 
dysfunction.  
5.1.3 Aims 
The aims of the work described in this chapter were to characterize pressure-volume work 
of the isolated working rabbit heart 8 weeks after induction of an ischaemic myocardial 
insult, and following this to determine the effects of acute administration of K201 on left 
ventricular contractile function.  Results from the previous chapters highlight a dichotomy 
regarding the actions of K201.  Despite application of K201 in hearts from healthy animals 
causing a decline in mechanical function, in the setting of elevated Ca2+ and β-adrenergic 
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stimulation which induced contractile dysfunction K201 proved to be beneficial.  
Therefore, based on the results presented in Chapter 3 it was hypothesized that application 
of K201 to hearts exposed to chronic myocardial infarction 8 weeks previous would result 
in a decrease in contractile performance.  
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5.2 Methods 
5.2.1 Coronary artery ligation model of myocardial infarction 
The rabbit myocardial infarct model by ligation of the circumflex branch of the left 
coronary artery was employed for this study.  This model has been described in detail 
previously (Pye et al., 1996).  All procedures were carried out in accordance with The 
Animals (Scientific Procedures) Act 1986, and were approved by the University of 
Glasgow’s ethics committee.   
 
All surgical procedures were performed by Michael Dunne.  Briefly, adult New Zealand 
White rabbits (2.5 – 3.5 kg) were pre-medicated with intramuscular fentanyl/fluanizone 0.3 
ml.kg-1 (Hypnorm, Jansen Pharmaceuticals).  Anaesthesia was induced with midazolam (1 
– 2 mg.kg-1) administered in the marginal ear vein via an indwelling cannula.  Rabbits 
were intubated and ventilated, with anaesthesia maintained using a 1:1 mixture nitrous 
oxide and oxygen containing 1 % halothane.  A left thoracotomy was performed through 
the 4th intercostal space to gain access to the left coronary artery.  10 mg.kg-1 Quinidine 
hydrochloride (Sigma Pharmaceuticals) was intravenously administered immediately prior 
to coronary artery ligation to reduce the incidence of ventricular fibrillation during the 
procedure.  A ligation was made in the major ventricular branch of the left coronary artery 
halfway between its origin and the apex of the heart, quickly resulting in the appearance of 
an ischaemic area of myocardium.  Animals were allowed to stabilise for a period of 10-15 
minutes before the wound was closed and saline administered to replace fluids lost during 
the procedure.  Post-operative analgesia (buprenorphine, 0.05 mg.kg-1) was provided every 
8 hrs for 3-4 days.  Animals were kept in a warm, clean environment and checked regularly 
for signs of distress in order to aid convalescence.  Ligation resulted in an infarct 
accounting for 20-30% of the left ventricle following 8 weeks of recovery, at which point 
animals underwent haemodynamic assessment.  The same surgical procedure was carried 
out in a second population of animals with the exception of the coronary artery ligation.  
This group of animals acted as sham-operated controls.      
5.2.2 Isolated working heart setup 
Hearts from 8 male New Zealand White rabbits that had undergone surgery 8 weeks 
previously (myocardial infarct; n = 4; sham control; n = 4) were excised and perfused 
initially in Langendorff mode on the isolated working heart apparatus as described in the 
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General Methods chapter section 2.1.3.  After cannulation of the left atrium working heart 
mode was initiated and solution was recirculated to perfuse hearts from a fixed volume of 
540 ml.  Preload was set at 7.4 mmHg and afterload set to 60 mmHg.  These settings 
remained constant throughout the experimental protocol.  A pair of platinum subdermal 
needle electrodes connected to a constant voltage isolated stimulator and train generator 
were attached to the right atrial tissue and hearts were paced at 200 beats.min-1 throughout 
the protocol.   
5.2.3 Left ventricular function by pressure-volume catheterisation 
A 3F Scisense multi-segmental catheter with three recording electrode segments of 5.5 mm 
each was advanced slowly past the aortic valves and into the left ventricle to obtain 
pressure-volume measurements throughout the experimental protocol.  Recording software 
was set to display volume signals from each individual segment in separate channels, with 
the total volume signal achieved by summation of all three segments.  The individual 
segments delineated 3 discrete regions within the left ventricular chamber, denoted Apex, 
Mid and Base, respectively, from which regional stroke volume and stroke work was 
assessed.   
5.2.4 Solutions 
Perfusion of the isolated working heart was performed using Tyrode’s solution, the 
composition of which is described in General Methods section 2.1.3.  K201 stock solution 
was created by dissolving K201 in a 10% DMSO solution to yield a stock concentration of 
1 mM.  K201 was prepared 10 min prior to the beginning of each experiment and stored in 
a light-shielded container.   
5.2.5 Experimental Protocol 
After initiation of working heart perfusion, the multi-segmental catheter was slowly 
advanced through the aortic valves into the LV chamber.  The catheter was positioned such 
that recording segment 1 (denoted Apex) was as close to the apex of the heart as possible 
without interfering with regular heart rhythm and contractile function.  Following 
assessment of parallel conductance with saline bolus injection, hearts were allowed to 
stabilize before performing a transient occlusion of the left atrial inflow line to assess end 
diastolic pressure-volume relationships.  Afterwards, 540 µL of K201 stock (1.0 mM) was 
added to the recirculating reservoir to yield a final concentration of 1.0 µM K201.  Hearts 
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were perfused with K201 for a total of 9 min, with continuous pressure-volume 
measurements recorded throughout for assessment of the acute effects of the drug.  
5.2.6 Data recording and statistical analysis  
All working heart functional data were recorded on a Dell PC using LabChart software 
version 5.5.6 at a sampling rate of 1000 Hz, and analysed offline using LabChart’s Blood 
Pressure Module and LabScribe2.0 software.  Assessment of end diastolic pressure-volume 
relationships was performed by fitting a mono-exponential relationship to the end diastolic 
pressure-volume points obtained during transient occlusion of the left atrial inflow line.  
This mono-exponential relationship was of the form EDP = Cexp(β*EDV), where EDP is the 
end diastolic pressure, C is a curve fitting constant, β is the diastolic stiffness constant and 
EDV is the end diastolic volume (See General Methods section 2.3.7).  All results were 
saved to an external hard drive. Two-sample Student’s t-test was used to compare values 
between groups on a number of functional parameters.  A P-value of < 0.05 was 
considered statistically significant. 
5.3 Results 
5.3.1 Baseline haemodynamic function of 8 week ligation vs. 
sham 
Baseline haemodynamic function was assessed prior to addition of 1.0 µM K201 with the 
multi-segmental pressure volume catheter.  This catheter was not available for 1 of the 4 
sham control experiments, and pressure-volume work was instead assessed with a 3F VSL 
catheter (19 mm electrode spacing).  Data from this heart was not included in the 
subsequent assessment of regional function (see section 5.3.3).   
5.3.1.1 Load-independent left ventricular function  
As can be seen in Figure 5.1A, PV loops from 8 week ligation hearts appear shifted to the 
right in comparison to those from sham controls.  Representative families of PV loops 
obtained using transient atrial inflow line occlusion are plotted in Figure 5.1B(i = sham, ii 
= 8 week ligation).  Mean diastolic stiffness constant values (Figure 5.1C(ii) ) were not 
significantly different between groups.  Therefore despite the presence of an apical infarct, 
by 8 weeks post ligation the diastolic stiffness constant was not significantly altered. 
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Figure 5.1 Pressure-volume relationships: 8 week ligation vs. sham control.  A.  Representative steady 
state pressure-volume loops from sham (black line) and 8 week ligation (red line) hearts.  B.  Families of PV 
loops obtained by transient occlusion of the left atrial inflow line in sham (i) and 8 week ligation (ii) hearts.  
The EDPVR curve fit for these individual hearts is shown on the graph.  C.  Mean diastolic stiffness 
constants (β) are shown for each group.  Sham control, n = 4; 8 week ligation, n = 4.  Mean stiffness 
constants compared using unpaired student’s t-test. 
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5.3.1.2 Baseline systolic and diastolic function of 8 week ligation hearts vs. 
sham controls 
Mean values for contractile and relaxation indices are shown in the top panels of Figure 5.2 
with values up to and including time 0 indicating baseline function prior to addition of 
K201.  There was a tendency for left ventricular peak pressure (Figure 5.2(i)) to be higher 
in the sham operated hearts, but this did not reach significance.  Contractility, as assessed 
by dP/dtmax (Figure 5.2(ii)) was not significantly different between the two groups at 
baseline.  End diastolic pressure (Figure 5.2(iii)) was not significantly different between 
the two groups, however dP/dtmin (Figure 5.2(iv), an index of ventricular relaxation was 
significantly lower in 8 week ligation hearts [-1675.72 ± 55.05 mmHg.s-1 (8 week ligation) 
vs. -2175.69 ± 137.59 mmHg.s-1 (sham control); P < 0.05].  There were no differences in 
the relaxation constant τ (Figure 5.2(v)) between groups. 
5.3.1.3 Baseline volume parameters of 8 week ligation hearts vs. sham 
controls 
Aortic flow (Figure 5.3 A(i)) and stroke volume (Figure 5.3 A(ii)) both tended to be higher 
in the sham operated hearts compared to the 8 week ligation, but this did not reach 
significance in either parameter.  There was no significant difference in end diastolic 
volume (EDV – Figure 5.3 A(iii)) between groups at baseline, though this tended to be 
higher in the 8 week ligation hearts.  End systolic volume (ESV – Figure 5.3 A(iv)) 
however, was significantly higher at baseline in the ligation hearts [1069.78 ± 56.87 µl (8 
week ligation) vs. 643.36 ± 56.70 µl (sham control); P < 0.01].  Ejection fraction (Figure 
5.3A(v)) was also found to be significantly lower in the 8 week ligation group compared to 
the sham operated hearts [51.83 ± 4.09 % (8 week ligation) vs. 68.74 ± 1.38 % (sham 
control); P < 0.05].  Coronary flow (Figure 5.3B) was not significantly different between 
groups.  Baseline functional data demonstrate that some degree of functional impairment 
was apparent 8 weeks after coronary artery occlusion resulting in a significantly reduced 
ejection fraction and higher end systolic volume compared with sham operated controls. 
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Figure 5.2 Pressure, contractility and relaxation following addition of 1.0 µM K201.  (i-v).  Indices of 
LV mechanical function during the K201 perfusion protocol.  Top panels; mean ± SEM for each parameter in 
sham (black squares, n = 4) and 8 week ligation (red circles, n = 4) hearts; Bottom panels; mean values 
expressed as % of baseline (0 min).  Statistical significance between groups tested using unpaired student’s t-
test. 
5.3.2 Acute effects of K201 on mechanical function of 8 week 
ligation hearts 
5.3.2.1 Systolic and diastolic functional parameters 
In hearts from the sham operated animals peak systolic pressure (Figure 5.2A(i)) fell to 
93.72 ± 1.45 % of baseline (value at time 0) after 9 minutes of K201 perfusion, dropping  
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Figure 5.3 Volume and flow data following addition of 1.0 µM K201.  A(i-v).  Volume indices and flow 
measurements obtained before and during perfusion with K201.  Top panels; mean data from sham (black 
squares, n = 4) and 8 week ligation (red circles, n = 4) hearts; bottom panels; mean values expressed as % of 
baseline (0 min).  B.  Mean coronary flow measured at 5 min intervals during the protocol.  All values 
expressed as mean ± SEM. Statistical significance between groups tested with unpaired student’s t-test. 
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significantly further than the 8 week ligation hearts (98.62 ± 0.86 % of baseline).  
Similarly, contractility (assessed by dP/dtmax – Figure 5.2(ii)) was significantly more 
depressed in the sham control group (84.07 ± 2.09 %) vs. the 8 week ligation (92.51 ± 0.65 
%; P < 0.01) after 9 min of K201 perfusion, although it should be noted that dP/dtmax was 
significantly reduced relative to baseline in the 8 week ligation hearts by 9 min post-K201 
perfusion (100.00% vs. 92.51 ± 0.65%; P < 0.01, not indicated on graph).  LVEDP (Figure 
5.2(iii)) was significantly elevated in sham control (11.10 ± 0.28 mmHg) vs. 8 week 
ligation hearts (8.63 ± 0.93 mmHg; P < 0.05) following 9 min of K201 perfusion, however, 
as can be seen from Figure 5.2(iv) the % change from baseline was not significantly 
different between groups. 1.0 µM K201 led to a significantly greater fall in dP/dtmin in the 
sham control hearts (86.59 ± 3.94 %) vs. 8 week ligation hearts (98.42 ± 2.34 %) after 9 
min of perfusion.  In addition, the relaxation constant τ (Figure 5.2(v)) increased 
significantly more in the sham controls (109.80 ± 3.10 %) vs. 8 week ligation hearts 
(100.66 ± 2.40 %; P < 0.05) after 9 min of K201 perfusion.  
5.3.2.2 Volume parameters 
Aortic flow (Figure 5.3A(i)) fell from baseline by a significantly greater degree in sham 
control hearts (89.51 ± 1.86 %) vs. 8 week ligation (101.04 ± 3.59; P < 0.05) after 9 min in 
1.0 µM K201, as did stroke volume (Figure 5.3A(ii)) [92.07 ± 1.38 (sham control) vs. 
99.46 ± 1.95 (8 week ligation); P < 0.05].  As shown in Figure 5.3A(iii) & (iv), the % 
change from baseline in end diastolic volume and end systolic volume was not 
significantly different between groups at any point, although tended to be greater in the 
sham controls.  The % change in ejection fraction from baseline was not significantly 
different between groups after addition of K201, although sham controls tended to show a 
greater degree of change.  K201 did not significantly alter coronary flow at any stage 
however (Figure 5.3B).  In sham control hearts therefore, 1.0 µM K201 had a negative 
inotropic effect, but this was significantly reduced in hearts that had undergone coronary 
artery ligation 8 weeks previously.      
5.3.3 Regional function in the isolated working heart 
Use of the 3 segment, multi-segmental pressure-volume catheter permitted comparative 
assessment of regional stroke volume and stroke work in the 8 week ligation and sham 
control hearts.  Figure 5.4A shows representative pictures of an isolated heart from an 8 
week ligation animal, with the right hand panel demonstrating the relative positions of each 
volume segment.  Segment 1 was positioned closest to the area of infarction, with the 
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Figure 5.4 Regional function in 8 week ligation vs. sham control hearts.  A.  8 week ligation heart intact 
(i) and opened (ii) showing position of volume segments.  B&C.  Mean stroke work and stroke volume 
measured from 3 discrete catheter segments.  Left hand panels; mean values ± SEM from each segment 
before and 9 min after K201.  Right hand panels; mean values ± SEM from each segment expressed as % of 
total (sum of all 3 segments).  Sham, n=3; 8 week ligation, n=4.  
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remaining segments measuring volume within the middle and basal portions of the left 
ventricular chamber respectively.  As shown in Figure 5.4B(i), stroke work for any given 
segment was not significantly different between sham or 8 week ligation hearts, although 
there was a tendency for apical stroke work to be lower in the 8 week ligation group.  
There were no significant differences between segments in the sham control group, 
however within the 8 week ligation, apical stroke work (17283.87 ± 5401.09 mmHg*µl. µl-
1) was significantly lower than that of the mid chamber (34655.62 ± 3628.33 mmHg*µl.µl-
1; P < 0.05).  A similar trend emerged when segmental stroke work was expressed as a % 
of total stroke work (Figure 5.4B(ii)).  The % contribution of each region to the total stroke 
work was similar before and 9 minutes after perfusion with 1.0 µM K201 in both groups.  
Stroke volume (Figure 5.4C(i)) in the apical region from sham controls tended to be higher 
than that of the 8 week ligation hearts, but this did not reach significance.  The % 
contribution of each segment to total stroke volume was not significantly different in the 
sham controls, but was significantly lower in the apical region of 8 week ligation hearts 
(24.48 ± 4.80 %) in comparison to the mid chamber region (44.56 ± 6.03 %; P < 0.05).  1.0 
µM K201 did not significantly alter the contribution of each region to the total stroke 
volume in either group, suggesting that there is no regional effect of K201.  
5.4 Discussion 
5.4.1 K201 is negatively inotropic in sham operated hearts but not 
in infarcted hearts 
The 1, 4-benzothiazepine derivative, K201 has been shown to prevent the adverse effects 
of pacing-induced left ventricular remodelling in the canine heart and result in improved 
function in a mouse myocardial infarction model of heart failure when chronically 
administered during the period of induction (Wehrens et al., 2005; Yano et al., 2003).  The 
effects of K201 are not however, limited to cardiac tissue.  Improved skeletal muscle 
function in heart failure has been demonstrated in FKBP12.6-/- mice chronically treated 
with K201, despite no improvement in cardiac function (Wehrens et al., 2005).  K201 has 
also been shown to enhance glomerular filtration rate and natriuresis in vivo in healthy 
dogs, an effect which is potentially beneficial but which has not yet been described in heart 
failure models (Lisy & Burnett, Jr., 2006).  Therefore, the therapeutic potential of K201 on 
cardiac function in heart failure models has yet to be studied without the confounding 
influence of the compounds’ systemic effects.  Additionally, the aforementioned heart 
failure models employed chronic administration of K201 during the period of heart failure 
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induction, but there is little information on the acute effects of the drug following a period 
of remodelling.  In the current study, isolated rabbit hearts which had undergone a 
coronary artery ligation 8 weeks previously were functionally assessed using a multi-
segmental pressure-volume catheter and compared to hearts from sham-operated control 
animals before and after perfusion with 1.0 µM K201.  Prior to K201 administration, 
baseline functional indices demonstrated that 8 week coronary artery ligation resulted in a 
reduction in left ventricular relaxation (Figure 5.2(iv)) and ejection fraction (Figure 
5.3A(v)), while other indices of contractility did not appear significantly different from 
controls.  Comparison of left ventricular stiffness constants between both groups, as seen 
in Figure 5.1C, also did not reveal a significant difference.  This was believed to be due in 
part to the low numbers in each group (n = 4; 8 week ligation and sham control).  Peak 
systolic pressure, dP/dtmax and aortic flow all tended to be higher in the sham control 
hearts, and with more numbers in each group it is possible these would have achieved 
significance.  Ng et al. (2002) using isolated working rabbit hearts exposed to chronic (8 
weeks) coronary artery ligation demonstrated a significant difference in cardiac output 
(~17%) and peak LV pressure (~10%) between 8 week ligation and sham operated hearts 
with n-values of 8 for each group (Ng et al., 2002). In the current study, preliminary power 
calculations suggest that between 10 and 12 hearts per group would be required to report a 
significant difference in cardiac output and peak pressure between groups.      
 
From the results discussed in Chapter 3, 1.0 µM K201 was shown to be negatively 
inotropic in hearts from healthy animals, and the same effect was expected to occur in 
hearts from sham operated animals.  The acute effects of K201 on hearts that had 
undergone coronary artery ligation to produce a myocardial infarction however were not 
known.  From the results shown in Figures 5.2 and 5.3, perfusion with 1.0 µM K201 was 
more negatively inotropic in sham operated control hearts compared to 8 week ligation 
hearts, with the effect being most pronounced at 9 minutes post-K201 perfusion.  Function 
did not decline in 8 week ligation animals following addition of K201, with only dP/dtmax 
becoming significantly reduced relative to baseline.  Contrary to the findings discussed in 
chapter 3 and the result hypothesised earlier in this chapter, K201 did not significantly 
effect cardiac mechanical function in 8 week ligation hearts in contrast to the cardio-
depressive response demonstrated in the sham operated control hearts. 
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5.4.2 The pattern of regional function in isolated working hearts 
does not alter following perfusion with K201 
Stroke volume and stroke work within discrete regions of the left ventricular chamber was 
assessed using a multi-segmental pressure-volume catheter.  The catheter was positioned 
within the left ventricle such that the first segment lay within the infarcted region as shown 
in Figure 5.4 A(ii), with the remaining 2 segments spanning the rest of the left ventricular 
chamber.  In the 8 week ligation hearts, the largest area of infarction was found in the 
apical region.  There were no differences in either stroke volume or stroke work within the 
apex between the 8 week ligation hearts and sham controls, although there was a tendency 
for both parameters to be lower in 8 week ligation hearts.  Increasing the number of hearts 
in this study may therefore have revealed a significant difference between groups.  The % 
contribution of each segment in the 8 week ligation hearts however was not uniform, and 
there was a significantly greater contribution from the mid region to total stroke volume 
and stroke work in comparison to the apical region, while in sham hearts the relative 
contribution of each segment to total stroke volume/work was similar.  The distinct 
differences in functional response to K201 between groups may have been better 
understood by a differential regional response between the two groups.  For example, 
K201 may be functionally beneficial in the region closest to infarction, such that the 
contribution to total function by this region is increased relative to the remaining regions.  
Figures 5.4 B(ii) and C(ii) show that the relative contribution of each region to total stroke 
work and stroke volume remain almost identical in both groups before, and 9 min after 
perfusion with K201, demonstrating that the effect of K201 on cardiac function is similar 
throughout the myocardium. 
5.4.3 Differential response to K201 between 8 week infarct and 
sham control hearts:  Possible mechanisms 
It has been well documented that in cardiac disease states such as heart failure, there are 
marked changes in Ca2+ handling mechanisms (Bers et al., 2003; Hasenfuss & Pieske, 
2002; Shannon et al., 2003).  Heart failure is associated with a reduction in SERCA2a 
expression and function, as well as altered phospholamban phosphorylation which may 
work to reduce SR Ca2+ content following myocardial infarction and left ventricular 
dysfunction (Bers et al., 2003).  The rabbit model ligation model of left ventricular 
dysfunction demonstrates the same phenotype (Currie & Smith, 1999) however, while 
NCX gene and protein expression has also been shown to be upregulated in heart failure 
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(Hasenfuss et al., 1999; Studer et al., 1994b), previous reports published using the current 
rabbit ligation model of left ventricular dysfunction have indicated that NCX function is 
significantly reduced (Quinn et al., 2003).  Recently, interest has focused on the relative 
contribution of altered RyR2 function to cardiac contractile dysfunction in heart failure 
(Belevych et al., 2007; Shannon et al., 2003; Tateishi et al., 2009).  The idea that diastolic 
Ca2+ leak could contribute to heart failure was initiated in a study by Marx et al., (2000) 
who demonstrated that phosphorylation of RyR2 by PKA resulted in dissociation of a 
binding protein, FKBP12.6, from the channel complex, an increase in channel open 
probability (Po) and the induction of subconductance states (Marx et al., 2000).  In intact 
myocytes from human and canine failing hearts the amount of FKBP12.6 bound to RyR2 
was already significantly reduced.  The importance of PKA ‘hyperphosphorylation’ to this 
mechanism has been hotly debated, with several investigations failing to demonstrate a 
link between PKA phosphorylation and increased RyR2-mediated Ca2+ leak (Bers et al., 
2003; Curran et al., 2007).  Regardless of the initiating mechanism, the idea that RyR2-
mediated SR Ca2+ leak can significantly contribute to a reduced SR Ca2+ content is also a 
contentious issue.  Shannon et al. (2003) assessed SR Ca2+ leak in intact myocytes from 
failing rabbit cardiomyocytes and found it to be increased in heart failure for any given 
total SR Ca2+ content (Shannon et al., 2003).  They reasoned that while this mechanism 
may work in tandem with enhanced NCX function and reduced SR Ca2+ uptake to lower 
SR Ca2+ content, data for that particular heart failure model would suggest enhanced NCX 
function plays a greater role.  Belevych et al. (2007) reported that SR Ca2+ content and 
fractional Ca2+ release were reduced in myocytes from a canine pacing-induced model of 
heart failure, and attributed this finding to a significantly enhanced SR Ca2+ leak, as SR 
Ca2+ uptake was not significantly altered compared to controls and NCX function only 
upregulated by 30 % (Belevych et al., 2007).  A well-documented action of K201 involves 
its interaction with the RyR2.  K201 has been demonstrated to reduce spontaneous SR Ca2+ 
release in ventricular myocytes subjected to Ca2+ overload (Hunt et al., 2007; Loughrey et 
al., 2007).  The specific binding site for K201 on the RyR2 has also recently been reported 
(Yamamoto et al., 2008).  If SR Ca2+ leak is a significant contributory factor to the reduced 
SR Ca2+ content and loss of inotropy in heart failure, then K201 would likely result in an 
inhibition of this leak and a partial restoration of cardiac inotropy.  In line with this, K201 
has been demonstrated to inhibit SR Ca2+ leak in failing canine cardiac myocytes, as well 
as preventing ventricular remodelling associated with a chronic pacing-induced model of 
heart failure (Yano et al., 2003).  K201 has also been shown to restore the rate of Ca2+ 
release in SR vesicles from failing canine cardiomyocytes back towards control levels 
(Kohno et al., 2003).  From the results described in Chapter 3, 1.0 µM K201 is negatively 
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inotropic in the isolated working rabbit heart.  Hearts from 8 week ligation animals 
however demonstrated a blunted negative inotropic response to K201 in comparison to 
sham operated controls, with only dP/dtmax demonstrating a significant decline from 
baseline function in the ligated hearts.  This may have resulted from a reduction in SR Ca2+ 
leak by K201’s interaction with the RyR2 in 8 week ligation hearts.  K201 does not only 
target the RyR2 however, and a number of competing effects may have resulted in the 
overall action of the drug in 8 week ligation hearts.  K201 has been shown to reduce the 
SR Ca2+ uptake via SERCA2a (Loughrey et al., 2007), and several reports have 
demonstrated a concentration-dependent inhibition of ICaL (Chen et al., 2008; Inagaki et 
al., 2000b; Kimura et al., 1999) although this does not reach significance in rabbit 
ventricular myocytes at 1.0 µM (Loughrey et al., 2007).   
5.4.4 Alternative mechanisms of K201 action 
From the results presented in Chapter 3 application of 1.0 µM K201 in isolated working 
hearts from healthy rabbits leads to a significant decline in mechanical function and 
cardiac inotropy.  Alternative mechanisms of action may therefore be responsible for 
divergent effects seen between 8 week myocardial infarction hearts and sham operated 
controls and it is possible K201 is interacting with an intracellular target that improves 
function in infarcted hearts.   
 
The levels of nitric oxide (NO) in cardiac tissue have been shown to influence myocardial 
contractility (Rastaldo et al., 2007).  NO is synthesised primarily through several types of 
NO-synthase; endothelial (e)NOS, neuronal (n)NOS and inducible (i)NOS, the relative 
expressions and functions of which are believed to be altered in cardiac disease states, 
including ischaemic heart failure (Rastaldo et al., 2007).  Mice in which eNOS has been 
genetically ablated develop more severe left ventricular dysfunction and remodelling in 
comparison to wild-type controls (Scherrer-Crosbie et al., 2001).  A similar result was also 
reported in mice lacking expression of nNOS (Dawson et al., 2005).  Induction of 
myocardial infarction in nNOS-/- mice led to left ventricular dilatation and severe 
functional impairment that developed at a faster rate than left ventricular dysfunction in 
wild type mice subjected to the same ligation protocol, an effect that was independent of 
infarct size.  In patients with non-ischaemic dilated cardiomyopathy levels of iNOS and 
eNOS gene expression correlated with severity of LV dysfunction, such that increased 
expression was associated with greater stroke work and stroke volume (Heymes et al., 
1999).  In patients with elevated left ventricular end diastolic filling pressures (> 16 
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mmHg) coronary injection of substance P to stimulate endothelial cell production of NO 
also resulted in an increase in stroke work and stroke volume, indicative of improved 
ventricular filling.  Kawabata et al. (2002) reported that the preservative effects of K201 on 
metabolism following ischaemia-reperfusion in isolated rabbit hearts were abolished 
following treatment with the NOS inhibitor L-NAME (Kawabata et al., 2002).  A portion 
of K201’s action appears to be mediated through NOS, and upregulation of one or more 
subtypes of NOS may be acting to improve myocardial relaxation in the current study.                  
5.4.5 Use of the multi-segmental pressure-volume catheter to 
assess regional function in the isolated working heart 
Multi-segmental pressure-volume analysis has been used in previous studies to assess 
regional mechanical dyssynchrony (Bleeker et al., 2006; Steendijk et al., 2004; Strum & 
Pinsky, 2006).  Steendijk et al. (2004) described the use of this technique in quantification 
of mechanical dyssynchrony in heart failure patients by identification of altered segmental 
volume phase relative to the total volume signal (Bleeker et al., 2006; Steendijk et al., 
2004).  They reported that this approach successfully identified significantly greater 
mechanical dyssynchrony in congestive heart failure patients with left bundle branch 
block, compared to coronary artery disease patients presenting essentially preserved left 
ventricular function.  Several conductance-derived indices of mechanical dyssynchrony 
were also shown to correlate significantly with septal-to-lateral delay, an index of 
dyssynchrony obtained by tissue Doppler echocardiography (Steendijk et al., 2004).  The 
present investigation reports for the first time the assessment of regional myocardial 
function in an ex vivo rabbit heart preparation.  Function was assessed using a 3 segment 
multi-segmental pressure-volume catheter, with each segment delineating a discrete region 
of the left ventricular chamber.  Regional stroke volume and stroke work were compared 
between 8 week ligation hearts and sham controls, as well as between each region within 
groups.  Despite the presence of a transmural infarct within the apical region of hearts from 
8 week ligation animals, no significant differences in apical stroke volume or stroke work 
were detected between the 8 week ligation hearts and the sham controls.  Stroke work and 
stroke volume (as a % of total) were however found to be significantly lower in the apical 
region in comparison to mid region in 8 week ligation hearts, while function in all 3 
regions appeared similar in sham controls.  Use of the multi-segmental pressure-volume 
catheter therefore has utility in assessment of regional myocardial function.  The groups 
were comprised of small numbers (sham = 3; 8 week ligation = 4), which may have 
accounted for the failure in detecting significant differences between groups within the 
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apical region.  It was initially proposed that the blunted negative inotropic response of 8 
week ligation hearts to K201 perfusion in comparison to sham controls may have resulted 
from regionally specific effects of K201 which would presumably alter the contribution of 
each region to total stroke work/stroke volume relative to other segments measured.  
However, as the results in Figure 5.4B(ii) & C(ii) demonstrate, regional myocardial 
contributions to both of these parameters were unchanged following application of K201, 
suggesting that the effect of K201 was uniform throughout the myocardium.   
5.5 Summary        
In the present study the effects of acute administration of K201 on mechanical function in 
a model of left ventricular dysfunction were investigated.  Although 1.0 µM K201 did not 
improve mechanical function in 8 week ligation hearts, a blunted negative inotropic 
response was found in comparison with sham controls.  This may reflect a balance of 
positive effects of the drug on Ca2+ handling mechanisms (improved RyR2 function and 
decreased SR Ca2+ leak) and inhibitory effects (Inhibition of SR Ca2+ uptake).  Other 
reported effects of K201 involving stimulation of NOS may also play a role in 
counterbalancing the negative inotropic effects of the compound however these 
mechanisms have only been described in models of ischaemia-reperfusion injury and their 
influence on contractile function following development of myocardial infarction requires 
further investigation.  Novel assessment of regional myocardial stroke volume and stroke 
work with a multi-segmental pressure-volume catheter in an ex vivo rabbit heart 
preparation demonstrated that K201 showed no regionally specific effects. 
   
 
 
 
 
 
 
 
 
 
6 Pharmacological inhibition of SR Ca2+ uptake in 
the isolated working rabbit heart 
 
 
 
 
 
 
 
 
 
Allen Kelly - 2010  Chapter 6 
 175
6.1 Introduction 
Re-sequestration of Ca2+ into the sarcoplasmic reticulum (SR) following Ca2+-induced 
Ca2+-release (CICR) is performed by the Sarco-Endoplasmic Reticulum Ca2+-ATPase, or 
SERCA.  As SR Ca2+ content is a crucial determinant of the size of the systolic Ca2+ 
transient and therefore the strength of contraction, the activity of SERCA is critical to the 
normal regulation of cardiac contractility (Antoons et al., 2003; Periasamy & Huke, 2001).  
The activity of SERCA2a, the isoform present in cardiac cells, is regulated by an inhibitory 
protein Phospholamban (PLB).  Phosphorylation of PLB by cAMP-mediated protein 
kinase A, or Ca2+/Calmodulin dependent protein kinases results in a removal of PLB’s 
inhibitory effect and an increase in SR Ca2+ uptake by SERCA (Simmerman & Jones, 
1998).  This effect contributes to the overall positive inotropic and lusitropic effects 
associated with β-adrenergic stimulation in cardiac muscle, the final outcome of which is 
an increase in SR Ca2+ content (Hussain & Orchard, 1997).  In heart failure, a common 
finding is a reduction in SR Ca2+ content and concomitant diminution of the systolic Ca2+ 
transient (Bers et al., 2003; Hasenfuss & Pieske, 2002).  Furthermore, there is general 
agreement that in failing human hearts (Beuckelmann et al., 1992; Hasenfuss et al., 1994a) 
and animal models of heart failure (Neary et al., 2002a; Yamaguchi et al., 1997) there is a 
reduction in SR Ca2+ uptake which may be attributable to altered SERCA expression or 
function.  Decreased SERCA2a expression and/or function could result in the development 
of diastolic abnormalities (Kass et al., 2004).  NCX expression in some cases is reported to 
be upregulated in heart failure models (Pogwizd et al., 1999b) which may help to limit 
diastolic dysfunction but at the same time result in an increased Ca2+ efflux during diastole, 
further contributing to the reduction in SR Ca2+ content.  Recently, transgenic rat and 
mouse models displaying upregulated SERCA2a expression, as well as variant isoforms of 
SERCA (1a, 2b) have allowed further insight into the importance of SR Ca2+ uptake to 
normal cardiac function.  More recently inducible knockout of SERCA2a using an in vivo 
murine model has allowed for greater characterisation of the specific role of SERCA2a in 
maintenance of normal cardiac function (Andersson et al., 2009).               
6.1.1 Functional consequences of SERCA2a down-regulation 
The SERCA2 gene appears to be absolutely essential for normal development, as it is not 
possible to create mice with homozygous null mutations of this gene (Ji et al., 2000; 
Periasamy et al., 1999; Seth et al., 2004).  Down-regulation of SERCA2a has been 
achieved using heterozygous null mutations of the SERCA2 gene with the resulting 
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phenotype exhibiting decreased SERCA2a mRNA and protein expression (55 % and 35 % 
respectively), a reduced SR Ca2+ uptake and reduction in left ventricular function (Ji et al., 
2000; Periasamy et al., 1999).  Moreover, Ca2+ handling properties are markedly altered in 
this model, as evidenced by a decline in protein expression but increased phosphorylation 
of PLB, increased expression and function of NCX, and a reduction in Ca2+i transient 
amplitude and SR Ca2+ content (Ji et al., 2000).  The associated peripheral alterations in 
Ca2+ handling protein expression and function following transgenic down-regulation make 
it difficult to discern the specific contribution that reduced SERCA2a function makes to 
impairment of cardiac function.  Reduction of SERCA2a expression and its consequences 
for compensatory upregulation of auxiliary Ca2+ transport pathways has been studied in 
cultured cardiomyocytes using RNA interference (RNAi) (Seth et al., 2004).  Reduction of 
SR Ca2+ uptake to 20% of control values 48-72 hours after treatment resulted in increased 
NCX, stimulating protein 1 (sp1) and myocyte enhancer factor 2 (MEF2) transcription, 
with no changes detected in sarcolemmal Ca2+ ATPase, L-Type Ca2+ channel or PLB 
transcription levels.  Most recently, an interesting result was reported by Andersson et al. 
(2009) using an acute tamoxifen-inducible cardiac SERCA2 knockout model in mice 
(Andersson et al., 2009).  1 week after treatment with tamoxifen SERCA2a protein levels 
were reduced to 20% of controls, with no detectable SERCA2a in isolated cardiomyocytes 
after 4 weeks.  Assessment of Ca2+ handling properties revealed Ca2+i transients that were 
significantly reduced in amplitude as well as being heavily reliant on SR-independent Ca2+ 
influx mechanisms, explained in part by a 120% increase in L-type Ca2+ current density 
due to prolonged inactivation times.  At 7 weeks SERCA2a knockout mice demonstrated 
evidence of diastolic dysfunction but surprisingly there were no overt signs of cardiac 
dysfunction or circulatory failure after 4 weeks, despite reduced cardiac function and near 
complete absence of SERCA2a expression in the heart.  These results suggest that while 
long term reduction of SERCA2a function eventually results in severe cardiac dysfunction, 
the short term effects only involve a mild reduction in cardiac function without stimulation 
of hypertrophic mechanisms (Andersson et al., 2009).  
6.1.2 Pharmacological inhibitors may better highlight the role of 
SERCA2a in normal cardiac function     
While these recent studies afford greater insight into the specific role of SERCA2a in 
regulating cardiac function, in vivo manipulation of SERCA2a expression in the heart is 
accompanied by compensatory changes in the expression and function of Ca2+ handling 
proteins associated with Ca2+ transport during the transient.  Separating the influence of 
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compensatory mechanisms from the effects of acute disruption of SERCA2a may provide a 
better understanding of the specific role this protein plays in normal cardiac function.  A 
number of pharmacological agents exist which inhibit SERCA, the most specific and 
potent of which is thapsigargin (Kirby et al., 1992; Treiman et al., 1998).  While specific 
inhibition of SR Ca2+ uptake using thapsigargin is not possible in vivo due to unwanted 
systemic effects, the isolated working rabbit heart provides a useful model for examining 
the influence of specific pharmacological SERCA2 inhibition on cardiac function. 
6.1.2.1 Thapsigargin:  Mechanism of action 
The reaction for Ca2+ uptake into the SR by SERCA has been described in detail in 
Chapter 1.  Briefly, in the ground state (E1) there are two high affinity Ca2+ transport sites 
exposed on the cytosolic side of the SR membrane.  2 Ca2+ ions bind to this site and in the 
presence of ATP the Ca2E1 complex is phosphorylated to Ca2E1-P, resulting in Ca2+ ion 
occlusion, meaning the Ca2+ is trapped within the complex and cannot be released to either 
the SR or the cytosol.  A conformational change occurs (E2 state) whereby the affinity of 
the phosphorylated ATPase for Ca2+ is decreased, causing Ca2+ to be released into the SR 
(Mintz & Guillain, 1997).  Sagara et al. (1992) reported that thapsigargin was able to 
inhibit two stages of the ATPase reaction, Ca2+ binding and de-phosphorylation of the 
enzyme (Sagara et al., 1992).  The rate of thapsigargin’s inhibitory effect on the ATPase 
was slowed in the presence of Ca2+ but markedly increased in the presence of the Ca2+ 
chelator EGTA.  Thapsigargin binds to the channel in its low Ca2+ affinity (E2) state, 
effectively creating a ‘dead-end’ complex where the pump can no longer be 
phosphorylated and continue cycling Ca2+ into the SR (Sagara et al., 1992).  Attempts to 
identify the binding location for thapsigargin have shown that the M3 segment is an 
essential requirement (Norregaard et al., 1994).  This was highlighted by Xu et al. (2004) 
using COS-1 cells expressing SERCA1 enzymes with specific mutations corresponding to 
the M3 (Phe-256), M5 (Ile-765) and M7 (Tyr-837) segments which resulted in a reduction 
in the inhibitory effect of thapsigargin as well as its binding affinity for SERCA (Xu et al., 
2004) 
6.1.2.2 Comparison of Thapsigargin with alternative pharmacological 
inhibitors of SERCA 
Along with thapsigargin, two other agents have been identified as potent and selective 
inhibitors of SERCA; Cyclopiazonic acid (CPA) (Goeger et al., 1988; Goeger & Riley, 
1989) and 2,5-Di(Tert-Butyl)-1,4-Benzohydroquinone (TBQ) (Nakamura et al., 1992).  
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Thapsigargin possesses the highest affinity for SERCA, with a reported Kd of < 2 pM 
(Davidson & Varhol, 1995) and near 1:1 stoichiometry with SERCA (Inesi et al., 2005; 
Sagara & Inesi, 1991).  CPA also exhibits a high degree of specificity and can inhibit 
SERCA in the submicromolar concentration range (Seidler et al., 1989).  Both CPA and 
TBQ inhibition is similar in character to that of thapsigargin albeit with less affinity, 
involving a stabilization of SERCA enzyme in the E2 state and formation of a dead end 
complex (Inesi et al., 2005). TBQ is a far less potent inhibitor of SERCA activity than 
thapsigargin, with half maximal inhibition occurring at 1.5 µM (Nakamura et al., 1992).  
Reported non-specific effects of TBQ, including inhibition of L-type Ca2+ channels 
(Nelson et al., 1994) and inwardly rectifying K+ channels (Hassessian et al., 1994) overlap 
significantly with its SERCA blocking actions.  Furthermore, higher concentrations (0.1 
mM) have been shown to inhibit the plasma membrane Ca2+ ATPase (Luo et al., 2000), 
making it difficult to class this compound as a truly selective inhibitor of SR Ca2+ uptake.  
CPA does not appear to exhibit non-specific effects at higher concentrations (Dettbarn & 
Palade, 1998) however its affinity for SERCA is several orders of magnitude lower than 
thapsigargin.  Thapsigargin therefore represents the most efficacious and selective of the 
three compounds and as such is the initial compound of choice for pharmacological 
inhibition of SERCA.          
6.1.3 Aims 
The study outlined in this chapter aims to investigate the functional consequences of acute 
pharmacological inhibition of SR Ca2+ uptake in the isolated working rabbit heart using the 
specific inhibitor thapsigargin, and ascertain to what degree contractile function is 
suppressed by this compound in an isolated working heart preparation.  It was 
hypothesized that inhibition of the SR Ca2+ ATPase in the isolated working heart with 
thapsigargin would result in a significant decline in LV contractility and cardiac output 
compared to vehicle controls. 
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6.2 Methods 
6.2.1 Isolated working heart setup 
Hearts from 10 male New Zealand White rabbits were excised and perfused initially in 
Langendorff mode on the isolated working heart apparatus as described in the General 
Methods chapter section 2.1.3.  After cannulation of the left atrium working heart mode 
was initiated and solution was recirculated to perfuse hearts from a fixed volume of 540 
ml.  Preload was set at 7.4 mmHg and afterload set to 60 mmHg.  These settings remained 
constant throughout the experimental protocol.  A pair of platinum subdermal needle 
electrodes connected to a constant voltage isolated stimulator and train/delay generator, 
were attached to the right atrial tissue and hearts were paced at 220 beats.min-1 throughout 
the protocol.   
6.2.2 Left ventricular function by pressure-volume catheterisation 
A 3F Scisense VSL catheter with a recording electrode segment of 19 mm was calibrated 
as described in the General Methods chapter (See sections 2.2.3 and 2.3.1) and positioned 
just distal to the aortic cannula.  After initiation of working heart perfusion the catheter was 
advanced slowly past the aortic valves into the left ventricle to obtain continuous recording 
of pressure and volume throughout the experimental protocol.     
6.2.3 Solutions 
Perfusion of the isolated working heart was performed using Tyrode’s solution, the 
composition of which is described in General Methods section 2.1.3.  A nominally Ca2+-
free Tyrode’s solution containing 50 µM EGTA was also prepared.  This solution was 
gassed and heated to 37ºC in a water bath before being transferred to a second water-
jacketed afterload reservoir attached to the isolated working heart system.  Thapsigargin 
(TG) was dissolved in 0.51 ml DMSO to yield a stock concentration of 3.0 mM.  When 
added to the perfusion reservoir this yielded a final TG concentration of 2.83 µM.  This 
concentration was chosen to ensure enough TG was available to reach all cells within the 
isolated working heart, but was low enough to avoid any non-specific effects reported with 
higher (+5 µM) concentrations of TG (Nelson et al., 1994).  DMSO was used as the 
vehicle in the control group.  Both solutions were prepared 30 min prior to commencing 
perfusion of the isolated heart and stored in light-shielded containers until required.  
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Homogenisation buffer containing a protease/phosphatase inhibitor cocktail was prepared 
according to the method of Ji et al. (1999) (Ji et al., 1999b).  The buffer solution was 
prepared in 10 mM imadazole, pH 7, and contained (in mM) 10 NaF, 1 Na3VO4, 2 NaPP, 2 
β – GP and 0.05 Calyculin A.     
6.2.4 Experimental Protocol 
6.2.4.1 Pre-experiment set up 
Hearts were split into 2 groups; hearts perfused with TG (n=5) and hearts perfused with 
vehicle (n=5).  Prior to commencing experiments a second, water-jacketed afterload 
chamber was attached to the working heart system and connected via a length of Tygon 
tubing to a side-port on the aortic cannula.  A 2-way tap at the end of this line separated 
solution from coming into contact with the rest of the working heart system.  The tubing 
line was primed with nominally Ca2+-free Tyrode’s containing 50 µM EGTA and the 
second afterload chamber (Afterload 2) was filled with this solution before being set at a 
perfusion pressure of 60 mmHg.  For control experiments an additional water-jacketed 
preload chamber (Preload 2) was attached to the atrial cannula via a side-port arm and 2-
way stopcock.  This chamber was filled with 250 ml of normal Tyrode’s solution 
containing 2.83 µM TG and set at a perfusion pressure of 7.4 mmHg.   
6.2.4.2 Working heart experiments 
Following initiation of working heart mode and assessment of parallel conductance with 
saline bolus injection, hearts in the TG group were allowed to stabilize before 0.51 ml of 
3.0 mM TG was added directly to the recirculation reservoir to yield a final TG 
concentration of 2.83 µM.  In vehicle control experiments, 0.51 ml DMSO was added to 
the recirculating reservoir, yielding a final recirculating DMSO of ~0.09 %.  Lights were 
turned off for the entire duration of working heart perfusion with TG or DMSO vehicle.  
Coronary flow values were obtained by timed measurements of coronary effluent every 5 
min, while LV function and aortic flow were continuously measured until forward flow 
(aortic flow) reached 0.  At this point the peristaltic pump was stopped, the atrial inflow 
line occluded and coronary perfusion switched from the working heart afterload chamber 
to Afterload 2, and hearts were perfused in Langendorff mode for 2 min with nominally 
Ca2+-free Tyrode’s solution containing 50 µM EGTA.  In control experiments, 0.51 ml of 
TG vehicle (DMSO) was added directly to the recirculating reservoir and hearts were 
perfused continuously in working heart mode for a period of 60 min.  After 60 min 
perfusion with the vehicle the atrial inflow line from the isolated working heart preload 
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chamber was occluded and Preload 2 was opened to perfuse hearts with Tyrode’s solution 
containing 2.83 µM TG for 30 s.  This ensured TG was present in homogenate samples 
from vehicle treated hearts and acted as a further measure of control for subsequent SR 
Ca2+ uptake assays.  Preload 2 perfusion was then stopped, and coronary perfusion was 
switched from the working heart afterload chamber to Afterload 2 as described above for 
the TG group.  Endpoint was defined as the time of aortic flow cessation in the TG group, 
while in the Vehicle control group endpoint was reached 60 min after addition of the 
vehicle.   
6.2.4.3 Preparation of tissue homogenates 
Following 2 min perfusion with nominally Ca2+ free 50 µM EGTA Tyrode’s solution in 
both groups, the PV catheter was removed from the left ventricular chamber and a section 
of left ventricular free wall weighing approximately 1.5 g was cut from the heart; excess 
fatty tissue was removed.  Tissue was weighed before being snap frozen in liquid nitrogen.  
Tissue was roughly chopped using a clean scalpel blade before being pulverized using a 
mortar and pestle.  Five-times volume of ice-cold homogenization buffer was gradually 
added during this time, and tissue was homogenized using an Ultraturrax T8 
(Labortechnik) until no solid pieces of tissue remained.  Samples remained on ice to limit 
protein degradation.  The final homogenate was aliquoted into labeled 1.5 ml Eppendorff 
tubes and stored at -80 ºC prior to subsequent biochemical analysis. 
 
Investigation of SR Ca2+ uptake by SERCA2a in tissue homogenate samples using oxalate 
facilitated Ca2+ uptake was performed by Dr Elspeth Elliott, University of Glasgow.        
6.2.5 Data recording and statistical analysis  
All working heart functional data were recorded on a Dell PC using LabChart software 
version 5.5.6 at a sampling rate of 1000 Hz, and analysed offline using LabChart’s Blood 
Pressure Module and LabScribe2.0 software.  All results were saved to an external hard 
drive. Two-sample Student’s t-test was used to compare values between groups on a 
number of functional parameters.  A P-value of < 0.05 was considered statistically 
significant. 
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6.3 Results 
Perfusion of isolated working hearts with 2.83 µM TG caused a decline in left ventricular 
function that eventually resulted in premature cessation of forward flow (assessed by aortic 
flow) in comparison to hearts receiving only the vehicle control.  The drug perfusion time 
in the TG group varied between 7 min and 67 min, with the mean time to cessation of 
aortic flow 31 ± 11 min.  As can be seen in Figure 6.1(i-iii), application of TG led to an 
initial steep decline in left ventricular function developing over the first 5 minutes of 
perfusion, followed by a steady state period leading to a gradual decline in function until 
cessation of aortic flow occurred.  Representative pressure-volume loops in Figure 6.1(iv) 
show the decline in stroke volume at three different timepoints after addition of TG, with 
the volume trace demonstrating a leftward shift as the time of TG perfusion increases.  
Mean values for systolic and diastolic functional parameters are also given in table 6.1. 
 
Vehicle (n=5) TG (n=5) Vehicle (n=5) TG (n=5) Vehicle (n=5) TG (n=5)
Parameter
PSP (mmHg) 106.87 ± 2.83 106.07 ± 1.86 106.20 ± 2.77 92.18 ± 1.39* 99.16 ± 3.78 78.77 ± 1.90*
EDP (mmHg) 9.72 ± 1.83 8.49 ± 1.60 9.97 ± 1.71 12.22 ± 1.24 11.91 ± 1.00 14.19 ± 1.23
dP/dtmax (mmHg.s
-1) 2136.62 ± 164.14 2001.54 ± 206.55 2056.79 ± 131.06 1377.24 ± 58.31* 1744.08 ± 140.28 1024.10 ± 14.35*
dP/dtmin (mmHg.s
-1) -2156.01 ± 182.18 -2255.47 ± 99.25 -2146.63 ± 150.74 -1596.81 ± 82.08* -1779.12 ± 89.64 -1242.45 ± 84.84*
Tau (ms) 21.40 ± 0.23 27.80 ± 0.32 21.40 ± 0.24 42.60 ± 0.69* 27.30 ± 0.42 74.70 ± 0.90*
SV (ml) 1.056 ± 0.089 1.173 ± 0.047 1.041 ± 0.079 0.824 ± 0.034 0.876 ± 0.091 0.392 ± 0.017*
AF (ml.min-1) 163.08 ± 18.03 180.47 ± 17.76 160.55 ± 15.92 103.06 ± 12.71* 124.57 ± 19.44 n/a
CF (ml.min-1) 72.80 ± 5.08 82.00 ± 1.74 72.00 ± 5.22 83.20 ± 2.58 71.20 ± 5.57 81.20 ± 1.74
Table 6.1 Thapsigargin treatment:  Left Ventricular Systolic and Diastolic Functional Indices from Isolated Working Rabbit Hearts
Pre-addition Addition + 5 min Endpoint
 
Table 6.1 Left ventricular function following TG treatment.  Left ventricular functional indices in TG 
(2.83 µM) or DMSO (0.09 %) perfused working rabbit hearts.  Endpoint in TG group occurs when aortic 
flow = 0.  In vehicle control, endpoint occurs at 60 min post-addition.  PSP; peak systolic pressure, EDP; end 
diastolic pressure, SV; stroke volume, AF; aortic flow, CF; coronary flow.  * P < 0.05 TG vs. vehicle. 
6.3.1 Effect of TG on systolic functional parameters 
Figure 6.2 shows a number of contractile and relaxation parameters 5 min after TG/Vehicle 
addition and at the endpoint of the experiment, expressed as a percentage of baseline 
values (defined as 2 min before addition of TG/Vehicle).  The mean values are also 
displayed in table 6.1.  No significant change in peak pressure (Figure 6.2 (i)) was evident  
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Figure 6.1 Representative pressure, volume and aortic flow recordings (i-iii), and corresponding PV 
loops (iv), from an isolated working heart perfused with TG. 
 
in vehicle perfused hearts within the 60 min perfusion period.  In TG treated hearts 
however peak pressure fell to 86.96 ± 1.29 % of baseline values 5 min after addition (P < 
0.01).  At the time of aortic flow cessation peak pressure had fallen to 74.36 ± 2.28 % of 
baseline (P < 0.01).  60 min of perfusion with the vehicle control resulted in a significant 
drop in dP/dtmax to 81.57 ± 1.25 % of baseline values (P < 0.01), but there was no change 
present after 5 min.  However, dP/dtmax (Figure 6.2(ii)) was significantly depressed in the 
TG treated group at 5 min post addition (70.58 ± 4.53 % of baseline; P < 0.01) and this 
was even more pronounced at endpoint (53.44 ± 5.62 % of baseline).     
6.3.2 Effect of Thapsigargin on diastolic functional parameters 
TG also caused a significant increase in LVEDP (Figure 6.2(iii)) by endpoint (189.25 ± 
30.99 % of control; P < 0.05).  Perfusion of the vehicle control did not significantly alter 
LVEDP at either time point.  A significant decline in dP/dtmin was seen after 60 min  
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Figure 6.2 Ventricular function following TG treatment.  Pressure, contractility and relaxation indices in 
the isolated working rabbit heart 5 min after addition of TG (Grey bars, n=5) or vehicle (white bars, n=5) and 
at the endpoint of the protocol.  All values expressed as a % of baseline (mean + SEM), indicated by dashed 
line.  Significance tested using paired Student’s t-test. 
 
vehicle perfusion (83.88 ± 5.47 % of baseline; P < 0.05) but not after 5 min.  In TG treated 
hearts dP/dtmin (Figure 6.2(iv)) was significantly depressed after 5 min, falling to 70.81 ± 
2.01% of baseline (P < 0.001), and declining further still (55.84 ± 5.08 % of baseline; P < 
0.001) by the endpoint.  The relaxation constant τ (Figure 6.2(v)) was unchanged in vehicle 
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treated hearts but significantly prolonged vs. baseline following TG perfusion, increasing 
to 150.66 ± 13.37 % after 5 min (P < 0.05), and to 271.28 ± 25.88 % at the endpoint (P < 
0.01).   
6.3.3 Effect of Thapsigargin on left ventricular volume parameters 
Relative changes in volume in the isolated working heart following treatment with TG and 
vehicle are plotted in Figure 6.3.  While there was a significant fall in aortic flow (Figure 
6.3A(i))in the vehicle control at endpoint (76.15 ± 6.77 % of baseline; P < 0.05) no change 
was evident 5 min after addition.  Aortic flow in the TG treated hearts fell to 56.60 ± 1.51 
% of baseline 5 min after TG addition (P < 0.001) and, as described above was no longer 
measureable at the endpoint.    Neither the TG nor vehicle treatments influenced coronary 
flow (Figure 6.3A(ii)) suggesting that reduced perfusion did not play a role in the drop in 
performance seen in either group.  The relative end systolic and end diastolic volumes 
expressed as a % of baseline are plotted in Figure 6.3A(iii) and (iv) respectively.  While 60 
min of perfusion with the vehicle control resulted in a small but significant rise in EDV 
(105.59 ± 0.85 % of baseline; P < 0.01) and ESV (115.71 ± 3.91 % of baseline; P < 0.05), 
there was no change evident after 5 min.  EDV demonstrated a significant drop from 
baseline values in TG perfused hearts 5 min after TG addition.  At the time of aortic flow 
cessation EDV had fallen further, to 71.65 ± 2.08 % of baseline (P < 0.001).  Similarly 
ESV had fallen to 77.25 ± 2.10 % of baseline (P < 0.001) by the endpoint.  This tendency 
for EDV (and correspondingly ESV) to fall during TG perfusion suggests an impairment of 
ventricular filling.  As predicted from the fall in aortic flow, stroke volume (Figure 
6.3A(v)) was also significantly reduced 5 min after application of TG (to 70.21 ± 0.41 % 
of pre-addition values; P < 0.001) while no significant change was found in the vehicle 
control.  At endpoint, stroke volume in the TG group had fallen to 33.59 ± 2.28 % of pre-
addition values (P < 0.001).  Stroke volume was significantly reduced in the vehicle 
control group after 60 min (to 83.02 ± 4.66 %; P < 0.05) however this parameter was still 
significantly elevated in comparison to the TG group at endpoint [0.88 ± 0.09 ml (vehicle) 
vs. 0.39 ± 0.02 ml (TG); P < 0.01)].  
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Figure 6.3 Flow and relative volume measurements following application of TG.    A(i-v) Flow and 
volume indices in isolated working rabbit hearts 5 min after addition of TG (Grey bars, n=5) or vehicle 
(white bars, n=5) and at the endpoint of the protocol.  All values expressed as a % of baseline (mean + SEM), 
indicated by dashed line.  B.  Ejection fraction in the TG treated group only at pre-TG addition, 5 min after 
addition, and endpoint. 
 
 
Assessment of parallel conductance was successfully achieved in 3 of the 5 hearts treated 
with TG allowing conversion to absolute LV volumes in these hearts.  Typical pressure, 
volume, and aortic flow recordings from an isolated working heart exposed to TG are 
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shown in Figure 6.1, along with PV loops at the corresponding stages of the protocol.  
Application of TG led to a decline in both end diastolic and end systolic volume in the 
isolated working hearts, resulting in a leftward shift in the pressure volume loops relative 
to steady state (Figure 6.1 (iv)).  As a result, stroke volume gradually fell as left ventricular 
function declined (shown in Figure 6.3A(v)) but ejection fraction (Figure 6.3B) was not 
significantly altered after 5 min TG perfusion [54.79 ± 8.79 % (pre-addition) vs. 48.04 ± 
10.52 % (+ 5 min); P > 0.05], and similarly was not significantly altered from baseline 
immediately prior to cessation of aortic flow [54.79 ± 8.79 % (pre-addition) vs. 63.15 ± 
10.31 % (+ 5 min); P > 0.05].  These results suggest application of TG causes a significant 
impairment of left ventricular diastolic filling with relatively preserved ejection fraction. 
6.4 Discussion 
6.4.1 Acute inhibition of SERCA2a in the isolated working heart 
leads to left ventricular dysfunction and premature 
cessation of aortic flow 
Thapsigargin is a naturally occurring plant alkaloid that has been shown to selectively 
inhibit the SERCA family of Ca2+ pumps with a high potency (Kirby et al., 1992; Sagara & 
Inesi, 1991).  In the current study, thapsigargin was applied to an isolated working heart 
model to assess the functional consequences of SERCA2a inhibition.  It was found that 
2.83 µM TG was sufficient to cause a decline in contractility and relaxation parameters in 
the isolated working heart, eventually resulting in premature cessation of aortic flow in 
comparison to vehicle controls.  Based on the high potency and specificity of thapsigargin 
for SERCA these effects are almost certainly the result of inhibition of SR Ca2+ uptake and 
a depletion of the SR Ca2+ stores.  Thapsigargin did not alter coronary flow at any stage of 
the protocol suggesting tissue perfusion was not impaired.  Perfusion with thapsigargin 
resulted in a profound depression of left ventricular relaxation, as evidenced by elevated 
LVEDP, a reduction in dP/dtmin and significant prolongation of the relaxation constant τ 
indicating prolonged relaxation (see Figure 6.2 and table 6.1).  Another notable finding 
was the observed fall in left ventricular end diastolic and end systolic volumes, as 
represented by the PV loops shown in Figure 6.1(iv), indicative of impaired diastolic left 
ventricular filling.  Reduction in the rate of SR Ca2+ uptake has been implicated in 
impaired relaxation and diastolic dysfunction in heart failure (Kass et al., 2004).  In 
addition, genetic upregulation of SERCA2a expression or ablation of PLB has been 
demonstrated to result in enhanced SR Ca2+ uptake and improved left ventricular function 
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(Hoshijima et al., 2002; Miyamoto et al., 2000; Muller et al., 2003).  In the current study 
SR Ca2+ uptake in an isolated working heart was specifically and acutely inhibited, 
resulting in impairment of relaxation and the appearance of diastolic abnormalities.  These 
findings support the notion that SR Ca2+ uptake by SERCA2a plays a significant regulatory 
role in normal left ventricular relaxation. 
6.4.2 To what degree is SERCA inhibited when cardiac function 
fails? 
In order to characterise the functional role of SERCA2a in the present study it was 
necessary to study the degree of SERCA inhibition in the isolated working heart at the time 
of aortic flow cessation.  Elliott et al. (2009) assessed Ca2+ uptake in left ventricular tissue 
homogenates prepared from hearts perfused with TG and vehicle controls in the current 
study, using oxalate facilitated Ca2+-uptake (Elliott et al., 2009).  The investigators 
reported that a significant level of Ca2+ uptake was detectable in all samples from vehicle 
control hearts, but that no detectable levels of Ca2+ uptake were apparent from TG treated 
samples.  This was true even when protein sample size was 6 times higher than control, 
indicating that at the time of aortic flow cessation in isolated working hearts SERCA2a 
activity had been negligible.  These findings suggest that while SERCA2a is important in 
regulating cardiac function, with a particularly important role in relaxation, the function of 
this protein may be reduced to insignificant levels (<10 %) before the heart can no longer 
sustain working function.  This observation is in agreement with the results of Andersson 
et al. (2009) who demonstrated that in the complete absence of SERCA2 protein, cardiac 
function is depressed but overt signs of cardiac failure are absent, at least within the first 
several weeks after SERCA downregulation (Andersson et al., 2009).  Important 
limitations exist in this model with regards to quantifying the specific role of SERCA2a to 
cardiac function.  The inducible knockout, while currently the most acute method of 
SERCA protein ablation available in vivo, is associated with upregulation of other Ca2+ 
handling proteins such as NCX and the L-type Ca2+ channel which may be sufficient to 
compensate for the loss of SR function.  Blockade of SERCA2a with TG in the current 
study is unlikely to be over a sufficient timescale as to be associated with alterations in 
Ca2+ handling protein expression and may therefore prove a more effective model to study 
the specific role of SERCA2a in regulating cardiac function.     
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6.4.3 Thapsigargin as a selective inhibitor of SERCA 
In order to investigate the role of SR Ca2+ uptake to cardiac function using a 
pharmacological agent it was essential to use a specific inhibitor of SERCA so as to 
minimise potential for secondary effects to complicate the result.  The plant-derived 
compound thapsigargin (TG) has been demonstrated to possess potent and highly selective 
inhibitory action on the known isoforms of SERCA.  Thastrup et al. (1990) demonstrated 
inhibition of Ca2+-ATPase activity in rat liver microsomes, an effect attributable to 
blockade of Ca2+ uptake into the Endoplasmic reticulum (Thastrup et al., 1990).  The high 
specificity of this compound was reported by Kirby et al. (1992) who found that 
application of TG to intact rat ventricular myocytes resulted in a marked reduction in 
[Ca2+]i transient amplitude, a decline in twitch shortening to 22.6 % of control and a 
greater than 2-fold increase in the [Ca2+]i transient rate decay constant after approximately 
5 min, attributable to a primary reduction in SR Ca2+ uptake (Kirby et al., 1992).  Oxalate 
facilitated Ca2+ uptake in permeabilised myocytes was inhibited by TG with half-maximal 
potency in the 10-20 nM range, underlining the high efficacy of this compound.  TG was 
also shown to have no direct influence on sarcolemmal membrane currents or ICa (Bassani 
et al., 1993; Kirby et al., 1992).  Bassani et al. (1993) reported on the rate of TG inhibition 
in isolated rabbit ventricular myocytes, demonstrating that exposure to 5 µM TG resulted 
in complete inhibition of the caffeine-induced [Ca2+]i transient within 90 s.  TG has been 
used to investigate the SR Ca2+ uptake rates in rat and rabbit ventricular myocytes, as well 
as the SERCA pump density (Bassani et al., 1994; Hove-Madsen & Bers, 1993).  
Furthermore, addition of >5 nmol TG per mg cell protein resulted in complete inhibition of 
Ca2+ uptake after 15 s (Hove-Madsen & Bers, 1993).  In the present study, control hearts 
were perfused with TG at the end of the 60 min in order to eliminate the possibility that TG 
binding to SERCA was still occurring in the homogenate preparations.  Uptake results 
from Elliott et al. (2009) confirmed that SERCA inhibition had not taken place after 
homogenisation of ventricular tissue as evidenced by the detection of significant levels of 
Ca2+ uptake from these preparations.    
 
Baudet et al. (1993) used TG and a second SERCA inhibitor (CPA) to assess the influence 
of SR Ca2+ uptake on twitch force development in multi-cellular muscle preparations 
(ventricular trabeculae and papillary muscle) (Baudet et al., 1993).  It was found that the 
SR Ca2+ content, indirectly assessed using rapid cooling contractures (RCCs) was only 
reduced by very high [TG] (500 µM) and was still incomplete, as a caffeine and ryanodine 
sensitive component still remained.  This is in apparent contrast to reports using intact 
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single cells where rapid application of 5 µM TG results in depletion of SR Ca2+ content in 
less than 2 min (Bassani et al., 1994).  Nevertheless, Elliott et al. (2009) reported that in 
tissue homogenates from isolated working rabbit hearts used in the current study, oxalate-
facilitated SR Ca2+ uptake levels were negligible when samples were taken at the time of 
aortic flow cessation, indicating an almost total inhibition of SERCA2a by TG in a whole 
heart preparation (Elliott et al., 2009).  The apparent discrepancy in these findings is not 
fully understood, however it is likely that differences in the preparations are responsible, 
something Baudet et al. (1993) cited as being the likely explanation for the discrepancy 
between results from single cell preparations and their multi-cellular preparation when 
exposed to similar protocols (Baudet et al., 1993).  It is possible that the more 
physiological perfusion conditions in the isolated working heart facilitate the entry of TG 
into the intracellular environment.  The differences in perfusate temperature (30ºC vs. 
37ºC) are unlikely to play a role as significant slowing of TG binding to SERCA is only 
demonstrable at relatively low temperature (15 ºC) and high pH (8.0) (Sagara et al., 1992).  
Khandoudi et al. (1998) using Langendorff-perfused rabbit hearts, found that 60 min 
perfusion with 1 µM TG was sufficient to elicit a decrease in peak isovolumetric pressure 
of ~43 %, an increase in diastolic pressure of  ~580 %, and a reduction in dP/dtmax by 
~50%, however a 45 min exposure to 500 µM TG was required to depress twitch force in 
isolated superfused trabeculae by 48 %, with rapid cooling contracture (as a measure of SR 
Ca2+ content) only reduced by 62 % (Baudet et al., 1993; Khandoudi et al., 1998).  In the 
current study, 2.83 µM TG was sufficient to reduce dP/dtmax to 51.58 % of pre-TG values 
at the time of aortic flow cessation. Differences between preparations therefore clearly play 
a role, and lower concentrations of TG in isolated coronary perfused hearts appear to be 
more effective in reducing contractility than in isolated superfused muscle strips, although 
the reasons for this are unclear and potentially require further investigation.  
6.4.4 Functional decline in DMSO treated hearts following 60 min 
of perfusion 
The data presented in General Methods demonstrated that the current isolated working 
heart setup was capable of maintaining stable contractile function for 60-90 min with less 
than a 10% decline in cardiac output by 60 min, in agreement with previously published 
data.  However, in the present investigation vehicle treated controls displayed a significant 
decline in dP/dtmax and dP/dtmin, and output (stroke volume/aortic flow) greater than 15%.  
There are a number of reasons why this may have occurred.  The current study employed a 
pacing rate of 220 beats.min-1 for all hearts throughout the protocol to eliminate the 
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occurrence of pacing breakthrough, while in the longevity experiments all hearts were 
paced at a lower rate of 200 beats.min-1.  The increased work rate in the current study may 
have therefore contributed to a quicker decline in mechanical function.  The presence of 
0.1 % DMSO in the perfusion solution for 60 min may also have influenced the longevity 
of the working heart preparation.  DMSO has been demonstrated in guinea pig skeletal 
muscle preparations to reduce developed stresses and contractility at concentrations as low 
as 0.007 % (Reid & Moody, 1994).  Effects of DMSO on myocardial tissue are species 
dependent; in dog and cat trabecule and papillary muscle preparations respectively, 
exposure to 0.5 % DMSO was enough to provoke a negative inotropic response, whereas 
in rabbit atrial muscle preparations DMSO has been shown to elicit a positive inotropic 
response at relatively low concentrations (<1 %) but induce negative inotropy at higher 
concentrations (>3 %) (Shlafer et al., 1974; Spilker, 1970).  It is unclear what the direct 
effects of prolonged exposure to 0.1 % DMSO has on ventricular contractile function in 
the isolated working rabbit heart.  This could have been investigated further by conducting 
a series of longevity experiments under identical loading and pacing conditions.      
6.4.5 Ongoing investigation of the role of SERCA2a in normal 
cardiac function 
The results of this study provide an initial framework for further investigation of the 
specific role SERCA2a plays in regulating left ventricular function.  The protocol used in 
the current study was successful in creating a model of acute SERCA2a inhibition in the 
intact rabbit heart where left ventricular function could be monitored throughout.  While it 
was found that at the time of cessation of forward flow in the isolated working rabbit heart 
SERCA2a function was negligible (Elliott et al., 2009), it is not known at what stage this 
level of block was achieved.  Andersson et al. (2009) found that inducible SERCA2a 
knockout mice demonstrated depressed cardiac function but no overt signs of left 
ventricular hypertrophy or cardiac failure up to four weeks after SERCA2a levels were 
undetectable in cardiac tissue (Andersson et al., 2009).  This may suggest that hearts can 
still function in the short term following complete loss of SERCA2a, with only a small 
depression of cardiac function.  Loss of SERCA2a in the above mouse model was also 
associated with compensatory changes in the expression and function of a number of Ca2+ 
handling components, including the L-type Ca2+ channel, NCX and the plasma membrane 
Ca2+-ATPase (PMCA).  The acute nature of SERCA2a inhibition in the current study 
means that compensatory over-expression of intracellular Ca2+ handling components 
would not be likely to be involved.  To better quantify how SERCA2a inhibition alters 
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regular cardiac function future work using this protocol will also focus on inducing 
intermediate levels of SERCA2a blockade in the isolated working heart, in order to 
establish a relationship between the degree of contractile dysfunction and the level of 
SERCA2a inhibition.  This may be accomplished by varying the concentration of TG used 
to induce blockade and obtaining tissue samples at a set time following addition, or 
perhaps taking tissue samples at different time points after addition of the same TG 
concentration.  Alternatively, it may be possible to use the degree of reduction in a specific 
parameter of contractility (for example dP/dtmax) to specify the endpoint of an experiment.  
6.5 Summary 
Blockade of SR Ca2+ uptake in the isolated working rabbit heart using the selective 
SERCA inhibitor thapsigargin led to a decline in left ventricular contractile and relaxation 
parameters, with hearts demonstrating signs of systolic and diastolic dysfunction, 
supporting the notion that SR Ca2+ uptake plays a prominent role in ventricular relaxation.  
SERCA2a inhibition with thapsigargin eventually led to cessation of forward flow in the 
isolated working heart.  Subsequent analysis of tissue homogenates revealed that at the 
time of forward flow cessation SERCA2a activity was negligible (Elliott et al., 2009).  
These results are in agreement with a previous investigation of prolonged SERCA2a 
ablation in mice (Andersson et al., 2009).   
   
 
 
 
 
 
 
 
7 General Discussion 
 
       
 
 
 
 
 
   
The general aim of this thesis was to investigate the role of the sarcoplasmic reticulum in 
the mechanical function of an intact, whole heart preparation through pharmacological 
manipulation of SR Ca2+ handling proteins. 
…the initial aim of the work described in this thesis was to set up and characterise an 
isolated working heart preparation using rabbit hearts that would act as a platform for 
manipulation of SR function using various pharmacological approaches. 
To achieve this aim an appropriate whole heart preparation had to be established 
resembling as close to physiological mechanical function as possible.  The isolated 
working rabbit heart preparation was chosen for this purpose.  Non-working Langendorff 
perfused preparations permit the measurement of contractile function through use of 
balloon insertion into the left ventricle however such isovolumic contractions are less 
energetically demanding than in vivo ejecting beats and as such are less physiologically 
representative of heart function.  The isolated working rabbit heart performs external work 
similar to in vivo and therefore more closely represents physiological cardiac mechanical 
function.  Mechanical function was characterised using miniaturised pressure-conductance 
technology, regarded as the gold standard for assessment of ventricular function.  Use of 
this technique in conjunction with an ex vivo rabbit heart preparation has not been 
previously reported and commercially available catheter systems from two companies, 
Millar and Scisense, were examined to ascertain suitability.  Perfusion of isolated working 
hearts with a modified Tyrode’s solution caused saturation of the conductance (and hence 
volume) signal of the Millar system.  The Scisense technology however permitted 
adjustment of volume signal gain and offset, allowing measurement of relative left 
ventricular volume changes in an isolated working rabbit heart preparation.  Calibration of 
the relative volume changes to obtain a true volume signal was achieved by calculating 
parallel conductance through injection of a bolus of 20% saline into the left atrial inflow 
line, and through calculation of the calibration factor α, which was possible by measuring 
true cardiac output of the working heart with an ultrasonic flow meter (aortic flow) and 
timed measurement of coronary effluent (coronary flow).  The isolated working rabbit 
heart preparation was capable of sustaining steady state contractile function under baseline 
loading conditions (left atrial filling pressure = 7.4 mmHg, afterload = 60 mmHg) for 60-
90 min with less than 10% decline in cardiac output, in agreement with previously 
published data.  Pharmacological agents were added to the perfusion fluid reservoir and 
reached the working heart within 15s.  A sampling rate of 1 kHz was sufficient to 
instantaneously monitor acute changes in left ventricular pressure and volume in the 
isolated working heart throughout the experimental period. 
   
 
…the second aim was to characterise working heart mechanical function following 
exposure to varying concentrations of K201. 
 
The actions of the 1,4-benzothiazepine compound K201 on intracellular Ca2+-handling 
components of the cardiac myocyte, especially the SR Ca2+ release channel RyR2, have 
been studied extensively using intact and permeabilised ventricular myocytes, as well SR 
vesicle preparations.  The impact on left ventricular mechanical function of the isolated 
ejecting heart is unknown and was investigated using the current model.  1.0 µM and 3.0 
µM led to a significant decline in ventricular contractility and relaxation when normalised 
to controls.  In the case of 3.0 µM the negative inotropic response was so potent that 
working heart function was unsustainable in several preparations after 2 min.  While a 
significant negative chronotropic effect was noted using 1.0 and 3.0 µM, paced control 
hearts confirmed that the direct actions of K201 itself on cardiac function and not changes 
in heart rate, were responsible for the negative inotropic effects of the compound.  These 
findings highlight the need to establish a therapeutic window for K201.  A large number of 
studies indicate 1.0 µM as an optimum concentration for reduction of RyR2 Po, however 
this concentration exhibits a negative inotropic effect in normally functioning isolated 
working hearts and initially this would appear to counter-indicate the use of 1.0 µM for 
therapeutic strategies utilising K201. 
 
The study then aimed to investigate the influence of acute perfusion of K201 under 
conditions where SR Ca2+ release is thought to be altered; 1) using elevated [Ca2+]o and 
β-adrenergic stimulation, known to cause Ca2+ overload in intact ventricular myocyte 
preparations and 2) in a rabbit ligation model of left ventricular dysfunction.  
Under conditions which have been shown to cause Ca2+ overload and diastolic SR Ca2+ 
release in intact field-stimulated ventricular myocyte preparations (perfusion with 4.5 mM 
[Ca2+]o and 150 nM isoproterenol), isolated working rabbit hearts exhibited a transient 
increase in mechanical function following the first 20s of isoproterenol perfusion.  
Following this transient phase working hearts demonstrated a decline in contractile 
function concomitant with a marked increase in interbeat interval variability, resulting in 
loss of working heart function within the first 600s of isoproterenol perfusion in 6 of 11 
hearts.  Despite exhibiting clear negative inotropic effects when applied on its own, 
application of 1.0 µM K201 shortly after isoproterenol perfusion led to a preservation of 
contractility and relaxation in the isolated working heart.  Furthermore, interbeat interval 
variability was significantly lower in K201-treated hearts at 600s post-ISO compared with 
non-treated hearts.  These results have obvious implications for conditions involving 
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elevated circulating catecholamines or in conditions where increased frequency of 
spontaneous diastolic SR Ca2+ release is thought to occur.  It is important to highlight 
however, that conditions which result in Ca2+ overload are also known to inhibit 
mitochondrial function and potentially result in loss of ATP production which could also 
account for the negative inotropic response reported in this study.  Previous investigations 
of ischaemia-reperfusion injury, in which mitochondrial Ca2+ overload is believed to play a 
prominent role, have suggested K201 mediates protection against IR-injury and contractile 
dysfunction by indirectly influencing mitochondrial KATP channels, although how this 
relates to the current study is unknown, and the direct effects of K201 on mitochondrial 
function warrant further investigation.    
Left ventricular dysfunction caused by chronic myocardial infarction is associated with a 
disruption of SR Ca2+ handling proteins, including a reduction in SERCA function and 
altered ryanodine receptor Ca2+ sensitivity leading to an increased rate of diastolic Ca2+ 
leak.  Isolated working hearts from rabbits that had undergone coronary artery ligation 
surgery 8 weeks previously demonstrated a reduction in some indices of mechanical 
function in comparison to sham operated controls, however diastolic stiffness remained 
similar between the two groups.  Use of a multisegmental pressure-volume catheter was 
successful in identifying changes in regional left ventricular mechanical function using 
discrete segmental volumes, demonstrating the potential usefulness of this approach for 
studying regional dysfunction in rabbit hearts.  Sham operated hearts exposed to 1.0 µM 
K201 exhibited a similar degree of negative inotropism as had been reported for normally 
functioning hearts in Chapter 3.  While it was hypothesised that K201 would exert a 
similar negative inotropic effect on hearts from the ligation animals, almost all functional 
indices remained at baseline levels.  Only dP/dtmax was significantly depressed in 
comparison to baseline function, and was not reduced to the same degree as in sham 
operated hearts.  This result highlights a dichotomy regarding the influence of K201 on 
mechanical function between healthy and infarcted hearts.  It is possible that inhibition of 
RyR2 in this model is beneficial to mechanical function by reducing RyR-mediated 
diastolic Ca2+ leak, however this is likely offset by inhibitory effects of K201 on SERCA.  
It is also possible that other targets of K201 other than SR Ca2+ handling proteins (e.g. 
NOS) are altered following myocardial infarction, and it is important that these offtarget 
actions are identified to investigate what contribution they make to K201’s effects on 
whole heart mechanical function.          
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The final set of aims was to assess the contribution of intact SR Ca2+ uptake to normal 
left ventricular contractility and relaxation by perfusion of isolated working hearts with 
the selective SERCA inhibitor thapsigargin to inhibit Ca2+ uptake into the SR. 
 
The consequences of acute inhibition of SR Ca2+ uptake on cardiac mechanical function 
were investigated for the first time using an isolated ejecting heart preparation.  
Thapsigargin treatment of led to a progressive decline in left ventricular contractility and 
relaxation, manifest as a leftward shift in the pressure-volume loop, indicative of impaired 
left ventricular filling.  This result emphasised the importance of intact SR Ca2+ uptake 
function for normal left ventricular relaxation.  Subsequent Ca2+ uptake experiments 
reported elsewhere revealed that tissue samples taken from hearts treated with TG in the 
current investigation did not possess a measureable degree of SERCA function, despite 
previous reports suggesting complete pharmacological SERCA blockade in multicellular 
preparations was technically difficult to achieve even using thapsigargin concentrations 
several orders of magnitude higher than those used in the current study.  Specific and 
inducible downregulation of cardiac SERCA2 has been recently demonstrated in a 
transgenic mouse model resulting in negligible levels of SERCA protein within 1 week and 
a reduced cardiac pump function but no overt signs of ventricular remodelling within 4 
weeks.  Compensatory upregulation of other intracellular Ca2+ handling proteins occurred 
in that model, but would be unlikely to play a role in acute pharmacological blockade 
performed in the isolated working heart.  These findings suggest that while SERCA 
function is critical for maintaining regular systolic and diastolic left ventricular function, 
functional levels of this protein, and presumably the contribution of the SR to normal 
contractile function in the isolated working rabbit heart, can be reduced to very low levels 
before cardiac pump function fails.  
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Final Conclusion 
From the results of this thesis it can be seen that the isolated working heart when paired 
with miniaturised pressure-conductance technology provides an excellent means of 
assessing cardiac mechanical function under a variety of different pharmacological and 
pathological conditions, which can extend to assessment of regional ventricular function 
using a rabbit heart model.  Specific manipulation of SR function using an isolated 
working heart model provides a better understanding of the critical role SR Ca2+ handling 
plays in mechanical function of the whole heart and may enhance the knowledge already 
gained from single-cell manipulation of SR proteins. 
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